Text

Calculation Nedc 05-031, Review of Alion Calculation ALION-CAL-NPPD-3236-001, Radiological Dose Analysis for a Fuel Handling Accident (FHA) at Cooper Nuclear Station.
	ML052780184
Person / Time
Site:	Cooper
Issue date:	09/29/2005
From:	Drasler J; ALION Science & Technology Corp
To:	; Office of Nuclear Reactor Regulation
References
	NLS2005075 NEDC 05-031, Rev 1
	Download: ML052780184 (180)
	v • d • e

NLS2005075 ENCLOSURE 1 NEDC 05-031, Rev. 1 Radiological Dose Analysis for a Fuel Handling Accident (FHA)

At Cooper Nuclear Station

ATTACHMENT 1 DESIGN CALCULATION COVER SHEET Page I of 6

Title:

Review of Alion Calculation ALION-CAL- Calculation Number: NEDC 05-031

-PPD-3236-001. Radiological Dose Analysis for a Fuel Handline Accident (FHA) at Cooper Nuclear Station CEDIEE Number: NIA System/Structure: HV, SGT. SC Setpoint Change/Part Eval Number: N/A Component: N/A Discipline: Mechanical Design Classification: [XI Essential; [ ] Non-Essential SQAP Requirements Met? [ ] Yes; pX] N/A Proprietary Information Included? f 1Yes; [Il No

Description:

PURPOSE:

This calculation incorporates by attachment Alion Science & Technology Calculation No. ALION-CAL-NPPD-3236-001, Rev.0, in accordance with CNS Engineering Procedure 3.4.7. The calculation determines the dose to a Control Room

'ccupantand to a person at the Exclusion Area Boundary (EAB) and the Low Population Zone (LPZ) at the Cooper I Nuclear Station site following a design basis Fuel Handling Accident (FHA). The analysis is performed using an NUternate Source Term (AST) in accordance with the guidance provided by the NRC in Regulatory Guide 1.183 (July

?000) and as authorized by 10 CFR 50.67. This calculation has been prepared as a Status 2 calculation for NRC review and will be as-built upon NRC approval.

Rev. 1 incorporates Rev. 1 of Alion's calculation, which was revised primarily to incorporate an additional Case 1 analysis to determine total Control Room dose assuming 168 hour0.00194 days 0.0467 hours 2.777778e-4 weeks 6.3924e-5 months fuel decay time before fuel movement and without CREFS operation.

RESULTS AND CONCLUSIONS:

rhe results are tabulated in Section 5 of Alion's calculation for each of the three (3) receptor locations: I

1. Control Room,

2. Low Population Zone (LPZ), and

3. Exclusion Area Boundary (EAB).

klI calculated doses were found to be below the stipulated limits. It is therefore concluded that the regulatory dose umits will not be exceeded following a postulated design basis FHA at Cooper Nuclear Station.

VTTACHMENTS:

1. Alion calculation ALION-CAL-NPPD-3236-001, Rev. 1 (including attachments thereto) I

2. GE Letters REK:99-152 and REK:99-211 (References 6.10 and 6.9 of Alion's calculation) a N/A I N/A Todd Stevens Prepared By/Date Reviewed By/Date IDVed BIDt AByrDate Status Codes

1. Active 4. Superseded or Deleted 7. PRA/PSA

2. Information Only 5. OD/OE Support Only

3. Pending 6. Maintenance Activity Support Only PROCEDURE 3.4.7 REVISION 26 PAGE 1 OF 31 l

I ATTACHMENT 2 DESIGN CALCULATION CROSS-REFERENCE INDEX3 I Page: 2 of 6 NEDC: 05-031 Rev. Number: 1 1 Nebraska Public Power District DESIGN CALCULATION CROSS-REFERENCE INDEX PENDING CHANGES DESIGN INPUTS REV. NO. TO DESIGN INPUTS efer to Attachment 1 listing, I

I PROCEDURE 3.4.7 l REVISION 26 l PAGE 2 OF 31 l 2

I ATTACHMENT 2 DESIGN CALCULATION CROSS-REFERENCE INDEX 3 I Page: 3 of 6 NEDC: 05-031 Rev. Number: 1 1 Nebraska Public Power District DESIGN CALCULATION CROSS-REFERENCE INDEX ITEM NO. AFFECTED DOCUMENTS REV. NUMBER N/A for a Status 2 calculation I

I I PROCEDURE 3.4.7 l REVISION 26 l PAGE 3 OF 31 l 3

ATTACHMENT 3 AFFECTED DOCUMENT SCREENING Page: 4 of 6 NEDC: 05-031 Rev. Number: 1 The purpose of this form is to assist the Preparer in screening new and revised design calculations to determine potential impacts to procedures and plant operations.lb SCREENING QUESTIONS YES NO UNCERTAIN

1. Does it involve the addition, deletion, or manipulation of [I] [X [II a component or components which could impact a system lineup and/or checklist for valves, power supplies (breakers), process control switches, HVAC dampers, or instruments?

2. Could it impact system operating parameters (e.g., [i mI II temperatures, flowrates, pressures, voltage, or fluid chemistry)?

3. Does it impact equipment operation or response such as II [XI II valve closure time?

4. Does it involve assumptions or necessitate changes to the [I[XI [I sequencing of operational steps?

5. Does it transfer an electrical load to a different circuit, or [ ][ X [II impact when electrical loads are added to or removed from the system during an event?

6. Does it influence fuse, breaker, or relay coordination? []I

7. Does it have the potential to affect the analyzed [II conditions of the environment for any part of the Reactor Building, Containment, or Control Room?

8. Does it affect TS/TS Bases, USAR, or other Licensing [I I[ II Basis documents?

9. Does it affect DCDs? 1]I M [I

10. Does it have the potential to affect procedures in any way not already mentioned (refer to review checklists in I] [I Procedure EDP-06)? If so, identify:

If all answers are NO, then additional review or assistance is not required.

If any answers are YES or UNCERTAIN, then the Preparer shall obtain assistance from the System Engineer and other departments, as appropriate, to determine impacts to procedures and plant operations. Affected documents shall be listed on Attachment 2.

PROCEDURE 3.4.7 REVISION 26 l PAGE 4 OF 31 l 4

ATTACHMENT 4 DESIGN CALCULATION SHEET Page: 5 of 6 NEDC: 05-031 Rev. Number: 1 Nebraska Public Power District DESIGN CALCULATIONS SHEET PURPOSE This calculation incorporates by attachment Alion Science & Technology Calculation No.

ALION-CAL-NPPD-3236-001, Rev. 0, in accordance with CNS Engineering Procedure 3.4.7. The calculation determines the dose to a Control Room operator and to a person at the Exclusion Area Boundary (EAB) and the Low Population Zone (LPZ) at the Cooper Nuclear Station site following a design basis Fuel Handling Accident (FHA). The analysis is performed using an Alternate Source Term (AST) in accordance with the guidance provided by the NRC in Regulatory Guide 1.183 (July 2000) and as authorized by 10 CFR 50.67. This calculation has been prepared as a Status 2 calculation for NRC review and will be as-built upon NRC approval.

Rev. 1 incorporates Rev. 1 of Alion's calculation, which was revised primarily to incorporate an additional Case 1 analysis to determine total Control Room dose assuming 168 hour0.00194 days 0.0467 hours 2.777778e-4 weeks 6.3924e-5 months fuel decay time before fuel movement and without CREFS operation. In addition, Rev. 1:

Added additional Assumption (9)

Added Bromine source term table (Table 3)

Added un-decayed activity source term table (Table 4)

Added Bromine evaluation per RG1.183 conformance Nuclear inventory modified to 29 isotopes to accommodate bromines Shine analysis modified to provide a qualitative estimate of dose.

Incorporated various typos and rewording EXTENT OF REVIEW Alion's calculation was performed under their own QA program, which included an independent technical review. Therefore, the NPPD review does not include in-depth checks of mathematical calculations, but rather focuses on general acceptability of design inputs, assumptions, methodology, and conclusions. Any significant comments or concerns identified during the review have been resolved with Alion and incorporated.

REVIEW

SUMMARY

Alion's calculation is organized into a single main portion along with Attachments A through H, which include the computer files as well as Alion's Design Review Checklist.

1. Purpose - The purpose of the calculation is as given above and as stated in Section 1 of Alion's calculation. This section was reviewed and found to be acceptable.

PROCEDURE 3.4.7 l REVISION 26 l PAGE 5 OF 31 l 5

ATTACHMENT 4 DESIGN CALCULATION SHEET Page: 6 of 6 NEDC: 05-031 Rev. Number: 1

2. Design Inputs - Design Inputs are contained in the Cross Reference Index given on page 4 of Alion's calculation and are discussed in Section 2 of Alion's calculation. The design inputs were reviewed and found to be acceptable. Non-status 1 inputs were verified using additional information and were found to be acceptable for use in this calculation.

Although Alion identified some documents as having been affected in the Cross Reference Index, it is noted that this calculation is Status 2, awaiting review by the NRC. The affected documents will be identified when the NRC has completed its review, the calculation changes to Status 1, and an implementing document is completed. Until that occurs, there are no affected documents.

3. Assumptions - Major assumptions are identified in Section 3 of Alion's calculation.

Additional assumptions are inferred in the input documents used and identified throughout Alion's calculation by inference according to context and use. The assumptions were reviewed and found to be acceptable.

4. Methodology - The methodology is described in Section 4 of Alion's calculation. The methodology was reviewed and found to be acceptable.

5. Results / Conclusions - Results and conclusions are given in Section 5 of Alion's calculation. The results and conclusions were reviewed and found to be acceptable.

All calculated doses are below the corresponding regulatory limits.

6. References - References are listed in Section 6 of Alion's calculation. The references were reviewed and found to be acceptable.

7. Attachments

1. Alion calculation ALION-CAL-NPPD-3236-001, Rev. 1 (including attachments thereto)

2. GE Letters REK:99-152 and REK:99-211 (References 6.10 and 6.9 of Alion's calculation)

PROCEDURE 3.4.7 REVISION 26 l PAGE 6 OF 31 l 6

PAGE 02 JANBOSTELMAt PAGE 01 l9/2E/2005 151:05 4025453981 AL fNU Ii:

4U0J2O f4iA.3 JmLPN ELI4AI PA e2./~1 09/26/200S 11:51 4025453581 17CEMCAL D( CUMENT.CO'VER A LI O IClt*g AND 'ftCNOLOQf N SI EET jw- N-n NM ]v MO (NM)

PyloJctNam AST 1odceoVImp dn ito ONS VoKUMzt ftluOWUn12ry IU ~mm- oftgz cvtt1ic it to dsttid the &Ost Ovc beds Arco By(WKW '~~it )f*M widbie Lw Ppap"~On zone (I) atufmco N ~ Ral a~afIw £d~~s!

tke duze :oio'~by XNRI2 Regisocy (u~d 183 (Iit 3M t" fotl 10Cf lP^.S.I All caI==at*osuz ae win to be below tb T*FsIt* WUmlafrm! splt V~~

PerNMPPD Gwl Sf ~ca>Azruri~t~ i75440 T>4 479J~O, Ae'60 , My 15, 3OO. d fitw=of e cakuatim meen l tfqwMM f0%mad PUM I &SfruI1 lPiDCNS CfhO NPPD proedrwe do$, sRUhdyfiM 4U pwAsr4dP 3. Dox C tudaii vdAxndf. rion S.

thnonato,amreimikr AlS? rkt IA*1d and AX de5 NY O0JiM~g qfAa CdadaftxVJ a e Jph4k nrf .insrobu tmdmeur t~ ~Z~*reat ofqeA*tV*A Fa Q>uMtCp~m IS Ubi Ga~cIl91O2lis gtajdaid with tbm A~kw uia w2pqpm A~-f All soft-Amused in thy s-z~*It Of*is Gask" WSS onf so in acosodzne wet QAP 3.5, U7fk~ Wrft~WawerfldEbdErti?1&2I5ev1 w eia NEDC-9.22 L Rev /L-Att 1 page / ofL ° 1I

Radiological Dose Analysis for a Fuel Handling Accident (FHA) at Cooper A L IO N SCIENCt AND T9cNNDoL*G Nuclear Station Document No: Revision: Date:

ALION-CAIUNPPD-3236-001 Ii 23-September-05 P. 2 of 168 REVISION HISTORY LOG CA .lANDtIHON Form 6.1.3 Revision: 0 Effective Date: Page 1 of 1

-T 01 6/28/05 Instructions:

Project Manager to provide a brief description of each document revision, including rationale for the change and, if applicable, identification of source documents used for the change.

Revision Description 0 Original Issue

Calculation revised to incorporate additional Case I analysis to determine total Control Room dose assuming 168 hour0.00194 days 0.0467 hours 2.777778e-4 weeks 6.3924e-5 months fuel decay time before fuel movement and without CREFS operation.

Added additional Assumption (9)

Added Bromine source term table (Table 3)

Added un-decayed activity source term table (Table 4)

Added Bromine evaluation per RGI.183 conformance

Nuclear inventory modified to 29 isotopes to accommodate bromines

Shine analysis modified to provide a qualitative estimate of dose.

Incorporated various typos and rewording NEDC O.5)/ RevJ./.

Att I page-.A--ot70f°

9) Radiological Dose Analysis for a Fuel Handling Accident (FHA) at Cooper A L IO N

$02WcT AND FC"01.0tv Nuclear Station Document No: Revision: Date:

ALION-CAL-NPPD-3236-001 I 23-September-05 Pg. 3 of 168 TABLE OF CONTENTS DESIGN CALCULATION CROSS-REFERENCE INDEX 4 ACRONYMS AND UNITS 6 1 PURPOSE ...................................................... 7 2 DESIGN INPUT DEVELOPMENT ..................................................... 8 2.1 Postulated Accident ........................................................... 8 2.2 Source Term ........................................................... 9 2.3 Release Rate from Secondary Containment .......................................................... 10 2.4 Control Room Parameters .......................................................... I1 2.5 Atmospheric Dispersion (X/Q) Factors .......................................................... 13 2.6 Additional Design Inputs .......................................................... 14 3 ASSUMPTIONS ..................................................... 15 4 ANALYSIS METHODOLOGY/CALCULATION . ................................................

17 4.1 Fuel Handling Accident Scenario .......................................................... 17 4.2 RADTRAD Computer Model .......................................................... 18 4.3 RADTRAD FILES .......................................................... 19 5 RESULTS AND CONCLUSIONS ............................................ 23 5.1 Base Case Results .......................................................... 23 5.2 Case I - 168 Hour Fuel Decay Time with CREFS not Operating ......................................... 23 5.3 External Airborne Shine Dose and CREFS Shine Dose to the Control Room .................. 24 6 REERENCES ..................................................... 28 7 ATTACHMENTS ..................................................... 30 NEDCo V03Rev /L At-L..pageJ ofL70v

NEDCO' ev...ZZ Page:_4 _ of_1 68 SE0tWca Ago TockdSotoo Att /page....+/-'of-LZ7 Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I DESIGN CALCULATION CROSS-REFERENCE INDEX ITEM PENDING CHANGES NO. DESIGN INPUTS REV. NO. TO DESIGN INPUTS I NEDC 99-031 5 N/A 2 NEDC 99-036 3 N/A 3 Burns and Roe Dwg 2019, sheet I N39 N/A Burns and Roe Dwg 2051, N20 DCN 04-0913 5 Burns and Roe Dwg 2052 N22 DCN 04-0916, DCN 98-1043 6 TS 1.1 Adm. 178 N/A 7 TS 3.7.4 Adrn. 178 N/A 8 TS 3.9.6 Adm. 178 N/A TS 5.5.7 Adm. 195 N/A 10 NPPD Response letter, NLS990117 12/2/1999 N/A II_ USAR XIV-6.4 04/06/05 N/A 12 NCS CR Inleakage Final Report 8/20/2004 N/A 13 Burns and Roe Calculation - Book 4, Retrieval No. 4/16/69 N/A 00103-0487 14 GE NEDC-32868P Rev.0, 1998 N/A 15 NUREG/CR-6331 Rev.1,1997 N/A 16 NUREG/CR-6604 Dec. 1997 N/A 17 NUREG-1465 Feb. 1995 N/A 18 Reg Guide 1.183 July 2000 N/A 19 USAECTID-14844 1962 N/A 20 Industrial Ventilation: Engineering Principles 1/1991 N/A 21 GE Letter REK:99-152 9/1/99 N/A 22 GE Letter REK:99-211 11/9/99 N/A 23 GE Letter GE-MIG-lH69L-062 2/29/2000 N/A 24 Federal Guidance Report 11 (FGR 11) 1988 N/A 25 Federal Guidance Report 12 (FGR 12) 1993 N/A 26 UCR 2002-019, Item 59 5/28/2002 N/A 27 General Operating Procedure 2.1.20.1 Rev. 12 N/A 28 The Health Physics and Radiological Health Mysies N/A N/A Handbook, Exposure and Shielding from External I Radiation, pages 188-193 ___ _ _

29 NEDC 01-065, Revision 1 5/1912004 N/A 30 NEDC 94-072, Revision 2 12/02/1996 N/A 31 NEDC 94-070, Revision 2 12/02/1996 N/A

Page:_5 _ of_168 A L I0 N 09PISC9 AWS TtC.40kQ4?

NED CAL -9°T/Rev Z/ Caic. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I Aft-/--page go'ofL/7°'

DESIGN CALCULATION CROSS-REFERENCE INDEX ITEM NO. AFFECTED DOCUMENTS REV. NUMBER Cooper Nuclear Station Updated Safety Analysis Report (USAR) Various Sections F

.I

___________ ~~~ ~~I I

NEOCR09-JfRev./ Page: 6 _ of_168 SCISOCSL^A*I ON A Calc. No.: ALION-CAL-NPPD-3236-001 TM.b01061 Att / page 41 od-7° Rev. Number: 1 Acronyms and Units Acronym Definition ALARA As Low as is Reasonably Achievable AST Alternate Source Term BWR Boiling Water Reactor CEDE Committed Effective Dose Equivalent CREFS Control Room Emergency Filtration System DBA Design Basis Accident DCF Dose Conversion Factor DDE Deep Dose Equivalent EAB Exclusion Area Boundary ESF Engineered Safety Features FHA Fuel Handling Accident FSAR Final Safety Analysis Report GUI Graphical User's Interface REM Roentgen Equivalent Man RP Regulatory Position RPF Radial Peaking Factor RADTRAD A Simplified Model for RADionuclide Transport and Removal And Dose Estimation SFP Spent Fuel Pool SGTS Standby Gas Treatment System TEDE Total Effective Dose Equivalent USAR Updated Safety Analysis Report V&V Verification and Validation Variable Definition and Units of Measure A Fission Product Activity (Ci/Mwt)

C Dilution Concentration (dimensionless) t Time (seconds)

Q Flow (ft 3 /Mnin.)

V Volume (ft 3 )

X/Q Atmospheric Dispersion Factor (sec/m3 )

IDNED CA i- -PRev -~ Page:_7 of_-168 AL I N Att I A.I.C9 page-7-of /?o0 G Calc. No.:

ALION-CAL-NPPD-3236-001 Rev. Number: I I PURPOSE The purpose of this calculation is to determine the dose to the control room occupant and to a person at the Exclusion Area Boundary (EAB) and the Low Population Zone (LPZ) at the Cooper Nuclear Station site following a design basis Fuel Handling Accident (FHA). The analysis is performed using an Alternate Source Term (AST) in accordance with the guidance provided by the NRC in Regulatory Guide 1.183 (July 2000) (Ref. 1) and as allowed by 10 CFR 50.67. The RADTRAD Version 3.03 (Ref. 2) computer code (currently used by the USNRC in performing radiological consequences assessments) is used to estimate the dose values at the above mentioned locations.

This analysis will be used by CNS in support of a License Amendment Request (LAR) for the implementation of various sections of Technical Specification Task Force (TSTF)

Standard Technical Specifications Change Traveler TSTF-5 1.

5 NEDC --o/Rev / Page: 8_of_168 L I0 N AtL / pageo E. of -7 9 Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I 2 DESIGN INPUT DEVELOPMENT 2.1 Postulated Accident FUEL HANDLING ACCIDENTS WITHIN THE REACTOR CAVITY The limiting postulated FHA event (accidents within the SFP were also considered) begins with the drop of a fuel assembly into the reactor core during refueling operations from a height of 32.95 feet (Ref. 3), which is the maximum height allowed by the fuel handling equipment. The resulting impact of the fuel assembly onto the top of the core will damage a number of fuel rods sufficiently to cause a release of radionuclides to the water pool above the core. Assuming primary containment remains open during refueling, it is assumed the radionuclides will be released to the refueling area and then to the environment over the following 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months period. The water pool above the core serves as a barrier to the release of a significant amount of the radionuclides. Release of the radionuclides to the environment may result in a dose to the control room occupants and to personnel located both within and beyond the site boundary.

The radionuclide source term generated during a fuel handling accident is based on the total number of fuel rods in the reactor core damaged as a result of the dropped fuel assembly (including attached rigging) on the irradiated fuel rods. General Electric provided CNS with a revised analysis for G14 fuel Compliance with Amendment 22 of NEDE-2401 1-P-A (GESTAR 11) regarding a refueling accident (Ref. 8). The analysis addresses the worst fuel drop using a comparison to validate the GE14 l0xl0 fuel. The activity released in a FHA for l0xl0 core is based on 151 rods assumed to have been damaged. Each bundle has an equivalent of 87.33 full length fuel rods. With a total of 548 fuel bundles in the core the fraction of the core damaged is calculated to be 151 damaged rods/(548x87.33)total rods = 0.003155.

FUEL HANDLING ACCIDENTS WITHIN THE SPENT FUEL POOL The CNS USAR (Ref. 3) specifically states the following, "Similarly, the most severe accident of the second variety is the dropping of a fuel assembly into the fuel pool, but this results in a smaller radioactivity release to the environs than that resulting from dropping a fuel assembly on the fuel in the reactor vessel during refueling."

With reference to the "second variety" meaning accidents that result in release directly to secondary containment or the environment. Therefore the limiting fuel handling accident and related accident source term is analyzed as occurring within the reactor core based on the amount of fuel rods damaged and their related activity level.

W o5-° 7 4ev /

NEDC Page: 9 of_168 A LI0 N SX1IMCS Aft T4CIDT~t AtL1Zpage.e.Yof L7 Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I 2.2 Source Term Since the publication of TID-1 4844 (Ref. 9), significant advances have been made in understanding the timing, magnitude, and chemical form of fission product releases from severe nuclear power plant accidents. In 1995, the NRC published NUREG-1465, "Accident Source Terms for Light-Water Nuclear Power Plants" (Ref. 10).

NUREG-1 465 used this research to provide estimates of the accident source term that were more physically based and that could be applied to the design of future light-water power reactors. NUREG-1465 presents a representative accident source term for a boiling-water reactor (BWR) and for a pressurized-water reactor (PWR). These source terms are characterized by the composition and magnitude of the radioactive material, the chemical and physical properties of the material, and the timing of the release to the containment. This analysis utilizes an accident specific nuclide inventory (Halogens, Noble Gases, and Alkali Metals for FHA) as matched to the CNS site inventory (Ref. 11) and as modified for gap release in accordance with Regulatory Guide 1.183, RP 3.2 Table 3 presented as Figure 1 below.

Table 311 Non-LOCA Fraction of Fission Product Inventory In Gap Group Fraction 1-131 0.08 Kr-85 0.10 Other Noble Gases 0.05 Other Halogens 0.05 Alkali Metals 0.12 The reafcons listed hee h been determuied to be acceptable for use with cutdy apprve LWR b edt wh a peak bump up to 62,000 MWDMMprided that the maximum liier heat geseation rife does not exceed 63kWA pea rod avage power for bNps exceedg 54 GWJMTU As 2n sedAmon gs release calculations peram using NRC-appoved methodologies may be considered on a case-by-cse basis. To be accepbk tee calculatous nnst use a projected poer history ftat will bound te limiting projected plant-speifc pore histoy for the specific fdM load For the BWR rod drop accdent and 1he PWR rod ejection accident, the gap *actions are asied to be 10% or iodines and noble gases.

Fiaure 1 All the gap activity in the damaged fuel rods is assumed to be instantaneously released to the pool per Regulatory Guide 1.183 Appendix B. Radionuclides considered include xenons, krytons, halogens, cesiums, and rubidiums. The chemical form of radioiodine released from the fuel to the pool is assumed to be 95% aerosol (cesium iodide, CsI), 4.85 percent elemental iodine, and 0.15 percent organic iodide.

The CsI released from the fuel is assumed to completely dissociate in the pool water.

Because of the low pH of the pool water, the iodine re-evolves as elemental iodine

NEDCa Rev0 P of 168 A

50IKIC L I0 N t

Aft--/-page/> C N. LICWgNPD3

-P _01LCaN D-_33-oO1 Rev. Number: 1 which is assumed to occur instantaneously. Regulatory Guide 1.183 Appendix B states if the depth of water above the damaged fuel is 23 feet or greater, as is the case at CNS (Ref. 3, 4, 5, and 6), the decontamination factors for the elemental and organic species are 500 and 1,respectively, giving an overall effective decontamination factor of 200 (i.e., 99.5% of the total iodine released is retained within the pool water). The difference in decontamination factors for elemental and organic iodine species results in the iodine above the water being composed of 57%

elemental and 43% organic species. Appendix B goes on to state the retention of noble gases in the pool water is considered negligible (i.e., decontamination factor of

1) which is assumed in this analysis.

The inventory of fission products in the fuel rods and available for release to the containment is based on the maximum full power operation of the core with an assumed core power equal to the current licensed rated thermal power of 2381 Mwt (Ref. 7). In addition, this value is multiplied by factor of 1.02 to account for maximum possible measurement uncertainty as required by Appendix K to 10 CFR 50 for nuclear reactor power operation. The core is assumed to have operated at this power level for an extended period of time such that fission product equilibrium is reached. For radionuclides which have not reached equilibrium the core inventory at time of shutdown is used. The source term used for this accident is based on General Electric's GE14 Amendment 22 for a bounding core inventory source term (References 8, 11, 12, and 13). The GE14 Amendment 22 source term was calculated using the isotope generation and depletion code ORIGEN2, incorporating the BWR extended burnup library BWRUE. In addition, a radial peaking factor of 2.0 is applied to the radionuclide inventory calculation to reflect the maximum possible value as provide by the fuel provider (GE).

2.3 Release Rate from Secondary Containment The approximate free volume of the refueling floor area is 7.95 x 105 3 based on Reference 14. The radioactive material that immediately escapes from the pool to the refueling floor area is then assumed to be released to the environment over a 2-hour period using the relationship for dilution with 100% makeup for an enclosed space (Ref. 15). For an enclosed containment the following equation can be applied:

C(t/C, = I - exp("") Equation I Where:

C(,) - Concentration of volume at time t (fraction 0-1.0, representing 0 to 100%)

C1, - Steady-State concentration at end of dilution period (fraction %,O- 1.0, representing 0 to 100%) Afi CAo6 Q - Constant flow rate of contaminate out of space (ft3 /min.)

V - Refueling floor (7.95E+05 ft3) t - time duration of dilution period (120 minutes)

) NEDCP -" /LRev_/- Page: 11 _ of_168 A LI0 N fiCltl":K AND ?INNtOOut Ant /L .pageiAt ofL.0 Caic. No.: ALiON-cAL-NPPD-3236-OOI Rev. Number: 1 As C(t) approaches steady state or complete dilution (assume a value of 99.9%)

C(t/C. approaches a value of I and the equation can be simplified to:

.999 = 1- [expo4')] or 0.001 =[exp(-Q~v)J Equation 2 Taking the natural log (In) of both sides gives:

ln(.001) = In [exp0-Qd)] or -6.9077 =-Qt/V Equation 3 Substituting all values and solving for Q (flow rate leaving the structure) yields:

Q = (6.9077 x 7.95 x 105)/120 = 4.576 x 104 (ft3 /min.)

This is the flow rate that will be used to simulate the rejection of the source term from the reactor building as a ground release to the outside environment within a 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months period.

2A Control Room Parameters The air intake rate to the control room, the control room HVAC system filter efficiency, and the control room volume are needed to determine the portion of radiological dose received within the control room area.

The total control room volume is made up of the control room proper and the cable spreading room area (Ref. 17 and 18). The volume of the control room is calculated below (rounded to the 3Yd significant figure), assuming 20% of the total volume is occupied by walls, floors, equipment, etc.

Control Room Volume drawing takeoff Width = 72' (Ref. 17)

Length = 80'-9" minus 13'-3" = 67.5' (Ref. 18)

Floor Elevation = 932'-6" (Ref. 18)

High point of roof slab = 949'-1.5" Cable Room west of column H7 Outside wall to H7 = 80'-9" - 13'-3" = 67.5' (Ref. 18)

N-S = 72' (Ref. 17)

Floor El = 918' (Ref. 17) column H7 to G H7 to G = 35' + 13'-3" = 48.25' (Ref. 18)

E-W =37'-3" (Ref. 17)

Floor El = 918' (Ref. 17)

) NEDC -3J RevL/- Page:_ 12 _ of_168 A LI 0 N At / pageLL- of...by; Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I Control Room proper Height = 949'- 1.5" - 932'-6" = 16.625' Volume = 72' x 67.5' x 16.625' = 80,800 ft3 Cable Room Height = 932'-6" -918' = 14.5' Volume = (72' x 67.5' x 14.5') + (37.25' x 48.25' x 14.5') = 96,530 ft3 Total Volume = 80,800 ft3 + 96,530 ft3 = 177,330 ft3 Assuming 20% of the volumes include walls, floors, and equipment, (Refer to Assumption 8) the net volumes equate to the following:

Control Room proper = 64,640 ft3 Control Center (CR Envelope) = 141,860 ft3 The air intake to the control room is modeled using two flow rates in order to represent the two distinct operating modes of normal fresh air intake prior to a high radiation isolation signal and operation in the Control Room Emergency Filtration (CREFs) lineup following isolation and pressurization.

Prior to isolation:

3235 normal ventilation system fresh air intake flow per reference (Ref. 19)

Unfiltered inleakage was set constant at a value of 400 CFM (see Section 3 Assumption 1). The 400 CFM CR inleakage is also greater than the actual CNS inleakage measured during tracer gas testing for the recirculation only mode of operation (64 CFM). This value includes the standard value of 10 CFM recognized by the industry for access/egress to the control room envelope.

Total air intake rate = 3,635 CFM After CREFS isolation:

900 +/- 10% CFM used 810 CFM CREFS design air intake flow per reference (Ref. 20 and 21) (lower value picked for conservative removal rate of radionuclides from control room space)

Unfiltered inleakage was set constant at a value of 400 CFM. The 400 CFM CR inleakage is also greater than the actual CNS inleakage measured during tracer gas testing for the recirculation only mode of operation (64 CFM). This value includes the standard value of 10 CFM recognized by the industry for access/egress to the control room envelope.

Total air intake rate = 1,210 CFM The control room emergency filtration system is currently specified as having 95%

efficiency (associates to a maximum methyl iodide penetration of 2.5% when tested

ANEL.pGeL.-L. Rev ~/

Page:_1 3 _ of_168 A L I ON Att /-page/3yW-7° Caic. No.: ALION-CAL-NPPD-3236-001 SCIgSOC A"@ TIVOO*k"T Rev. Number: I in accordance with Regulatory Guide 1.52, Revision 2) for all iodine species (Ref.

21). This efficiency is reduced by 1% to account for maximum bypass (Ref. 22). For this analysis in order to provide future analytical and operational margin a filter efficiency of 90% (using an appropriate penetration test criteria) for all iodine species will be assumed with a reduction of 1%for maximum bypass flow.

2.5 Atmospheric Dispersion (XIQ) Factors The XIQ values are taken from existing CNS calculations developed specifically for various Control Room Intake, Exclusion Area Boundary (EAB), and Low Population Zone (LPZ) receptor points for use in the development of the bounding Design Basis Accidents (DBA) Radiological Analysis. These receptor locations were previously determine to be the most limiting in determining compliance with the dose criteria established.

The control room intake x/Q values were taken from reference 23 for a release emanating from the Reactor Building. The reactor building vent release case was analyzed as a ground release for three release rates through the reactor building vent.

The lowest release flow which coincides with the highest X/Q values was chosen for the most conservative approach. The values were developed using the ARCON96 computer code (Ref 24) and are presented in Table 1 below.

I - 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months 2 - 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months I 8 - 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months I 1 - 4 days 4 - 30 days I 4.15E-3 3.24E-3 1.32E-3 9.01E-4 7.22E4 I Note: Units = seclm Table 1 The EAB and LPZ Atmospheric Dispersion X/Q values were taken from reference 25 for a ground release emanating from the Reactor Building. The X/Q values were developed from figures presented in Regulatory Guides 1.3 and 1.25 and corrected for building wake effects as appropriate. The values are presented in Table 2 below.

X/Q (sec/M 3)

EAB 0 - 0.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months 5.2E-4 (1) 0.5 - 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months (2) 5.2E-4 (1)

LPZ 0- 0.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months 2.9E-4 (1) 0.5 - 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months 2.9E-4 (1) 8 - 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months 7.3E-5 1 - 4 days 2.5E-5 4 - 30 days 5.2E-6 Table 2 Note: 1.Includes building wake considerations

2. Based on worst 2-hour period for the EAB which isthe 0 to 2-hour period for this event.

0 NEDCos-o/ RevJ.L. Page:_14_of_168 A LI0 N Aft LZ pageIV fotL2°' Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I 2.6 Additional Design Inputs The following inputs are used by the RADTRAD code in determining the TEDE for persons located at or beyond the boundary of the exclusion area which are consistent with the Regulatory Guide 1.183 RP 4.0 guidelines:

Dose calculations are based on the TEDE. The TEDE is determined as the sum of the committed effective dose equivalent (CEDE) from inhalation and the deep dose equivalent (DDE) from external exposure.

All doses are estimated by RADTRAD using the Federal Guidance Reports 11 and 12 (Ref. 26 and 27) (FGR 11 and 12) dose conversion factors (DCFs) for the following organs and pseudoorgans:

Gonads a Breast a Lungs

Red bone marrow

Bone surface

Thyroid

Skin

Effective dose equivalent

EAB and LPZ - For the first 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months , the breathing rate of persons is assumed to be 3.5 x E-4 m3/sec. From 8 to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months following the accident, the breathing rate is assumed to be 1.8 x E-4 m3/sec. After that and until the end of the accident, the rate is assumed to be 2.3 x E-4 m3/sec.

Control Room - The dose receptor for this analysis is the hypothetical maximum exposed individual who is present in the control room for 100% of the time during the first 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months after the event, 60% of the time between I and 4 days, and 40%

of the time from 4 days to 30 days. For the duration of the event, the breathing rate of this individual is assumed to be 3.5 x E-4 m3/sec.

The radiological acceptance criteria for the EAB, the outer boundary of the LPZ, and for the control room are in 10 CFR 50.67. These criteria are stated for evaluating reactor accidents of exceedingly low probability of occurrence and low risk of public exposure to radiation. For the FHA the EAB and LPZ dose criteria is presented in Table 6 of Regulatory Guide 1.183 and stated as 6.3 Rem TEDE for the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months accident duration. The acceptance criteria for the control room dose is stated by both 10 CFR50.67 (b) (2) (iii) and General Design Criteria 19 (GDC 19) from Appendix A to 10 CFR Part 50 as 5 Rem TEDE. Both the LPZ and control room dose criteria are based on a total period of 30 days.

NEDCa Rev I5 of_168 A LI 0 N WIN*CRAND TICK*ft"?

AtL/ page45s of.fL7- Calc. No.: ALIQN-CAL-NPPD-323O001 Rev. Number: 1 3 ASSUMPTIONS

1. A control room unfiltered inleakage value of 400 CFM was assumed for this analysis in order to provide future analytical and operational margin in lieu of the current tracer gas testing results (Ref. 16) measuring an inleakage value of 64 CFM with the CREF system in the pressurization mode in recirculation. This value includes the standard value of 10 CFM recognized by the industry for access/egress to the control room envelope.

2. The required time for isolation of the control room intake upon the start of the FHA is assumed to be 1 minute (60 seconds). This was selected as a conservative value in order to provide future analytical and operational margin in lieu of the current CNS CREF system having an auto-isolation time of 11 seconds upon receipt of a high radiation signal.

3. The control room emergency filtration system is currently specified as having a 95%

efficiency (associates to a maximum methyl iodide penetration of 2.5% when tested in accordance with Regulatory Guide 1.52, Revision 2) for all iodine species (Ref.

21). This efficiency is reduced by 1% to account for maximum bypass (Ref. 22). For this analysis in order to provide future analytical and operational margin a filter efficiency of 90% (using an appropriate penetration test criteria) for all iodine species will be assumed with a reduction of 1% for maximum bypass flow.

4. No credit is taken for reduction in the amount of radioactive material released from the reactor building as a result of operation of engineered safety feature (ESF) filter systems (i.e., SGTS).

5. The current source term decay time is 67 hours7.75463e-4 days 0.0186 hours 1.107804e-4 weeks 2.54935e-5 months . For this analysis (Base Case), a decay time of 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months was assumed, which represents the earliest expected start of refueling activities at CNS. Fuel which has had less than 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of decay time constitutes "recently irradiated fuel" for application of TSTF-5 1. A second analysis (Case 1) was performed assuming a decay time of 168 hours0.00194 days 0.0467 hours 2.777778e-4 weeks 6.3924e-5 months before fuel movement and not crediting the operation of CREFS.

6. No credit is taken for the use of personal protective equipment or prophylactic drugs.

7. The CNS Technical Specification Bases for AC Source -- Shutdown states that, having to assume a single failure and concurrent loss of all offsite power (LOOP) is not required when the unit is shutdown. Notwithstanding, it is determined a LOOP will not have an adverse impact on the radiological consequences of the Fuel Handling Accident. The basis for this is supported by the fact that a LOOP will cause the control circuit for the Group 6 PCIS signal to de-energize, resulting in Group 6 PCIS Control Room Emergency Filter System (CREFS) initiation (at T = 0 of the event). Therefore, the one-minute CREFS initiation time assumed in this analysis will bound diesel generator start time considerations associated with a LOOP which are determined to occur well within that time frame.

8. An occupied volume of 20% of the control room envelope was assumed based on review of applicable drawings and simple volumetric estimates.

lK 6 w~tlF4,

NEDCO-FO7/Ro Rev L.

Page:_l 6 _ of_168 A L I0 N Att / pageL.L of-L270 Calc. No.: ALION-CAL-NPPD-3236-001 SCIAMCC Am* TICRUDOO4T Rev. Number: I

9. No correction is made for depletion of the effluent plume by deposition on the ground I (Ref. 1, Regulatory Position 4.1.7)

O NEDC o -°/Rev/ Page:_17 _ of_168 AL I O N AXtLLpageL7_ofZ2°0 Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: 1 4 ANALYSIS METHODOLOGYICALCULATION A V&V version (developed by Alion Science & Technology, ITSCO) of the NRC computer code RADTRAD Version 3.03 was used to analyze a postulated Fuel Handling Accident (FHA) at the Cooper Nuclear Station. The radiological consequences of an accident in a nuclear power plant depend upon the quantity of the radioactive material that escapes to the environment and/or enters the plant's control room. RADTRAD is designed to calculate doses at offsite locations, such as the low population zone, and in the control room. The code has two default source terms to describe fission product release to the containment: those from TID-14844 (Ref. 9) and those from NUREG-1465 (Ref. 10). As the material is transported through the containment and other buildings, credit is given for several natural and engineered removal mechanisms. Containment sprays remove aerosols, elemental iodine, and organic iodine. The flow between buildings or rooms may be through HEPA filters or a suppression pool. Leakage to the environment may occur. Aerosols can deposit on surfaces within rooms and also in connecting paths. Models are provided within RADTRAD for these different removal mechanisms. Alternatively, the user may elect to input time-dependent values for a specific removal coefficient. After transporting the nuclides to different locations, RADTRAD calculates the dose at user-specified locations (i.e., EAB, LPZ, control room, etc.).

4.1 Fuel Handling Accident Scenario Currently by CNS procedure, fuel handling activities in the fuel pool and containment areas cannot be initiated until 67 hours7.75463e-4 days 0.0186 hours 1.107804e-4 weeks 2.54935e-5 months after reactor shut down (this analysis will assume a period of 24 hour2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months sP) as described in Section 3 Assumption 5). It is postulated that the accident results in the damage of 151 fuel rods thus releasing all of the fuel gap activity associated with those rods. As discussed in Section 2, the gap fractions utilized for Non-LOCA analyses follow the recommended values stated in Regulatory Guide 1.183 Table 3. A radial peaking factor of 2.0 is applied to the activity release based on recommendation by the CNS fuel vendor. The activity (consisting of noble gases, halogens, and alkali metals) is instantaneously released to the pool which has a minimum of 23 ft of water above the damaged fuel assembly.

The radioiodine release from the water is assumed to escape into the reactor building area and out through the reactor building vent over a two (2) hour period. The radioiodine released from the fuel gap is assumed to be 95% Csl, 4.85% elemental, and 0.15% organic.

Due to the nature of the water in the pool, the Csl is assumed to immediately disassociate, thus changing the chemical form of the iodine in the water to 99.85% elemental and 0. 15%

organic. Based on decontamination factors of 500 and I for the elemental and organic iodines, respectively the chemical form of the iodines above the pool is 57% elemental and 43% organic. Noble gas and unscrubbed iodines are assumed to rise to the water surface where they are mixed in the available air space. Per Regulatory Guide 1.183 it is assumed all of the alkali metals released from the gap are retained in the pool.

(1) note - fuel handling can occur at any time within the spent fuel pool, as long as the fuel has experienced a minimum of at least 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of decay time.

NEDC e~- /e-L ALON Page:_1 8 _ of_168 A I 0R NIRUO AntL-PageL-ff L 27 Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I The radiological activity associated with a FHA is collected within the reactor building (secondary containment). Since it is assumed there is no means of isolating the area release (no credit is taken for maintaining secondary containment boundary) all of the airborne activity is postulated to be exhausted out of the building within a period of 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months .

The worst case atmospheric dispersion factors (X/Q) assuming a ground release from the reactor building release point were used based on the guidance in Regulatory Guide 1.183 Appendix B, Section 4 considering the assumption of direct openings to the environment (i.e., railroad airlock, ground level doors, etc.).

4.2 RADTRAD Computer Model Figure 2 below represents a simplified representation of the radiological release and transport model used in the CNS FHA analysis. The model simulates an accident which has initially released within the containment. Radionuclides are then released to the environment (pathway 1). Once released to the environment radionuclides are diluted as a function of the atmospheric conditions (X/Q values), thus leaving a smaller fraction available for intake into adjacent buildings (i.e., control room) or site boundary defined locations. The radionuclides may enter the control room from either the Control Room Emergency Filtration System (CREFS) air intake (pathway 2) or indirectly as unfiltered inleakage (pathway 3).

Radionuclides mixed within the control room volume are then exhausted (pathway 4).

Environment t CP1 m EFilter Unit inIs R m CD = Compartment CD~~~~ 2 Pathway aha Figure 2 Radionuclide release and transport model

N NEDOO5-/Rev Page: 19 _of_168 ALI0 N Att / pageLof Cabc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: 1 4.3 RADTRAD FILES RADTRAD 3.03 requires the use/development of four individual input files in order to perform a radiological dose analysis. These files include; the plant specific compartment/pathway model file (PSF), the nuclide inventory file (NIF), the release fraction and timing file (RFT), and the dose conversion factor file (INP).

PlantSpecific File (PSI)

This file was created using the RADTRAD Graphical User's Interface (GUI) and defines all the plant specific parameters required to perform the analysis including specifying all compartments and pathways as detailed in Figure 2 above. The pathways for the FHA model were developed using the filtered pathway option in RADTRAD in order to specify fixed flow rate values. The following major parameters were inputted based on values documented/determined in Section 2 of this analysis:

PlantPowerLevel - Is based on the rated thermal power multiplied by the fraction of fuel damaged, maximum power uncertainty, and the fuel peaking factor. The radionuclide inventory is multiplied within RADTRAD by this value to determine the total amount of radionuclides released to the pool. The following value was calculated:

Power level = 2381 x 3.156E-3 x 1.02 x 2.0 = 15.329 Mwt Model Compartments andPathways Compartment 1 - Refueling floor volume (7.95E+05 ft3)

Compartment 2 - Environment volume (O.OOE+00 ft3) Note: treated as an infinite space within the code Compartment 3 - Control room volume (1.4186E+05 fI)

Pathway 1 - primary to environment (flow = 4.571E+04 ) CFM in order to remove 99.9% of the radionuclides from the containment envelope in the first 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months )

Pathway 2 - environment to control room (flow = 3235 CFM at time 0 to 1 min., flow = 810 CFM at time 1 min. to end of event using a filter efficiency of 89%)

Pathway 3 - environment to control room (flow = 400 CFM of unfiltered inleakage for duration of event. The 400 CFM CR inleakage is also greater than the actual CNS inleakage measured during tracer gas testing for the recirculation only mode of operation (64 CFM)..

Pathway 4 -control room to environment (flow = 3635 CFM outflow at time 0 to I min.,

flow = 1210 CFM at time 1 min. to end of event)

Source Term Decay time = 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months Iodine chemical fractions = Aerosol = .95, Elemental = .0485, Organic = .00 15 Decay and Daughter products is invoked and generated by RADTRAD Dose Locations Three dose locations were defined as control room, EAB, and LPZ. Input values for X/Q values, breathing rates, and occupancy factors for the control room were provided.

NEDC e~ 7/Rv-.Z... Page: 20 of_168 LON AtL .LPageA.L--of..L7Z SCIIMC? AOS 1IC"09tO4y Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: 1 Attachment A of this analysis provides the associated RADRAD input file.

Nuclide Inventory File (NIF)

The nuclear inventory file was created by modifying the RADTRAD default file bwrnonloca.nif based on the CNS specific nuclide activity values (Ci/Mwt) as defined in Section 2 of this analysis.

All of the Bromine isotopes identified by the CNS specific GE Fission Product Inventory (Ref. 11) had been initially considered as possible dose sources. Those Bromine isotopes are listed below, along with their half lives.

Nucide Haflife Half life Name (seconds) (hours)

Br-82 1.27E+05 35.30400 Br-82m 3.66E+02 0.10167 Br-83 8.64E+03 2.40000 Br-84 I.91E+03 0.53000 Br-84m 3.60E+02 0.10000 Br-85 1.72E+02 0.04784 Br-86 5.55E+01 0.01542 Br-87 5.59E+01 0.01553 Br-88 1.64E+01 0.00456 Br-89 4.37E+00 0.00121 Br-90 1.90E+00 0.00053 Br-91 5.40E-01 0.00015 Br-92 3.40E-01 0.00009 Br-93 I.OOE-0I 0.00003 Br-94 7.OOE-02 0.00002 Bromine Isotopes Included in GE (CNS Specific) Inventory with Half Lives Table 3 Examination of this data revealed that all of the Bromine isotopes present in the core except for Br-82, 83, and 84 would decay to negligible amounts over the duration of the 24 hour2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months delay period following a FHA. It was therefore hypothesized that only these Bromine isotopes could potentially be a factor in this analysis.

A nuclide inventory file that contained 29 isotopes was created based on the CNS GE14 source term library. These 29 isotopes were all halogens and noble gases that were previously evaluated in CNS GE 14 EQ dose calculations (Ref. 29), with the exception of Xe 137, Br 84m, Br85, Br 87 and Kr 89. These nuclides were excluded since their half life is less than 3.9 minutes.

NEDC6G2-2/-Rev-1Z Page: 21 _ of_168 A LIO0N Catc. No.: ALION-CAL-NPPD-3236-001 AtL....page.AL-ofZMP.

%CIgW99AND 1CNNtOV Rev. Number: 1 eFHA Source Core Term Inventory at Fraction of (Cl)

Power Total Core Radioactive Time After Time After Core Water Pool Radial RADTRAD Uncertainty Inventory Hat Wfe Shutdown Shutdown Inventory Decon Peaking Fraction of Core Isotope CIIMWt' MWt Factor (Cl) (J! ) (sec) (Cl)(3 Released Factor Factor Failed Br-82 1.800E+02 2381 1.02 4.372E+05 1.271 E+05 86400 2.729E+05 0.05 0.005 2.00 0.003155123 4.305E-01 Br-83 3.260E+03 2381 1.02 7.917E+06 8.604E+03 86400 7.522E+03 0.05 0.005 2.00 0.003155123 1.187E-02 Br-84 5.610E+03 2381 1.02 1.362E+07 1.908E+03 86400 3.204E-07 0.05 0.005 2.00 0.003155123 5.054E-13 Kr-83m 3.270E+03 2381 1.02 7.942E+06 6.588E+03 86400 8.970E+02 0.05 1 2.00 0.003155123 2.830E-01 Kr-85 3.660E+02 2381 1.02 8.889E+05 3.383E+08 86400 8.887E+05 0.10 1 2.00 0.003155123 5.608E+02 Kr-85m 6.810E+03 2381 1.02 1.654E+07 1.613E+04 86400 4.038E+05 0.05 1 2.00 0.003155123 1.274E+02 Kr-87 1.3001+04 2381 1.02 3.157E+07 4.578E+03 86400 6.595E+01 0.05 1 2.00 0.003155123 2.081E-02 Kr-88 1.830E+04 2381 1.02 4.444E+07 1.022E+04 86400 1.272E+05 0.05 1 2.00 0.003155123 4.013E+01 1-128 4.190E+02 2381 1.02 1.018E+06 1.499E+03 86400 4.575E-12 0.05 0.005 2.00 0.003155123 7.217E-18 1-130 1.060E+03 2381 1.02 2.574E+06 4.450E+04 88400 6.703E+05 0.05 0.005 2.00 0.003155123 1.057E+00 1-131 2.720E404 2381 1.02 6.606E+07 8.947E+05 88400 6.060E+07 0.08 0.005 2.00 0.003155123 1.530E+02 1-132 3.930E+04 2381 1.02 9.544E+07 8.280E+03 86400 8.90WE+04 0.05 0.005 2.00 0.003155123 1.089E-01 1-133 5.510E+04 2381 1.02 1.338E+08 7.488E+04 86400 6.015E+07 0.05 0.005 2.00 0.003155123 9.489E+01 1-134 6.0402+04 2381 1.02 1.467E+08 3.156E+03 86400 8.453E-01 0.05 0.005 2.00 0.003165123 1.334E-06 1-135 5.160E+04 2381 1.02 1.253E+08 2.380E+04 88400 1.012E+07 0.05 0.005 2.00 0.003155123 1.597E+01 TU429t') 8.790E403 2381 1.02 2.135E+07 4.176E+03 86400 1.266E+01 0.00 0.00 2.00 0.003155123 O.OOoE+00 Te-131t4 ) 2.420E+04 2381 1.02 5.877E+07 1.500E+03 88400 2.713E-10 0.00 0.00 2.00 0.003155123 O.OOOE 00 Te-131m"' 3.960E+03 2381 1.02 9.617E+06 1.080E+05 86400 5.524E+06 0.00 0.00 2.00 0.003155123 O.OOOE+00 Te-132('4 3.850E+04 2381 1.02 s.350E+07 2.815E+05 86400 7.559E+07 0.00 0.00 2.00 0.003155123 0.0002+00 Te-133t 4) 3.240E+04 2381 1.02 7.869E+07 7.470E+02 86400 1.217E-27 0.00 0.00 2.00 0.003155123 0.000+00 Te-133m'4) 1.980E+04 2381 1.02 4.809E+07 3.324E+03 86400 7.229E-01 0.00 0.00 2.00 0.003155123 O.OOoE+00 Te-134 4 4.500E+04 2381 1.02 1.093E+08 2.508E203 88400 4.681 E-03 0.00 0.00 2.00 0.003155123 0.0000E+0 Xe-129m 2.060E-01 2381 1.02 5.003E+02 6.912E+05 86400 4.588E+02 0.05 1 2.00 0.003155123 1.448E-01 Xe-131m 3.040E+02 2381 1.02 7.383E+05 1.028E+06 86400 6.965E+05 0.05 1 2.00 0.003155123 2.198E+02 Xe-133 5.260E+04 2381 1.02 1.277E+08 4.532E+05 86400 1.119E208 0.05 1 2.00 0.003155123 3.532E+04 Xe-1 33m 1.580E+03 2381 1.02 3.837E+06 1.890E+05 86400 2.796E+06 0.05 1 2.00 0.003155123 8.820E+02 Xe-135 1.860E+04 2381 1.02 4.517E+07 3.272E+04 86400 7.248E+06 0.05 1 2.00 0.003155123 2.287E+03 Xe-135m 1.090E+04 2381 1.02 2.647E+07 9.174E+02 88400 1.197E-21 0.05 1 2.00 0.003155123 3.776E-25 Xe-13S 4.500E+04 2381 1.02 1.093E108 8.502E+02 86400 2.841 E-23 0.05 1 2.00 0.003155123 8.963E-27 (1) From Reference 11 (2) From RADTRAD nudide inventory fle (NIF) Attachment B (3) Calculated from standard equation N* N x eq f)% >

(4) TellurIum Metals were Included In the nudide Inventory file (NIF) based on their daughterng contribution to bodine as analyzed by RAOTRAD Post-FHA Activity Released to Refueling Floor Used In RADTRAD (24 hrs. After Shutdown)

Table 4

OD NEDGR.L°/RevjL-- Page-_:22 _ of_168 A L I 0 N , wU Caic. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I The nif file was further modified to account for the increased Gap Fractions of I-131 (8%

versus the 5% assumed for all other halogens) and Kr-85 (10% versus the 5% assumed for all other noble gases). The following values were calculated:

I-13 1 activity level .08/.05 x 2.72E+04 4.352E+04 (CiIMwt)

Kr-85 activity level = .101.05 x 3.66E+02 7.32E+02 (CiIMwt)

Attachment B of this analysis provides the associated RADRAD input file.

Radionuclide Release Fractions and Timing File (RF)

The radionuclide release fractions and timing file was created by modifying the RADTRAD default file nonLOCA.rft (which is based on RG 1.183 Table 3 and retention of all particulate radionuclides per Appendix B of the guide) for the decontamination factor of iodine (200). This was accomplished by modifying the release percentage (based on gap fraction) by the following:

Release fraction =.05 (iodine group gap fraction)/200 = 0.25E-03 The release fraction for noble gases was maintained at .05 (having a decontamination factor of 1) while all other radionuclide groups were given a zero (0) release fraction based on their retention in the pool. Cs and Rb isotopes, as well as all other particulates, are excluded from nuclide inventory and release fraction files since they are assumed to be retained by the water in the fuel pool or reactor cavity (i.e., infinite decontamination factor) per the guidance in RG 1.183.

Attachment C of this analysis provides the associated RADRAD input file.

Nuclide Dose Conversion File (aNP)

The nuclide dose conversion file used the RADTRAD default file fgrl 1&12.inp which is based on the Federal Guidance Reports 11 and 12 as documented in Section 2 of this analysis. This file was modified to match the CNS specific nuclide group defined by the Nuclear Inventory File .nif mentioned above.

Attachment D of this analysis provides the associated RADRAD input file.

Detailed Output File (00)

RADTRAD develops a detailed output file sequentially numbered (.o0, ol, o2, etc). as a function of the amount of cases generated (only one for this analysis) that documents all input parameters and output detail.

Attachment E of this analysis provides the associated RADRAD output file.

'a) NEDC OY-°O/Rev./. Page:_23 _ of_168 A L I 0 bN SCIStC9 Ade TSC1000WO At-L./page.L2f3 A Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I 5 RESULTS AND CONCLUSIONS 5.1 Base Case Results The results of the Base Case RADTRAD generated dose analysis as documented in Attachment E are summarized in Table 5 below:

Accumulated Dose Accident Dose Criteria Dose Location (rem TEDE) (rem TEDE)

Control Room 4.507 5.0 (l)

EAB 1.459 6.3 (2,3)

LPZ .815 6.3(2)

Table 5 Note: (1) based on both General Design Criteria (GDC) 19 from Appendix A to 10 CFR Part 50 and 10 CFR50.67 (b) (2) (iii)

(2) based on Regulatory Guide 1.183 Table 6 (based on the analysis release duration of 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months )

(3) Since the event is based on a 2-hour release, the worst 2-hour period for the EAB is the 0 to 2-hour period.

All calculated doses were found to be below the stipulated limits. It is therefore concluded that the regulatory dose limits will not be exceeded following a postulated design basis FHA at Cooper Nuclear Station.

5.2 Case I - 168 Hour Fuel Decay Time with CREFS not Operating An additional RADTRAD analysis was performed to evaluate the accumulated dose at the identified receptor points assuming an initial decay period of 168 hours0.00194 days 0.0467 hours 2.777778e-4 weeks 6.3924e-5 months before fuel movement and no credit for CREFS filtration (assumes CREFS non-operable). The results of the Case I RADTRAD generated dose analysis as documented in Attachment F are summarized in Table 6 below: All calculated doses were found to be below the stipulated limits.

Accumulated Dose Accident Dose Criteria Dose Location (rem TEDE)-: (rem TEDE)

Control Room 4.446 5.0 (1)

EAB 0.627 6.3 (2,3)

LPZ 0.350 6.3 (2)

Table 6 Note: (1,2,&3) Refer to Table 5 notes above.

W <>-03/ Rev.L.

NEDC Page: 24 _ of_168 A LI At paged of Calc. No.: ALION-CAL-NPPD-3236-oo1 Rev. Number: 1 5.3 External Airborne Shine Dose and CREFS Shine Dose to the Control Room The purpose of this discussion is to qualitatively assess potential gamma shine from external sources to the control room proper during FHA using alternative source terms to assess contained radioactivity while considering limited geometry. The radiation sources external to the control room would be from airborne external cloud and CREFS filters (located within the Control Room Envelope). The following were considered and should be evaluated for local administrative controls on occupant dose:

1. Doses were conservatively evaluated with credit for Control Room occupancy per RG 1.183 of 1.0 for the first day, 0.6 for the next 3 days, and 0.4 for the following 26 days.

If occupancy is limited the actual control room occupant dose would be lowered.

2. Administrative controls would be important for evaluating and maintaining control room occupant doses as low as is reasonably achievable (ALARA).

Cloud Shine Dose Comparison A Qualitative comparison was made to the CNS calculation (Ref. 30) for cloud shine dose contribution to the control room. The calculation noted a 0.004 Rem Gamma dose as a result of LOCA Cloud Shine for 30 day dose. This dose was calculated based on looking at Krypton 87, 88, 89 and Xe 138 isotopes. The calculation indicated that at 0.5 hrs after LOCA the following activity levels were available and released to the Environment with the largest combination of x/Qs for atmospheric dispersion (after this time period the X/Qs dropped significantly to 10-8s/m 3, and thus the dose was not a significant contributor after 0.5 hrs):

Isotope LOCA Activity Released Curies (at t=0.5 hrs)

Kr87 1.06E+03 Kr88 1.75E+03 Kr89 83 Xe138 1.43E+03 Table 7 In comparison to the RADTRAD output for the CNS FHA the amount of material that is released to the Environment (24 hour2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months decay, see Table 4) is as follows for the same isotopes:

Isotope - FHA Activity Released Curies (at t24 hrs)

Kr87 2.08E-02 Kr88 4.01E+01 Kr89 0 Xel38 0 Table 8

0 NEDC vsZ 7/ Rev..L. Page: 25 _ of_168 A LI 0 N AttL page t5 ofL 79 Calc. No.: ALION-CAL-NPPD-3236-001 Rev. Number: 1 In comparison, the amount of Kr88 available for shine contribution is a factor of:

40.1Ci/l750Ci = 0.023 or 2.3% of the LOCA source term available for shine. Thus, it is anticipated that the FHA cloud shine would be significantly less than the LOCA cloud shine for the 30 day period.

CREFS Shine Dose to the Control Room A qualitative assessment was made in comparing the Cooper 24 hour2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months decay FHA RADTRAD output to the existing analysis of record for CNS (Ref. 31). This qualitative assessment utilized RADTRAD v. 3.10 which calculates decay and resulting amount of Curies on a filter. The RADTRAD v.3.03 .psf file for a 24 hour2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months decay was directly read into RADTRAD v.3.10 and run to develop the inventory on the control room filter. The output file is provided as Attachment G.

The existing Post-LOCA 30 day cumulative shine dose from airborne radioactivity accumulated on the CREFS filter was documented in Reference 31 as 0.0183 Rem @ 375 cfm. The Control Room Intake Filter Halogen Activities calculated on the filter banks is provided below for peak activity utilizing the 375 cfm flowrate.

Isotope CR Filter Activity at Post LOCA (4Ci) 1129 5.0OE-04 1131 1.43E+04 1132 1.75E+04 1133 2.31E+04 I134 2.04E+04 I135 2.28E+04 1136 2.9E-03 Table from Ref. 31 (Activity at 0.5 hr)

Table 9

NEDO_~Of` YRev-J.. Page: 26 _ of _168 ALOD SIiuwCl Ass iIZOVmISOI AuL..L-Page.j!LofJ-L.Z0 Caic. No.: ALION-CAL-NPPD-3236-001 Rev. Number: 1 The Control Room Intake Filter Halogen Activities calculated in the RADTRAD Output file Attachment G (for the Iodine nuclides used in the FHA) on the filter banks for the 24 hour2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months decay release for peak activity was compared to the Ref. 31 values.

FHA RAD v FHA RAD v 3.10 Ratio of Curies 3.10P2) converted to Ref 3PI 3 . RAD 3.10 vs.

. (Ci) (1Ci) __-___ (pCi) Ref. 31 1130 1.16E-03 1.16E+03 NA NA I131 1.88E-01 1.88E+05 1.43E+04 1.32E+01 1132 8.38E-02 8.38E+04 1.75E+04 4.79E+00 I133 1.12E-01 1.12E+05 2.311E+04 4.83E+00 1134 1.33E-09 1.33E-03 2.04E+04 6.52E-08 1135 1.59E-02 l.59E+04 2.28E+04 6.98E-01 Notes:

(1) Based on CREFS flow of 810 CFM (2) Activity based on 26 hours3.009259e-4 days 0.00722 hours 4.298942e-5 weeks 9.893e-6 months , representing fIll release of source term to environment following 24 hr. decay (3) Activity based on .5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months post LOCA accident RADTRAD v. 3.10 Activity Compared to Ref. 31 (2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months Post Accident FHA)

Table 10 The amount of activity on filter at 720 hours0.00833 days 0.2 hours 0.00119 weeks 2.7396e-4 months (30 days) was also compared as follows.

FHA RAD v FHA RAD v 3.10 Ratio. of Curies 3.10(1) converted to Ref. 31(3 ) RAD 3.10 vs.

____ (Ci) (RCi) -____(ACi) Ref. 31 I130 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 I131 1.43E-02 1.43E+04 1.21E+03 1.18E+01 1132 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 1133 4.54E-12 4.54E-06 0.OOE+00 0.00E+00 1134 0.00E+00 O.OOE+00 O1.OOE+00 OOOE+00 I135 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Notes:

(I) Based on CREFS flow of 810 CFM (2) Activity based on 744 hours0.00861 days 0.207 hours 0.00123 weeks 2.83092e-4 months representing full release of source term to environment following 24 hr. decay (3) Activity based on 720 hours0.00833 days 0.2 hours 0.00119 weeks 2.7396e-4 months post LOCA accident RADTRAD v. 3.10 Activity Compared to Ref. 31 (720 hour0.00833 days 0.2 hours 0.00119 weeks 2.7396e-4 months Post Accident FRA)

Table 11

) NEDO-_OO3I/Rev../. Page: 27 _ of_168

.A I N An page2d7of L2 Caic. No.: ALioN-CAL-NPPD-3236001 Rev. Number: I The dose at 720 hours0.00833 days 0.2 hours 0.00119 weeks 2.7396e-4 months after accident indicates that I131 is the predominant source term and as such applying a conservative factor over time will be qualitatively appropriate. The RADTRAD v 3.10 FHA output file indicates a factor of 13.2 higher 1131 activity at 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months post accident (representing full release) versus the post LOCA analysis of record at peak activity point. Therefore it can be conservatively assumed the FHA source term captured on the CREFS is greater by a factor of 13.2 (with the contributing isotope for shine dose being 113 1). The resulting dose from CREFs shine for the FHA at 30 days would then be conservatively qualitatively estimated as 0.0183 Rem x 13.2 = 0.242 Rem.

When combined with the 30 Day Control Room Dose for inhalation the resultant total dose would still be below the regulatory criteria of 5 Rem TEDE.

/ NEDC25;>/ReY Page: 28 _of_168 I 0 N At . pago.oL it Caic. No.: ALIoN-cAL-NPPD-3236-0oo At / pago2 0 170Rev.

SMOUANDTIC~ft" Number: I 6 REFERENCES

1. Regulatory Guide 1.183, "Alternative Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors", July 2000.

2. NUREG/CR-6604, "RADTRAD: A Simplified Model for RADionuclide Transport and Removal And Dose Estimation", dated December 1997, including Supplement 1 (dated June 8, 1999) and Supplement 2 (dated October 2, 2002)..

3. Cooper Nuclear Station Updated Safety Analysis Report (USAR), Chapter XIV, Section 6.4., dated 4/06/2005.

4. Cooper Nuclear Station UFSAR Change Request (UCR) 2002-019, Item 59, dated 5/21/2002.

5. Cooper Nuclear Station Technical Specification, Section 3.9.6., Adm. 178.

6. Cooper Nuclear Station General Operating Procedure, 2.1.20.1, "Restoration From RPV Refueling", Rev. 12, dated 12/17/2004.

7. Cooper Nuclear Station Technical Specification, Section 1.1., Adm. 178.

8. GE NEDC-32868P, GE14 Compliance With Amendment 22 of NEDE-2401 1-P-A (GESTAR II), Proprietary Document, Rev. 0 1998.

9. J.J. DiNunno et al., "Calculation of Distance Factors for Power and Test Reactors Sites," USAEC TID-14844, U.S. Atomic Energy Commission, 1962.

10. L. Soffer et al., "Accident Source Terms for Light-Water Nuclear Power Plants,"

NUREG-1465, USNRC, February 1995.

11. GE letter GE-MIG- 1H69L-062, Erik Stromqvist to Paul Ballinger, dated February 29, 2000, GE14 Source Term Letter Report.

12. GE letter REK: 99-211, RE. Kingston to J. L. Lewis, dated November 9, 1999.

13. GE letter REK: 99-152, R.E. Kingston to J. L. Lewis, dated September 1, 1999.

14. Burns and Roe Calculation - System Sizing, Standby Gas Treatment System, Book 4, CNS Retrieval 00103-0487, dated 2/8/1968.

15. Robert Jennings Heinsohn PhD, PE, Industrial Ventilation: Engineering Principles, January 1991, John Wiley & Sons Canada, Ltd.

16. NCS Corporation, "Control Room Envelope Inleakage Testing at Cooper Nuclear Station", Final Report, dated August 20, 2004.

17. Cooper Nuclear Station, Burns & Roe Drawing No. 2051, Rev. N22.

18. Cooper Nuclear Station, Bums & Roe Drawing No. 2052, Rev. N14.

19. Cooper Nuclear Station, Bums & Roe Drawing No. 2019, Rev. N36.

20. Cooper Nuclear Station Technical Specification, Section 3.7.4., Adm. 178

0 NEDC 0.Fi./RevJ/ Page: 29 _ of_168 A LI0 Att / page-X$.of40fV7O Calc. No.: ALION-CAL-NPPD-3236-ooI 5 1 TICUtO~O@T "~ Rev. Number. 1

21. Cooper Nuclear Station Technical Specification, Section 5.5.7 as supplemented by NPPD Response to Generic Letter 99-02, NLS990117, December 2, 1999.

22. Cooper Nuclear Station Technical Specification, Section 5.5.7., Adm. 178.

23. Cooper Nuclear Station, Calculation NEDC 99-031, Revision 5, "Review of Scientech Calculation 17080-M-01, X/Q Values for Control Room Intake Using ARCON96", dated March 20,2003.

24. J.V. Ramsdell Jr. and C. A. Simonen, "Atmospheric Relative Concentration in Building Wakes, "NUREG/CR-6331, PNNL-10521, Revision 1,U.S. Nuclear Regulatory Commission, Washington, D.C., 1997.

25. Cooper Nuclear Station, Calculation NEDC 99-036, Revision 3, "EAB and LPZ Meteorological Dispersion Accident Analysis", dated April 20,2003.

26. K.F. Eckerman et al., "Limiting Values of Radionuclide Intake and Air Concentrations and Dose Conversion Factors for Inhalation, Submersion, and Ingestion," Federal Guidance Report 11, EPA-520/1-88-020, Environmental Protection Agency, 1988.

27. K.F. Eckerman and J.C. Ryman, "External Exposure to Radionuclides in Air, Water, and Soil," Federal Guidance Report 12, EPA402-R-93-081, Environmental Protection Agency, 1993.

28. The Health and Radiological Health Physics Handbook, Exposure and Shielding from External Radiation, pages 188-193.

29. Cooper Nuclear Station, NEDC 0 1-065, Revision 1, "Liquid & Gaseous EQ Source Terms Based on GE14 Fuel and a LOCA" dated 5/19/2004

30. Cooper Nuclear Station, NEDC 94-072, "Control Room Operator Dose due to Reactor Bldg. 10" Core Spray Line, and LOCA Cloud Shine", dated 12/02/1996.

31. Cooper Nuclear Station, NEDC 94-070, Revision 2, "Control Room Operator Dose due to Emergency Bypass Filter Shine", dated 12/02/1996.

0) NEDC.°S-°1/Rev zPage: 30_of_168 A L I0 N ANDT69100O UTSWU 1 A7t0/ pageo fL 7 Caic. No.: ALION-CAL-NPPD-3236-001 Rev. Number: I 7 ATTACHMENTS A. RADTRAD Plant Specific Input File (PSF)

B. RADTRAD Nuclear Inventory File (NIF)

C. RADTRAD Radionuclide Release Fractions and Timing File (RFT)

D. RADTRAD Nuclide Dose Conversion File (INP)

E. RADTRAD Base Case Detailed Output File (oO)

F. RADTRAD Case I Detailed Output File (oO)

G. RADTRAD v 3.10 Detailed Output File (oO) Qualitative CREFS Shine Analysis H. Design Calculations and Analysis Review Checklist

NEDC "c- °/Rev Page:__Al_ of__A5_

Caic. No.: ALION-CAL-NPPD-3236-001 ALIO N AC LtIea NceUo1 AtLn/ Pagae/ofJ 24° Rev. Number: 1 ATTACHMENT A RADTRAD Plant Specific Input File (PSF)

WEDC.2 °2/LRev /.

Agtf/l page 3 2- of-LZ7*

Radtrad 3.03 4/15/2001 Nuclide Inventory File:

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nif Plant Power Level:

1.5329E+01 Compartments:

3 Compartment 1:

primary 3

7.9500E+05 0

0 0

Compartment 2:

Environment 2

0.0000E+00 0

0 0

Compartment 3:

Control Room 1

l.4186E+05 0

0 0

Pathways:

4 Pathway 1:

primary to Environment 1

2 2

Pathway 2:

Environment to Control Room 2

3 2

Pathway 3:

Environment to Control Room 2

3 2

Pathway 4:

Control Room to Environment 3

2 2

End of Plant Model File Scenario Description Name:

NEDC 6-do ZRev-L.

AtL..L.ppage1-of-LZ7 Plant Model Filename:

Source Term:

1 1 1.OOOOE+00 C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inp C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\RG1_183FHA.RFT

2. 4000E+01 1

9.5000E-01 4.8500E-02 1.5000E-03 1.OOOOE+00 Overlying Pool:

0 0.OOOE+00 0

0 0

0 Compartments:

3 Compartment 1:

1 1

0 0

0 Compartment 2:

1 1

0 0

2.00+1 0 456E0 .OOE0 .OO+0 0OOEO 0

0 Compartment 3:

1 1

0 0

0 Pathways:

4 Pathway 1:

0 0

0 1

1 2.4000E+01 4.5760E+04 0.0000E+00 0.0000E+00 0.0000E+00

NEDCAL-JlReveL./-

AtL I pagel3YofLZ70 0

0 0

0 Pathway 2:

0 0

0 1

2 2.4000E+01 3.2350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 8.1OOOE+02 8. 9000E+01 8.9000E+01 8.9000E+01 0

0 0

0 Pathway 3:

0 0

0 1

1 2.4000E+01 4.0000E+02 O.OOOQE+00 O.OOOOE+00 O.OOOOE+00 0

0 0

0 Pathway 4:

0 0

0 1

2 2.4000E+01 3.6350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 1.2100E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

0 0

0 Dose Locatioris:

3 Location 1:

EAB 2

1 2

NEDC osfoTAev L Aft j- page .3rof /7° 2.4000E+01 5.2000E-04 2.6000E+01 O.OOOOE+00 1

4 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4 .8000E+01 2.3000E-04 7.4400E+02 O.OOOOE+00 0

Location 2:

LPZ 2

1 5

2.4000E+01 2.9000E-04 3.2000E+01 7.3000E-05 4.8000E+01 2.5000E-05 1.2000E+02 5.2000E-06 7.4400E+02 O.OOOOE+00 1

4 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 O.OOOOE+00 0

Location 3:

Control Room 3

0 1

2 2.4000E+01 3.5000E-04 7.4400E+02 O.OOOOE+00 1

4 2.4000E+01 1.OOOOE+00 4.8000E+01 6.0000E-01 1.2000E+02 4.0000E-01 7.4400E+02 O.OOOOE+00 Effective Volume Location:

1 6

2.4000E+01 4.1500E-03 2.6000E+01 3.2400E-03 3.2000E+01 1.3200E-03 4.8000E+01 9.0100E-04 1.2000E+02 7.2200E-04 7.4400E+02 O.OOOOE+00 Simulation Parameters:

0 Output Filename:

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHAcooper 9 05.ol 1

1 1

0 0

End of Scenario File

NEDO fs-°3/Rev / Page:_Bl_ of__B6_

Atn.L..page.3-!L.ofLL7 Caic. No.: ALION-CAL-NPPD-3236-001 A LI0 N SCnxAt*CrAus ec"Oe04"T Rev. Number: I ATTACHMENT B RADTRAD Nuclide Inventory File (NIF)

NEDOVf/ Rev /

Att I page5-7-of /-70 Nuclide Inventory Name:

Cooper GE14 Fission Product Inventory Kr85 and I131 Adjusted for NonLOCA Power Level:

1.OOOOE+00 Nuclides:

29 Nuclide 001:

Br-82 2

1.2708000000E+05 8.2000E+01 1.8000E+02 none O.OOOOE+00 none 0.OOOOE+00 none 0.OOOOE+00 Nuclide 002:

Br-83 2

8.6040000000E+03 8.3000E+01 3.2600E+03 Kr-83m 1.OOOOE+00 none 0.OOOOE+00 none 0.OOOOE+00 Nuclide 003:

Br-84 2

1.9080000000E+03 8.4000E+01 5.6100E+03 none 0.OOOOE+00 none 0.OOOOE+00 none 0.OOOOE+00 Nuclide 004:

Kr-83m 1

6.5880000000E+03 8.3000E+01 3.2700E+03 none 0.OOOOE+00 none 0.OOOOE+00 none 0.OOOOE+00 Nuclide 005:

Kr-85 1

3.3829747200E+08 8.5000E+01 7.3200E+02 none 0.OOOOE+00 none 0.0000E+00 none 0.OOOOE+00 Nuclide 006:

Kr-85m 1

1.6128000000E+04 8.5000E+01 6.8100E+03 Kr-85 2.1000E-01 none 0.OOOOE+00

NEDC _O-v7/RevJZ Att /LpageMltof /70 none O.OOOOE+00 Nuclide 007:

Kr-87 1

4.5780000000E+03 8.7000E+01 1.3000E+04 Rb-87 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 008:

Kr-88 1

1.0224000000E+04 8.8000E+01 1.8300E+04 Rb-88 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 009:

I-128 2

1.4994000000E+03 1.2800E+02 4.1900E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 010:

I-130 2

4.4496000000E+04 1.3000E+02 1.0600E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 011:

I-131 2

6.9465600000E+05 1.3100E+02 4.3520E+04 Xe-131m 1.10OOE-02 none O.OOOOE+00 none 0.OOOOE+00 Nuclide 012:

I-132 2

8.2800000000E+03 1.3200E+02 3.9300E+04 none O.OOOOE+00 none O.OOOOE+00 none 0.OOOOE+00 Nuclide 013:

I-133 2

7.4880000000E+04 1.3300E+02

NEDC °f-°3/ Rev L/

AttL/page3Y- oiLl?o 5.5100E+04 Xe-133m 2.9000E-02 Xe-133 9.7000E-01 none O.OOOOE+00 Nuclide 014:

I-134 2

3.1560000000E+03 1.3400E+02 6.0400E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 015:

I-135 2

2.3796000000E+04 1.3500E+02 5.1600E+04 Xe-135m 1.5000E-01 Xe-135 8.5000E-01 none O.OOOOE+00 Nuclide 016:

Te-129 4

4.1760000000E+03 1.2900E+02 8.7900E+03 I-129 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 017:

Te-131 4

1.5000000000E+03 1.3100E+02 2.4200E+04 I-131 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 018:

Te-131m 4

1.0800000000E+05 1.3100E+02 3.9600E+03 I-131 7.7800E-01 Te-131 2.2200E-01 none O.OOOOE+00 Nuclide 019:

Te-132 4

2.8152000000E+05 1.3200E+02 3.8500E+04 I-132 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 020:

Te-133

NEDC Of-.3/RevJ/

Aqtt-lpag e-te-off -7° 4

7.4700000000E+02 1.3300E+02 3.2400E+04 I-133 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 021:

Te-133m 4

3.3240000000E+03 1.3300E+02 1.9800E+04 I-133 8.7000E-01 Te-133 1.3000E-01 none O.OOOOE+00 Nuclide 022:

Te-134 4

2.5080000000E+03 1.3400E+02 4.5000E+04 I-134 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 023:

Xe-129m 1

6.9120000000E+05 1.2900E+02 2.0600E-01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 024:

Xe-131m 1

1.0281600000E+06 1.3100E+02 3.0400E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 025:

Xe-133 1

4.5316800000E+05 1.3300E+02 5.2600E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 026:

Xe-133m 1

1.8904320000E+05 1.3300E+02 1.5800E+03 Xe-133 1.OOOOE+00 none O.OOOOE+00

NEDC42 Rev./.

At-L page I-of L22 none O.OOOOE+00 Nuclide 027:

Xe-135 1

3.2724000000E+04 1.3500E+02 1.8600E+04 Cs-135 1.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 028:

Xe-135m 1

9.1740000000E+02 1.3500E+02 1.0900E+04 Cs-135 4.5000E-05 Xe-135 9.9990E-01 none O.OOOOE+00 Nuclide 029:

Xe-138 1

8.5020000000E+02 1.3800E+02 4.5000E+04 Cs-138 1.OOOOE+00 none 0.OOOOE+00 none O.OOOOE+00 End of Nuclear Inventory File

NEDCeAS- 7~/ RevY Page: Cl of C2_

5 Alt/L pagedi ofslo Caic. No.: ALION-CAL-NPPD-3236-001

~ALION SCu.%, LU.I C"* Rev. Number: I ATTACHMENT C RADTRAD Radionuclide Release Fractions and Timing File (RFT)

NEDC .ŽLO3 Rev.I.-

Att /L -pagelLLof-L7Z Release Fraction and Timing Name:

FtG 1.183, Tables 3, FHA with DF iodine=200, all aerosols Duration (h): NON-LOCA Accident chk inventory 0.0036E+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Noble Gases:

0.0500E+00 0.OOOOE+O0 O.OOOOE+00 0.OOOE+00 Iodine:

0.2500E-03 0.OOOOE+00 0.OOOE+00 0.OOOOE+00 Cesium:

O.OOOOE+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Tellurium:

0.000OE+00 O.OOOOE+00 0.OOOE+00 0.OOOOE+00 Strontium:

O.OOOOE+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Barium:

0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 Ruthenium:

0.OOOOE+00 o .OOOOE+00 0.0000E+00 0.OOOOE+00 Cerium:

0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Lanthanum:

0.OOOOE+00 0.0000E+00 0.0000E+00 0.0000E+00 Non-Radioactive Aerosols (kg):

0.0000E+00 0.0000E+00 O.OOOOE+00 0.OOOOE+00 End of Release File

NEDC Or- o/ Rev.L.

Att I pageVfy of_ 70 Page:_Dl_ of Dl I_

CaIc. No.: ALION-CAL-NPPD-3236-001 A L 1I as"""

N AND Tdc"X"04 Rev. Number: 1 ATTACHMENT D RADTRAD Nuclide Dose Conversion File (INP)

NED CS;°s Rev /-

Att / page1+/-ZofLL7 FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 29 NUCLIDES DEFINED IN THIS FILE:

Br-82 D Br-83 D Br-84 D Kr-83m Kr-85 Kr-85m Kr-87 Kr-88 I-128 D I-130 D I-131 D I-132 D I-133 D I-134 D I-135 D Including:Xe-135m Te-129 W Te-131 W Te-131m W Including:Te-131 Te-132 W Te-133 W Te-133m W Te-134 W Xe-129m Xe-131m Xe-133 Xe-133m Xe-135 Xe-135m Xe-138 CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HRSHINE 7DAYSHINE RATE ACUTE CHRONIC Br-82 GONADS 1.270E-13 7.116E-11 4.714E-10 2.670E-15-1.OOOE+00 2.520E-10 4.480E-10 BREAST 1.440E-13 6.796E-11 4.502E-10 2.550E-15-1.OOOE+00 2.370E-10 3.810E-10 LUNGS 1.270E-13 6.530E-11 4.326E-10 2.450E-15-1.OOOE+00 7.820E-10 3.840E-10 RED MARR 1.240E-13 6.663E-11 4.414E-10 2.500E-15-1.OOOE+00 2.540E-10 4.140E-10 BONE SUR 1.990E-13 9.355E-11 6.198E-10 3.510E-15-1.OOOE+00 2.310E-10 3.800E-10 THYROID 1.300E-13 6.690E-11 4.432E-10 2.510E-15-1.OOOE+00 2.380E-10 3.830E-10

NEDOCff.

0-O3/RevJ.-

AtL.L....p age-iLLofZ9 REMAINDER 1.220E-13 6.450E-11 4.273E-10 2.420E-15-1.OOOE+00 3.150E-10 5.800E-10 EFFECTIVE 1.300E-13 6.796E-11 4.502E-10 2.550E-15-1.OOOE+00 3.310E-10 4.620E-10 SKIN(FGR) 1.54OE-13 8. 129E-11 5.385E-10 3.050E-15-1.OOOE+00 0.OOOE+00 0.00OE+00 Br-83 GONADS 3.74OE-16 9. 637E-14 1.069E-13 8.610E-18-1.OOOE+00 3.280E-12 7.350E-12 BREAST 4.290E-16 9.302E-14 1.032E-13 8.310E-18-1.OOOE+00 3.290E-12 7.34OE-12 LUNGS 3.690E-16 8.608E-14 9.546E-14 7.690E-18-1.OOOE+00 1.500E-10 7.350E-12 RED MARR 3.540E-16 8.630E-14 9.570E-14 7.710E-18-1.OOOE+00 3.300E-12 7.350E-12 BONE SUR 6.750E-16 1.422E-13 1.576E-13 1.270E-17-1.OOOE+00 3.290E-12 7.330E-12 THYROID 3.800E-16 9.033E-14 1.002E-13 8.070E-18-1.OOOE+00 3.290E-12 7.330E-12 REMAINDER 3.520E-16 8.440E-14 9.359E-14 7.540E-18-1.OOOE+00 1.130E-11 6.54OE-ll EFFECTIVE 3.820E-16 9.100E-14 1.009E-13 8.130E-18-1.OOOE+00 2.330E-11 2.470E-11 SKIN(FGR) 1.850E-14 2.339E-11 2.594E-11 2.090E-15-1.OOOE+00 0.OOOE+00 o.OOOE+00 Br-84 GONADS 9.160E-14 4.569E-12 4 .569E-12 1.660E-15-1.000E+00 2.840E-12 6.750E-12 BREAST 1.020E-13 4.349E-12 4 .349E-12 1.580E-15-1.OOOE+00 3.310E-12 6.620E-12 LUNGS 9.270E-14 4.239E-12 4 .239E-12 1.540E-15-1.OOOE+00 1.560E-10 6.990E-12 RED MARR 9.260E-14 4. 377E-12 4 .377E-12 1.590E-15-1.OOOE+00 3.270E-12 6.210E-12 BONE SUR 1.280E-13 5.725E-12 5.726E-12 2.080E-15-1.OOOE+00 2.990E-12 5.560E-12 THYROID 9.500E-14 4. 1O1E-12 4.101E-12 1.490E-15-1.OOOE+00 3.120E-12 5.200E-12 REMAINDER 8.990E-14 4.267E-12 4.267E-12 1.550E-15-1.OOOE+00 1.870E-11 1.480E-10 EFFECTIVE 9.410E-14 4.404E-12 4 .404E-12 1.600E-15-1.OOOE+00 2.610E-11 4.910E-11 SKIN(FGR) 1.880E-13 3.523E-11 3.523E-11 1.280E-14-1.OOOE+00 0.OOOE+00 0.OOOE+00 Kr-83m GONADS 1.710E-18 5.572E-15 5.855E-15 6.160E-19-1.OOOE+00 o.OOOE+00 O.OOOE+00 BREAST 5.050E-18 9.498E-15 9.980E-15 1.050E-18-1.OOOE+00 0.OOOE+00 0.OOOE+00 LUNGS 1.640E-19 1.266E-16 1.331E-16 1.400E-20-1.OOOE+00 0.OOOE+00 O.OOOE+00 RED MARR 3.830E-19 5.617E-16 5.902E-16 6.210E-20-1.OOOE+00 0.OOOE+00 0.OOOE+00 BONE SUR 2.250E-18 3.437E-15 3.612E-15 3.800E-19-1.OOOE+00 0.OOOE+00 O.OOOE+00 THYROID 6.430E-19 7.698E-16 8.088E-16 8.510E-20-1.OOOE+00 0.OOOE+00 0.OOOE+00 REMAINDER 5.300E-19 1.393E-15 1.464E-15 1.540E-19-1.OOOE+00 0.OOOE+00 0.OOOE+00 EFFECTIVE 1.500E-18 3.437E-15 3.612E-15 3.800E-19-1.OOOE+00 0.OOOE+00

Att /.pageY-tZofJL-7Z 0.OOOE+00 SKIN(FGR) 3.560E-17 1.167E-13 1.226E-13 1.290E-17-1.OOOE+00 0.OOOE+00 0.000E+00 Kr-85 GONADS 1.170E-16 8.121E-14 1.704E-12 2.820E-18-1.000E+00 0. OOOE+00 0.000E+00 BREAST 1.340E-16 7.891E-14 1.656E-12 2.740E-18-1.000E+00 0.OOOE+00 0.OOOE+00 LUNGS 1. 140E-16 7.056E-14 1.481E-12 2.450E-18-1.000E+00 0.000E+00 O.000E+00 RED MARR 1.090E-16 6.998E-14 1.469E-12 2.430E-18-1.000E+00 0.000E+00 O.OOOE+00 BONE SUR 2.200E-16 1.287E-13 2.702E-12 4.470E-18-1.000E+00 0.000E+00 0.000E+00 THYROID 1.180E-16 7.459E-14 1.565E-12 2.590E-18-1.OOOE+00 0.OOOE+00 O.OOOE+00 REMAINDER 1.090E-16 6.941E-14 1.457E-12 2.410E-18-1.OOOE+00 0.OOOE+00 0.000E+00 EFFECTIVE 1.190E-16 7 .603E-14 1.596E-12 2.640E-18-1.000E+00 0.000E+00 0.OOOE+00 SKIN(FGR) 1.320E-14 2.304E-11 4 .835E-10 8.000E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 Kr-85m GONADS 7.310E-15 2.594E-12 3. 653E-12 1.570E-16-1.OOOE+00 0.000E+00 0.000E+00 BREAST 8.410E-15 2.527E-12 3.560E-12 1.530E-16-1.000E+00 .OOOE+00 0.OOOE+00 LUNGS 7.040E-15 2.379E-12 3.351E-12 1.440E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 RED MARR 6.430E-15 2.346E-12 3.304E-12 1.420E-16-1.000E+00 0.OOOE+00 0.OOOE+00 BONE SUR 1.880E-14 5.286E-12 7.446E-12 3.200E-16-1.000E+00 0.000E+00 0.OOOE+00 THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.000E+00 0.000E+00 0.OOOE+00 EFFECTIVE 7. 480E-15 2.511E-12 3.537E-12 1.520E-16-1.000E+00 0.OOOE+00 0.OOOE+00 SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.000E+00 0.OOOE+00 0.000E+00 Kr-87 GONADS 4.OOOE-14 4. 962E-12 5.026E-12 7.610E-16-1.000E+00 0.000E+00 0.OOOE+00 BREAST 4.500E-14 4.740E-12 4. 802E-12 7.270E-16-1.000E+00 0.OOOE+00 0.OOOE+00 LUNGS 4 .040E-14 4 .603E-12 4. 663E-12 7.060E-16-1.000E+00 0.000E+00 0.OOOE+00 RED MARR 4.OOOE-14 4.708E-12 4.769E-12 7.220E-16-1.000E+00 0. OOOE+00 0.OOOE+00 BONE SUR 6.020E-14 6.514E-12 6.598E-12 9.990E-16-1.000E+00 0.000E+00 0.OOOE+00 THYROID 4 . 130E-14 4 .473E-12 4.531E-12 6.860E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 REMAINDER 3. 910E-14 4.590E-12 4.650E-12 7.040E-16-1.000E+00 0.000E+00 0.OOOE+00 EFFECTIVE 4.120E-14 4.773E-12 4 .835E-12 7.320E-16-1.000E+00 0.OOOE+00 0.000E+00 SKIN(FGR) 1.370E-13 8.802E-11 8.916E-11 1.350E-14-1.000E+00 0.000E+00 0.OOOE+00

NEDC "%-"7l- 4/ev...L AttZ...page f'lofLZ7' Kr-88 GONADS 9.900E-14 2.278E-11 2.655E-11 1.800E-15-1.OOOE+00 O.OOOE+00 O.OOOE+0O BREAST 1.1OE-13 2. 177E-11 2.537E-11 1.720E-15-1.OOOE+0O O.OOOE+00 O.OOOE+00 LUNGS 1.O1OE-13 2.139E-11 2. 493E-11 1.690E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 RED MARR 1.OOOE-13 2.190E-1l 2.552E-11 1.730E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 BONE SUR 1.390E-13 2.886E-11 3.363E-11 2.280E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 THYROID 1.030E-13 2.012E-11 2.345E-11 1.590E-15-1.OOOE+00 O.OOOE+00 O.OOOE+O0 REMAINDER 9.790E-14 2.139E-11 2.493E-11 1.690E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 EFFECTIVE 1.020E-13 2.202E-11 2.567E-11 1.740E-15-1.OOOE+O0 O.OOOE+00 O.OOOE+00 SKIN(FGR) 1.350E-13 5.607E-11 6.534E-11 4.430E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 I-128 GONADS 4.070E-15 2.007E-13 2.007E-13 9.280E-17-1.OOOE+00 6.800E-13 1.390E-12 BREAST 4.670E-15 1. 938E-13 1.938E-13 8.960E-17-1.OOOE+00 7.150E-13 1.440E-12 LUNGS 4 .010E-15 1.795E-13 1.795E-13 8.300E-17-1.OOOE+00 7.220E-11 1.470E-12 RED MARR 3.850E-15 1. 804E-13 1.804E-13 8.340E-17-1.OOOE+00 7.170E-13 1.430E-12 BONE SUR 7.470E-15 2. 920E-13 2.920E-13 1.350E-16-1.OOOE+00 7.030E-13 1.390E-12 THYROID 4.130E-15 1.882E-13 1.882E-13 8.700E-17-1.OOOE+00 5.340E-11 1.080E-10 REMAINDER 3.830E-15 1.761E-13 1.761E-13 8.140E-17-1.OOOE+00 7.020E-12 6.710E-11 EFFECTIVE 4.160E-15 1.897E-13 1.897E-13 8.770E-17-1.OOOE+00 1.280E-11 2.430E-11 SKIN(FGR) 5.380E-14 1. 899E-11 1.899E-11 8.780E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 I-130 GONADS 1. OlOE-13 5. 105E-ll 1.412E-10 2.200E-15-1.OOOE+00 2.810E-11 5.520E-11 BREAST 1. 160E-13 4. 897E-11 1.354E-10 2.110E-15-1.OOOE+00 4.870E-11 7.320E-11 LUNGS 1.OlOE-13 4. 664E-11 1.290E-10 2.010E-15-1.OOOE+00 6.030E-10 7.180E-ll RED MARR 9.820E-14 4.734E-11 1.309E-10 2.040E-15-1.OOOE+00 4.550E-11 6.740E-ll BONE SUR 1.680E-13 6.869E-11 1.900E-10 2.960E-15-1.OOOE+00 4.030E-11 6.120E-11 THYROID 1.04OE-13 4.850E-11 1.342E-10 2.090E-15-1.OOOE+00 1.990E-08 3.940E-08 REMAINDER 9. 660E-14 4 .572E-11 1.265E-10 1.970E-15-1.OOOE+00 8.020E-11 1.970E-10 EFFECTIVE 1.040E-13 4. 873E-11 1.348E-10 2.100E-15-1.OOOE+00 7.140E-10 1.280E-09 SKIN(FGR) 1.360E-13 9.956E-11 2.754E-10 4.290E-15-1.OOOE+00 O.OOOE+00 O.OOOE+O0 I-131 GONADS 1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-11

NEDO CA7/41RevJ.Z.

AtLL/ page~~otlZ9-~

BREAST 2.040E-14 1.082E-11 1.730E-10 3.810E-16-1.000E+00 7.88OE-ll 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6.570E-10 1.020E-10 RED MARR 1.680E-14 1.022E-11 1.635E-10 3.600E-16-1.OOOE+00 6.260E-11 9.440E-11 BONE SUR 3.450E-14 1.675E-11 2.679E-10 5.900E-16-1.OOOE+00 5.730E-11 8.720E-11 THYROID 1.810E-14 1.053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4 .760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1.570E-10 EFFECTIVE 1.820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.44OE-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-1.OOOE+00 0.OOOE+00 0.OOE+00 I-132 GONADS 1.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9. 950E-12 2.330E-11 BREAST 1.240E-13 2.414E-11 2.652E-11 2.220E-15-1.OOOE+00 1.410E-ll 2.520E-11 LUNGS 1. 090E-13 2.305E-11 2.532E-11 2.120E-15-1.OOOE+00 2.710E-10 2.640E-11 RED MARR 1.070E-13 2.360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-ll 2.460E-11 BONE SUR 1.730E-13 3.327E-11 3. 655E-11 3.060E-15-1.OOOE+00 1.240E-ll 2.190E-11 THYROID 1.120E-13 2.381E-ll 2.616E-11 2.190E-15-1.OOOE+00 1.740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3.780E-ll 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.64OE-ll 2.210E-15-1.OOOE+00 1.030E-10 1.820E-10 SKIN(FGR) 1. 580E-13 8.199E-11 9.007E-11 7.540E-15-1.OOOE+00 0.OOOE+00 0.OOE+00 I-133 GONADS 2.870E-14 1.585E-11 6.748E-11 6.270E-16-1.OOOE+00 1. 950E-11 3.630E-11 BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-1.OOOE+00 2.940E-11 4.680E-11 LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-1.OOOE+00 8.200E-10 4.530E-11 RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-1.OOOE+00 2.720E-11 4.300E-11 BONE SUR 4.870E-14 2.i61E-ll 9.202E-11 8.550E-16-1.OOOE+00 2.520E-11 4.070E-11 THYROID 2. 930E-14 1.502E-11 6.393E-11 5.940E-16-1.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-1.OOOE+00 5.0O0E-l1 1.550E-10 EFFECTIVE 2. 940E-14 1.509E-11 6.425E-11 5.970E-16-1.OOOE+00 1.580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-1.OOOE+00 0.OOOE+00 0.OOOE+00 I-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-1.OOOE+00 4.250E-12 1.100E-11 BREAST 1.440E-13 1.145E-11 1. 147E-11 2.520E-15-1.OOOE+00 6.170E-12 1.170E-11 LUNGS 1.270E-13 1.100E-11 1.102E-11 2.420E-15-1.OOOE+00 1.430E-10

N-DC aS-PkR!Rov.j /

Att / page3"9?ofLLZ.9 1.260E-1l RED MARR 1.250E-13 1.127E-11 1. 129E-11 2.480E-15-1.00OE+00 6.080E-12 1.090E-11 BONE SUR 1.960E-13 1.568E-11 1.57lE-ll 3.450E-15-1.000E+00 5.310E-12 9.320E-12 THYROID 1.300E-13 1.127E-11 1. 129E-11 2.480E-15-1.000E+00 2.880E-10 6.210E-10 REMAINDER 1.220E-13 1.091E-11 1.093E-11 2.400E-15-1.OOE+00 2.270E-11 1.340E-10 EFFECTIVE 1.300E-13 1.150E-11 1.152E-11 2.530E-15-1.000E+00 3.550E-11 6.660E-11 SKIN(FGR) 1.870E-13 4.477E-11 4.485E-11 9.850E-15-1.00OE+00 0.OOOE+00 0.OOOE+00 I-135 GONADS 8.078E-14 3.113E-11 5.489E-11 1.599E-15-1.OOOE+00 1.700OE-11 3.610E-11 BREAST 9.143E-14 2.971E-11 5.240E-11 1.526E-15-1.000E+00 2.340E-11 3.850E-11 LUNGS 8.145E-14 2.886E-11 5.089E-11 1.482E-15-1.000E+00 4.410E-10 3.750E-11 RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-1.OO0E+00 2.240E-il 3.650E-11 BONE SUR 1.184E-13 3.983E-11 7.024E-1l 2.046E-15-1.OOOE+00 2.01OE-11 3.360E-11 THYROID 8.324E-14 2.852E-11 5.030E-11 1.465E-15-1.000E+00 8.460E-09 1.790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.000E+00 4.700E-11 1.540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-ll 1.535E-15-1.OO0E+00 3.320E-10 6.080E-10 SKIN(FGR) 1.156E-13 9.826E-11 1.733E-10 5.047E-15-1.OOOE+00 0.000E+00 0.000E+00 Te-129 GONADS 2.710E-15 3.889E-13 3.922E-13 6.510E-17-1.00OE+00 5.050E-13 1.590E-12 BREAST 3.120E-15 3.800E-13 3.832E-13 6.360E-17-1.00OE+00 5.390E-13 6.050E-13 LUNGS 2.640E-15 3.298E-13 3.326E-13 5.520E-17-1.OOOE+00 1.530E-10 4.910E-13 RED MARR 2.540E-15 3.298E-13 3.326E-13 5.520E-17-1.OOE+00 6.190E-13 7.640E-13 BONE SUR 4.880E-15 5.753E-13 5.802E-13 9.630E-17-1.000E+00 6.220E-13 5.400E-13 THYROID 2.740E-15 3.525E-13 3.555E-13 5.900E-17-1.00OE+00 5.090E-13 3.360E-13 REMAINDER 2.520E-15 3.262E-13 3.289E-13 5.460E-17-1.OOE+00 7.280E-12 1.790E-10 EFFECTIVE 2.750E-15 3.590E-13 3.621E-13 6.010E-17-1.000E+00 2.090E-11 5.450E-ll SKIN(FGR) 3.570E-14 3.429E-11 3.458E-11 5.740E-15-1.000E+00 0.OO0E+00 0.OOOE+00 Te-131 GONADS 1.990E-14 9.284E-13 9.284E-13 4.290E-16-1.OOE+00 2.170E-12 1.570E-11 BREAST 2.280E-14 8.937E-13 8.937E-13 4.130E-16-1.OOOE+00 2.670E-12 4.960E-12 LUNGS 1.960E-14 8.440E-13 8.44OE-13 3.900E-16-1.OOE+00 2.990E-10 3.390E-12 RED MARR 1.880E-14 8.483E-13 8.483E-13 3.920E-16-1.000E+00 2.940E-12 6.600E-12

AtL./.page-f-Lof-L-ZO BONE SUR 3.800E-14 1.459E-12 1. 459E-12 6.740E-16-1.OOOE+00 2.610E-12 3.690E-12 THYROID 2.030E-14 8.678E-13 8. 678E-13 4.010E-16-1.OOOE+00 2.660E-09 4.210E-09 REMAINDER 1.870E-14 8.267E-13 8.267E-13 3.820E-16-1.OOOE+00 2.210E-11 3.730E-10 EFFECTIVE 2.040E-14 8.873E-13 8.873E-13 4.100E-16-1.OOOE+00 1.240E-10 2.440E-10 SKIN(FGR) 6.890E-14 1.809E-11 1.809E-11 8.360E-15-1.OOOE+00 0.OOOE+00 O.OOOE+00 Te-131m GONADS 7.292E-14 4.020E-11 2.343E-10 1.535E-15-1.OOOE+00 2.345E-10 7.415E-10 BREAST 8.286E-14 3.853E-11 2.246E-10 1.472E-15-1.OOOE+00 9.309E-11 1.361E-10 LUNGS 7.265E-14 3.657E-11 2.131E-10 1.397E-15-1.OOOE+O0 2.296E-09 6.335E-11 RED MARR 7.097E-14 3.736E-11 2.178E-10 1.427E-15-1.OOOE+O0 1.417E-10 2.435E-10 BONE SUR 1.174E-13 5.467E-11 3.189E-10 2.090E-15-1.OOOE+00 2.276E-10 3.248E-10 THYROID 7.471E-14 3.741E-ll 2.181E-10 1.429E-15-1.OOOE+00 3.669E-08 4.383E-08 REMAINDER 6.965E-14 3.626E-11 2.113E-10 1.385E-15-1.OOOE+00 9.509E-10 3.153E-09 EFFECTIVE 7.463E-14 3.825E-11 2.229E-10 1.461E-15-1.OOOE+00 1.758E-09 2.514E-09 SKIN(FGR) 1.038E-13 1.033E-10 6.188E-10 4.056E-15-1.OOOE+00 0.OOOE+00 O.OOOE+00 Te-132 GONADS 1.020E-14 6.812E-12 7.706E-1I 2.450E-16-1.OOOE+00 4.150E-10 5.410E-10 BREAST 1.180E-14 6.756E-12 7.643E-11 2.430E-16-1.OOOE+00 3.630E-10 3.500E-10 LUNGS 9.650E-15 5.727E-12 6.479E-11 2.060E-16-1.OOOE+00 1.670E-09 3.300E-10 RED MARR 8.950E-15 5.588E-12 6.322E-11 2.010E-16-1.OOOE+00 4.270E-10 4.440E-10 BONE SUR 2.420E-14 1.273E-11 1.441E-10 4.580E-16-1.OOOE+00 7.120E-10 8.300E-10 THYROID 1.020E-14 5.978E-12 6.762E-11 2.150E-16-1.OOOE+00 6.28OE-08 5.950E-08 REMAINDER 9.160E-15 5.644E-12 6.385E-11 2.030E-16-1.OOOE+00 7.890E-10 1.490E-09 EFFECTIVE 1.030E-14 6.339E-12 7.171E-11 2.280E-16-1.OOOE+00 2.550E-09 2.540E-09 SKIN(FGR) 1.390E-14 8.313E-12 9.405E-11 2.990E-16-1.OOOE+00 0.OOOE+00 O.OOOE+00 Te-133 GONADS 4.490E-14 1.007E-12 1.007E-12 9.340E-16-1.OOOE+00 3.590E-13 1.850E-12 BREAST 5. 100E-14 9.656E-13 9.656E-13 8.960E-16-1.OOOE+00 6.050E-13 1.230E-12 LUNGS 4 .470E-14 9.236E-13 9.236E-13 8.570E-16-1.OOOE+00 4.640E-11 1.220E-12 RED MARR 4.360E-14 9.408E-13 9.408E-13 8.730E-16-1.OOOE+00 5.830E-13 1.180E-12 BONE SUR 7.500E-14 1.390E-12 1.390E-12 1.290E-15-1.000E+00 5.210E-13 7.730E-13 THYROID 4.590E-14 9.333E-13 9.333E-13 8.660E-16-1.OOOE+00 5.910E-10

NEDCOS5°3/ Rev /

AtLtpagel-z of /7°o 9.390E-10 REMAINDER 4.290E-14 9.117E-13 9. 117E-13 8.460E-16-1.OOOE+00 1.180E-12 6.050E-11 EFFECTIVE 4.600E-14 9. 635E-13 9.635E-13 8.940E-16-1.OOOE+00 2.390E-11 4.730E-11 SKIN(FGR) 1.060E-13 1. 088E-11 1.088E-11 1.010E-14-1.000E+00 0.OOOE+00 0.OOOE+00 Te-133m GONADS 1. 120E-13 1. llE-ll 1.113E-11 2.320E-15-1.000E+00 3.390E-12 3.680E-11 BREAST 1.270E-13 1.062E-11 1.065E-11 2.220E-15-1.OOOE+00 4.910E-12 1.140E-11 LUNGS 1.120E-13 1.019E-11 1.021E-11 2.130E-15-1.OOOE+00 2.060E-10 8.330E-12 RED MARR 1.090E-13 1. 043E-11 1.045E-11 2.180E-15-1.OOOE+00 4.890E-12 1.310E-11 BONE SUR 1.750E-13 1. 478E-11 1.482E-11 3.090E-15-1.OOOE+00 4.130E-12 6.610E-12 THYROID 1.150E-13 1.038E-11 1.041E-11 2.170E-15-1.OOOE+00 2.630E-09 4.170E-09 REMAINDER 1.070E-13 1. 009E-11 1.012E-11 2.110E-15-1.OOOE+00 1.430E-11 2.890E-10 EFFECTIVE 1.140E-13 1.062E-11 1.065E-11 2.220E-15-1.OOOE+00 1.10E-10 2.260E-10 SKIN(FGR) 1.740E-13 4 .832E-11 4 .843E-11 1.010E-14-1.000E+00 0.OOOE+00 0.OOOE+00 Te-134 GONADS 4.160E-14 3.299E-12 3.300E-12 9.120E-16-1.OOOE+00 7.900E-12 2.030E-11 BREAST 4.750E-14 3.J176E-12 3.177E-12 8.780E-16-1.OOOE+00 7. 960E-12 1.370E-11 LUNGS 4 . 100E-14 2.980E-12 2.981E-12 8.240E-16-1.OOOE+00 6.600E-11 1.290E-11 RED MARR 3. 940E-14 3.009E-12 3.01OE-12 8.320E-16-1.OOOE+00 8.380E-12 1.490E-11 BONE SUR 7.560E-14 4.883E-12 4 .885E-12 1.350E-15-1.OOOE+00 7.780E-12 1.230E-11 THYROID 4 .230E-14 3.100E-12 3.101E-12 8.570E-16-1.OOOE+00 5.560E-10 8.820E-10 REMAINDER 3.910E-14 2.923E-12 2.924E-12 8.080E-16-1.OOOE+00 1.090E-11 9.650E-11 EFFECTIVE 4 .240E-14 3.136E-12 3.137E-12 8.670E-16-1.OOOE+00 3.230E-11 6.630E-11 SKIN(FGR) 6.350E-14 7.813E-12 7.815E-12 2.160E-15-1.OOOE+00 0. OOOE+00 0.OOOE+00 Xe-129m GONADS 1.230E-15 1.993E-12 3.183E-11 7.020E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 BREAST 1. 600E-15 2. 135E-12 3.410E-ll 7.520E-17-1.OOOE+00 0. OOOE+00 0.OOOE+00 LUNGS 7.550E-16 9.425E-13 1.506E-11 3.320E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 RED MARR 6.450E-16 7.438E-13 1. 188E-1l 2.620E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 BONE SUR 2.840E-15 4.287E-12 6.847E-11 1.510E-16-1.OOE+00 0.OOOE+00 0.OOOE+00 THYROID 1.070E-15 1.340E-12 2.140E-11 4.720E-17-1.OOOE+00 0.000E+00 0.OOOE+00 REMAINDER 7. 600E-16 1.042E-12 1.664E-1l 3.670E-17-1.O0OE+00 0.OOOE+00 0.OOOE+00

NEDO fe$ Rev--L....

EFFECTIVE 1.060E-15 1.502E-12 2.399E-11 5.290E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 SKIN(FGR) 8.290E-15 3.151E-12 5.034E-11 1.110E-16-1.OOOE+00 0.OOOE+00 0.000E+00 Xe-131m GONADS 4 .570E-16 7.872E-13 1.371E-11 2.760E-17-1.OOOE+00 0.OOOE+00 0.000E+00 BREAST 6.020E-16 8.471E-13 1.475E-11 2.970E-17-1.OOOE+00 0. OOOE+00 O.000E+00 LUNGS 2. 670E-16 3.565E-13 6.209E-12 1.250E-17-1.OOOE+00 0.OOOE+00 O.OOOE+00 RED MARR 2.270E-16 2.792E-13 4.863E-12 9.790E-18-1.000E+00 0.OOOE+00 O.OOOE+00 BONE SUR 1.060E-15 1.677E-12 2.920E-11 5.880E-17-1.000E+00 0.OOOE+00 0.OOOE+00 THYROID 3.910E-16 5.220E-13 9.089E-12 1.830E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 REMAINDER 2.710E-16 3.993E-13 6.954E-12 1.400E-17-1.OOOE+00 0.000E+00 0.OOOE+00 EFFECTIVE 3.890E-16 5.876E-13 1.023E-11 2.060E-17-1.OOOE+00 0.OOOE+00 0.O0OE+00 SKIN(FGR) 4.820E-15 1.266E-12 2.205E-11 4.440E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 Xe-133 GONADS 1.610E-15 1.465E-12 2.052E-11 5.200E-17-1.OOOE+00 0.000E+00 0.OOOE+00 BREAST 1.960E-15 1.505E-12 2.107E-11 5.34OE-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 LUNGS 1.320E-15 1.045E-12 1.464E-11 3.710E-17-1.OOOE+00 0. OOOE+00 0.OOOE+00 RED MARR 1.070E-15 8.791E-13 1.231E-11 3.120E-17-1.OOOE+00 0. OOOE+00 0.OOOE+00 BONE SUR 5.130E-15 4.254E-12 5.958E-11 1.510E-16-1.OOOE+00 0. OOOE+00 o.OOOE+00 THYROID 1.510E-15 1.181E-12 1.653E-11 4.190E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 REMAINDER 1.240E-15 1.042E-12 1.460E-11 3.700E-17-1.OOOE+00 0.OOOE+00 0.000E+00 EFFECTIVE 1.560E-15 1.299E-12 1.819E-11 4.610E-17-1.OOOE+00 0.OOOE+00 0.000E+00 SKIN(FGR) 4. 970E-15 1.953E-12 2.734E-11 6.930E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 Xe-133m GONADS 1.420E-15 1.337E-12 1.188E-ll 4.890E-17-1.OOOE+00 0.OOOE+00 o.000E+00 BREAST 1.700E-15 1.383E-12 1.230E-11 5.060E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 LUNGS 1.190E-15 8.609E-13 7.656E-12 3.150E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 RED MARR 1.100E-15 7.844E-13 6.975E-12 2.870E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 BONE SUR 3.230E-15 2.599E-12 2.311E-11 9.510E-17-1.OOOE+00 0. OOOE+00 0.OOOE+00 THYROID 1.360E-15 1.028E-12 9.138E-12 3.760E-17-1.OOOE+00 0.OOOE+00 0.000E+00 REMAINDER 1.150E-15 8.855E-13 7.874E-12 3.240E-17-1.OOOE+00 0.OOOE+00 0.OOOE+00 EFFECTIVE 1.370E-15 1.112E-12 9.892E-12 4.070E-17-1.OOOE+00 0.OOOE+00 0.000E+00 SKIN(FGR) 1.040E-14 1.894E-12 1.684E-11 6.930E-17-1.OOOE+00 0.OOOE+00

WEDO_ _-___R_ /_

AtL / pageYZof7 0.OOOE+00 Xe-135 GONADS 1.170E-14 5.455E-12 1. 194E-11 2.530E-16-1.OOOE+00 0.OOOE+00 0.000E+00 BREAST 1.330E-14 5.325E-12 1. 166E-11 2.470E-16-1.OOOE+00 0.OOOE+00 0.000E+00 LUNGS 1.130E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+00 0.OOOE+00 0.000E+00 RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+00 o.OOOE+00 0.OOOE+00 BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-1.OOOE+00 0.OOOE+00 0.000E+00 THYROID 1.180E-14 5.023E-12 1.100E-11 2.330E-16-1.OOOE+00 0. OOOE+00 0.000E+00 REMAINDER 1.080E-14 4.829E-12 1.058E-11 2.240E-16-1.OOOE+00 0.OOOE+00 0.000E+00 EFFECTIVE 1.190E-14 5.217E-12 1.142E-11 2.420E-16-1.OOOE+00 0.000E+00 0.000E+00 SKIN(FGR) 3.120E-14 4.506E-11 9.867E-11 2.090E-15-1.OOOE+00 0.000E+00 0.OOOE+00 Xe-135m GONADS 2.000E-14 5.929E-13 5.929E-13 4.480E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 BREAST 2.290E-14 5.691E-13 5. 691E-13 4.300E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 LUNGS 1.980E-14 5.347E-13 5.347E-13 4.040E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 RED MARR 1. 910E-14 5.400E-13 5.400E-13 4.080E-16-1.000E+00 0.OOOE+00 0.OOOE+00 BONE SUR 3.500E-14 8.246E-13 8.246E-13 6.230E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 THYROID 2.040E-14 5.612E-13 5.612E-13 4.240E-16-1.OOOE+00 0. OOOE+00 0.OOOE+00 REMAINDER 1.890E-14 5.241E-13 5.241E-13 3.960E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 EFFECTIVE 2.040E-14 5.612E-13 5.612E-13 4.240E-16-1.OOOE+00 0.000E+00 0.OOOE+00 SKIN(FGR) 2. 970E-14 1.866E-12 1.866E-12 1.410E-15-1.OOOE+00 0.OOOE+00 0.OOOE+00 Xe-138 GONADS 5.590E-14 1.312E-12 1. 312E-12 1.070E-15-1.OOOE+00 0.OOOE+00 0.OOOE+00 BREAST 6.320E-14 1.251E-12 1.251E-12 1.020E-15-1.OOOE+00 0. OOOE+00 0.000E+00 LUNGS 5.660E-14 1.223E-12 1.223E-12 9.970E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 RED MARR 5.600E-14 1.251E-12 1.251E-12 1.020E-15-1.OOOE+00 0. OOOE+00 0.00EE+00 BONE SUR 8.460E-14 1.729E-12 1.729E-12 1.410E-15-1.OOOE+00 0. OOOE+00 0.000E+00 THYROID 5.770E-14 1.171E-12 1.171E-12 9.550E-16-1.OOOE+00 0. OOOE+00 0.000E+00 REMAINDER 5.490E-14 1.219E-12 1.219E-12 9.940E-16-1.OOOE+00 0.000E+00 o.000E+00 EFFECTIVE 5.770E-14 1.263E-12 1.263E-12 1.030E-15-1.OOOE+00 0.OOOE+00 0.000E+00 SKIN(FGR) 1.070E-13 9.383E-12 9.383E-12 7.650E-15-1.OOOE+00 0.OOOE+00 0.OOOE+00

NEDC.@S-°w/Rev ~/

0 AnL / page S1~of /7? Page:_El_ of_E35_

CaIc. No.: ALION-CAL-NPPD-3236-001 AL I O N

$090t "M C74P"NO?"T Rev. Number: 1 ATTACHMENT E RADTRAD Base Case Detailed Output File (oO)

NEDC2A12!/ReV.L Aftp-asa f(6 of no1-RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:27:16

4441*1444##414444441*###1*11441##*1114##4#41444#44444141*#4#4144#*#*414#

File information Plant file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHAcooper 9-21-05.psf Inventory file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nif Release file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\RG1_183FHA.RFT Dose Conversion file = C:\Cooper FRA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inp

30# 4 1 4 #5 #14 #* #

44 * #1 4## #4 1 *

14 444 #11 4 # 4# 444

44#

4#* #4 # ### #

Radtrad 3.03 4/15/2001 Nuclide Inventory File:

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nif Plant Power Level:

1.5329E+01 Compartments:

3 Compartment 1:

primary 3

7.9500E+05 0

0 0

Compartment 2:

Environment 2

O.OOOOE+00 0

0 0

Compartment 3:

Control Room 1

Att /page$I.Zof-LZ0 1.4 186E+05 0

0 0

Pathways:

4 Pathway 1:

primary to Ei:ivironment 1

2 2

Pathway 2:

Environment tto Control Room 2

3 2

Pathway 3:

Environment t:o Control Room 2

3 2

Pathway 4:

Control Room to Environrment 3

2 2

End of Plant Model File Scenario Description Name:

Plant Model Filename:

Source Term:

1 1 1.OOOOE+00 C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inp C:\Cooper FHA Analysis\Cooper FHA Files\Rev l 9-21-05\RG1_183FHA.RFT 2.4000E+01 1

9.5000E-01 4.8500E-02 1.5000E-03 1.0000E+00 Overlying Pool:

0 0.OOOOE+00 0

0 0

0 Compartments:

3 Compartment 1:

1 1

0 0

0

NEDO °5:.-o/ Rev /

Att / pageaSZoftLZ Compartment 2:

1 1

0 0

0 Compartment 3:

1 1

0 0

0 Pathways:

4 Pathway 1:

0 2.4000E+01 4.5760E+04 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

1 0

0 Pathway 2:

0 0

0 1

2 2.4000E+01 3.2350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 8.1000E+02 8.9000E+01 8. 9000E+01 8.9000E+01 0

1 2

0 0

Pathway 3:

0 0

0 1

NEDC0 9-" Rev../.

AtLt..page.Ztoftlo2 1

2.4000E+01 4.OOOOE+02 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0

0 0

0 Pathway 4:

0 0

1 2

2.4000E+01 3.6350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 1.2100E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

0 0

0 Dose Locations:

3 Location 1:

EAB 2

1 2

2.4000E+01 5.2000E-04 2.6000E+01 O.OOOOE+00 1

4 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 O.OOOOE+00 0

Location 2:

LPZ 2

1 5

2.4000E+01 2.9000E-04 3.2000E+01 7.3000E-05 4.8000E+01 2.5000E-05 1.2000E+02 5.2000E-06 7.4400E+02 ID.OOOOE+00 1

4 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 I2.3000E-04 7.4400E+02 IO.OOOOE+00 0

Location 3:

Control Room 3

NEDC5F- cl/Rev t.L Att / page*eb ofJLZ0 0

1 2

2.4000E+01 3.5000E-04 7.4400E+02 O.OOOOE+00 1

4 2.4000E+01 1.OOOOE+00 4.8000E+01 6.OOOOE-01 1.2000E+02 4.OOOOE-01 7.4400E+02 O.OOOOE+00 Effective Volume Location:

1 6

2.4000E+01 4.1500E-03 2.6000E+01 3.2400E-03 3.2000E+01 1.3200E-03 4.8000E+01 9.O100E-04 1.2000E+02 7.2200E-04 7.4400E+02 O.OOOOE+00 Simulation Parameters:

0 Output Filename:

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHAcooper 9 05.oO 1

1 1

0 0

End of Scenario File

NEDCoS/Rev ZL Att / pageL/ofd-27 This page intentionally left blank

NEDO or- 70/RevL/

Att t page .6-zot-/-O fltfltffffflflffflf##ffftfffft###############ffhfftlltfff#fI#ff###f##ff#f RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:27:16 Plant Description Number of Nuclides = 29 Inventory Power = 1.OOOOE+00 MWth Plant Power Level = 1.5329E+01 MWth Number of compartments = 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: primary Compartment volume = 7.9500E+05 (Cubic feet)

Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: primary to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: primary to Environment Inlet Pathway Number 4: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 1.4186E+05 (Cubic feet)

Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Inlet Pathway Number 3: Environment to Control Room Exit Pathway Number 4: Control Room to Environment Total number of pathways = 4

NEDC0,'-e3ZRev /_

AtJpage 0 of/Ze RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:27:16 Scenario Description Time between shutdown and first release = 2.4000E+01 (Hours)

Radioactive Decay is enabled Calculation of Daughters is enabled Release Fractions and Timings GAP EARLY IN-VESSEL LATE RELEASE RELEASE MASS 0.003600 hr 0.0000 hrs 0.0000 hrs (gm)

NOBLES 5.OOOOE-02 0.OOOOE+00 0.00OOE+00 1.659E+00 IODINE 2.5000E-04 0.OOOOE+00 0.OOOOE+00 1.615E-03 CESIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 TELLURIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 STRONTIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 BARIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 RUTHENIUM 0.OOOOE+00 0.OOOE+00 0.OOOOE+00 0.OOOE+00 CERIUM 0.0000E+00 0.0000E+00 0.OOOOE+00 0.000E+00 LANTHANUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 Inventory Power = 15. MWt Nuclide Group Specific half Whole Body Inhaled Inhaled Name Inventory life DCF Thyroid Effective (Ci/MWt) (s) (Sv-m3/Bq-s) (Sv/Bq) (Sv/Bq)

Br-82 2 1.800E+02 1.271E+05 1.300E-13 2.380E-10 3.310E-10 Br-83 2 3.260E+03 8. 604E+03 3.820E-16 3.290E-12 2.330E-11 Br-84 2 5.610E+03 1. 908E+03 9.410E-14 3.120E-12 2.610E-11 Kr-83m 1 3.270E+03 6.588E+03 1.500E-18 0.OOOE+00 0.OOOE+00 Kr-85 1 7.320E+02 3.383E+08 1.190E-16 0. OOOE+00 0.OOOE+00 Kr-85m 1 6.810E+03 1.613E+04 7.480E-15 0.OOOE+00 0.OOOE+00 Kr-87 1 1.300E+04 4.578E+03 4.120E-14 0.OOOE+00 0.OOOE+00 Kr-88 1 1.830E+04 1.022E+04 1.020E-13 0.OOOE+00 0.OOOE+00 I-128 2 4.190E+02 1. 499E+03 4.160E-15 5.340E-11 1.280E-11 I-130 2 1.060E+03 4 .450E+04 1.040E-13 1.990E-08 7.140E-10 I-131 2 4.352E+04 6.947E+05 1.820E-14 2.920E-07 8.890E-09 I-132 2 3.930E+04 8.280E+03 1.120E-13 1.740E-09 1.030E-10 I-133 2 5.510E+04 7.488E+04 2.940E-14 4.860E-08 1.580E-09 I-134 2 6.040E+04 3.156E+03 1.300E-13 2.880E-10 3.550E-11 I-135 2 5.160E+04 2.380E+04 8.294E-14 8.4 60E-09 3.320E-10 Xe-129m 1 2.060E-01 6.912E+05 1.060E-15 0.OOOE+00 0.OOOE+00 Xe-131m 1 3.040E+02 1.028E+06 3.890E-16 0.OOOE+00 0.OOOE+00 Xe-133 1 5.260E+04 4.532E+05 1.560E-15 0.OOOE+00 0.OOOE+00 Xe-133m 1 1.580E+03 1.890E+05 1.370E-15 0.OOOE+00 0.OOOE+00 Xe-135 1 1.860E+04 3.272E+04 1.190E-14 0.OOOE+00 0.OOOE+00 Xe-135m 1 1.090E+04 9.174E+02 2.040E-14 0.OOOE+00 0.OOOE+00 Xe-138 1 4.500E+04 8.502E+02 5.770E-14 0.OOOE+00 0.OOOE+00 Nuclide Daughter Fraction Daughter FractiorI Daughter Fraction Br-83 Kr-83m 1.00 none 0.00 none 0.00 Kr-85m Kr-85 0.21 none 0.00 none 0.00 Kr-87 Rb-87 1.00 none 0.00 none 0.00

NEBO ~5-~Rev--.I Kr-88 Rb-88 1.00 none 0.00 none 0.00 I-131 Xe-131m 0.01 none 0.00 none 0.00 I-133 Xe-133m 0.03 Xe-133 0.97 none 0.00 I-135 Xe-135m 0.15 Xe-135 0.85 none 0.00 Te-129 I-129 1.00 none 0.00 none 0.00 Te-131 I-131 1.00 none 0.00 none 0.00 Te-131m I-131 0.78 Te-131 0.22 none 0.00 Te-132 I-132 1.00 none 0.00 none 0.00 Te-133 I-133 1.00 none 0.00 none 0.00 Te-133m I-133 0.87 Te-133 0.13 none 0.00 Te-134 I-134 1.00 none 0.00 none 0.00 Xe-133m Xe-133 1.00 none 0.00 none 0.00 Xe-135 Cs-135 1.00 none 0.00 none 0.00 Xe-135m Cs-135 0.00 Xe-135 1.00 none 0.00 Xe-138 Cs-138 1.00 none 0.00 none 0.00 Iodine fractions Aerosol 9.5000E-01 Elemental 4.8500E-02 Organic 1.5000E-03 COMPARTMENT DATA Compartment number 1: primary Compartment number 2: Environment Compartment number 3: Control Room PATHWAY DATA Pathway number 1: primary to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filterr Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 4.5760E+04 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 3.2350E+03 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 2.4017E+01 8.1000E+02 8.9000E+01 8.9000E+01 8.9000E+01 Pathway number 3: Environment to Control Room Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 4.OOOOE+02 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 4: Control Room to Environment Pathway Filter: Removal Data

NEDC__ __-_Re_

AttL page.I cfL°'

Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 3.6350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 1.2100E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 LOCATION DATA Location EAB is in compartment 2 Location X/Q Data Time (hr) X/Q (s

mA-3) 2.4000E+01 5.2000E-04 2.6000E+01 0.000OE+00 Location Breathing Rate Data Time (hr) Breathing Rate (mA3

secA^-)

2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 0.OOOOE+00 Location LPZ is il n compartment 2 Location X/Q Data Time (hr) Xh ' (s

m^-3) 2.4000E+01 2.9000E-04 3.2000E+01 7.3000E-05 4.8000E+01 2.5000E-05 1.2000E+02 5.2000E-06 7.4400E+02 0.OOOOE+00 Location Breathing Ralte Data Time (hr) Brieathing Rate (m^3

sec^-l) 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 0.OOOOE+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr) X/5Q (s

m^-3) 2.4000E+01 4.1500E-03 2.6000E+01 3.24OOE-03 3.2000E+01 1.3200E-03 4.8000E+01 9.0100E-04 1.2000E+02 7.2200E-04 7.4400E+02 0.OOOOE+00 Location Breathing Rai:e Data Time (hr) Br(eathing Rate (mA3

sec^-1) 2.4000E+01 3.5000E-04 7.4400E+02 0.OOOOE+00 Location Occupancy Facctor Data Time (hr) Occcupancy Factor 2.4000E+01 1.OOOOE+00 4.8000E+01 6.O0O0E-01 1.2000E+02 4.OOOOE-01 7.4400E+02 0.OOOOE+00

NEDC °rI43ZRev /

AAtt page 600on2z 9 RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:27:16

1. 1. 1. # II #*### ##### I

11111*

# # I # # # #

I

# # 1I # # #

I

# # I #

I ## *

I

$ I # # * #

### #### I # # * # #t

1. III*lI*####*####I*I*II*I***I*I*II*I*II*I**#I#*I1*II#I*III*IIIIII##

Dose, Detailed model and Detailed Inventory Output EAB D#oses:I#I*II*IIIII#II#I***IIII**I#IIII#**II*III#**IIII*III*I EAB Doses:

Time (h) = 24.0036 Whole Body Thyroid TEDE Delta dose (rem) 2.7183E-03 2.0885E-01 9.1494E-03 Accumulated dose (rem) 2.7183E-03 2.0885E-01 9.1494E-03 LPZ Doses:

Time (h) = 24.0036 Whole Body Thyroid TEDE Delta dose (rem) 1.5160E-03 1.1648E-01 5.1026E-03 Accumulated dose (rem) 1.5160E-03 1.1648E-01 5.1026E-03 Control Room Doses:

Time (h) - 24.0036 Whole Body Thyroid TEDE Delta dose (rem) 2.1953E-06 3.5896E-03 1.1273E-04 Accumulated dose (rem) 2.1953E-06 3.5896E-03 1.1273E-04 primary Compartment Nuclide Inventory:

Time (h) = 24.0036 Ci kg Atoms Decay Br-82 4 .2789E-01 3.9523E-10 2. 9026E+15 1.5659E+11 Br-83 1.1766E-02 7.4478E-13 5.4038E+12 4.3073E+09 Kr-83m 9.2688E+00 4.4924E-10 3.2595E+15 3.3936E+12 Kr-85 5.5752E+02 1.4210E-03 1.0068E+22 2.0402E+14 Kr-85m 1.2648E+02 1.5369E-08 1.0889E+17 4.6295E+13 Kr-87 2.0586E-02 7.2677E-13 5.0307E+12 7.5391E+09 Kr-88 3.9805E+01 3.1745E-09 2. 1724E+16 1.4571E+13 I-130 1.0506E+00 5.3869E-10 2.4954E+15 3.8450E+11 I-131 1.5319E+02 1.2356E-06 5. 6802E+18 5.6057E+13 I-132 1.2356E+02 1.1970E-08 5.4610E+16 4.5232E+13 I-133 9.6439E+01 8.5132E-08 3.8547E+17 3.5292E+13 I-134 5.2119E-06 1.9537E-16 8.7803E+08 1.9094E+06 I-135 1.5858E+01 4.5155E-09 2.0143E+16 5.8038E+12 Xe-129m 1. 4389E-01 1.1372E-09 5.3088E+15 5.2654E+10 Xe-131m 2.3831E+02 2.8451E-06 1.3079E+19 8.7205E+13 Xe-133 3.8763E+04 2.0709E-04 9.3767E+20 1.4185E+16 Xe-133m 1.1043E+03 2.4611E-06 1. 1144E+19 4 .0412E+14

NEDC-4.Lc-3 / Rev...iZ.

Att / Zpage A5'.ofLZ5'o Xe-135 1.0706E+04 4.1923E-06 1.8701E+19 3.9181E-'15 Xe-135m 5.4903E+02 6.0272E-09 2. 6886E+16 2.0165E+14 primary Transport Group Inventory:

Time (h) = 24.0036 Atmosphere Sump Noble gases (atoms) 1.1049E+22 0.OOOOE+00 Elemental I (atoms) 2.9807E+17 0.0000E+00 Organic I.(atoms) 9.2188E+15 0.OOOOE+00 Aerosols (kg) 1.2713E-06 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 7.5708E-09 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 8.2062E-09 Total I (Ci) 3.8904E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.8825E+19 Elemental I (atoms) 0.OOOOE+00 1.8568E+15 Organic I (atoms) 0.OOOOE+00 5.7428E+13 Aerosols (kg) 0.OOOOE+00 7.9193E-09 Environment Integral Nuclide Release:

Time (h) = 24.0036 Ci kg Atoms Bq Br-82 2.6655E-03 2.4620E-12 1.8081E+13 9.8623E+07 Br-83 7.3299E-05 4.6398E-15 3.3665E+10 2.7121E+06 Kr-83m 5.7743E-02 2.7987E-12 2.0306E+13 2.1365E+09 Kr-85 3.4730E+00 8.8521E-06 6.2716E+19 1.2850E+11 Kr-85m 7.8793E-01 9.5745E-11 6.7834E+14 2.9154E+10 Kr-87 1.2826E-04 4.5279E-15 3.1342E+10 4.7455E+06 Kr-88 2.4798E-01 1.9776E-11 1.3533E+14 9.1751E+09 1-130 6.5448E-03 3.3557E-12 1.5545E+13 2.4216E+08 I-131 9.5425E-01 7.6971E-09 3.5384E+16 3.5307E+10 I-132 7.6969E-01 7.4567E-11 3.4019E+14 2.8479E+10 I-133 6.0075E-01 5.3032E-10 2.4013E+15 2.2228E+10 I-134 3.2473E-08 1.2173E-18 5.4707E+06 1.2015E+03 I-135 9.8786E-02 2.8129E-11 1.2548E+14 3.6551E+09 Xe-129m 8.9632E-04 7.0840E-12 3.3071E+13 3.3164E+07 Xe-131m 1.4845E+00 1.7723E-08 8. 1473E+16 5.4926E+10 Xe-133 2.4147E+02 1.2900E-06 5.8410E+18 8.9342E+12 Xe-133m 6.8792E+00 1.5331E-08 6.9418E+16 2.5453E+11 Xe-135 6.6692E+01 2.6115E-08 1.1650E+17 2.4676E+12 Xe-135m 3.4209E+00 3.7554E-11 1.6752E+14 1.2657E+11 Environment Transport Group Inventory:

Total Release Time (h) = 24.0036 Release Rate/s Noble gases (atoms) 6.8825E+19 5.3106E+18 Elemental I (atoms) 1.8568E+15 1.4327E+14 Organic I (atoms) 5.7427E+13 4.4311E+12 Aerosols (kg) 7.9191E-09 6.1105E-10 Dose Effective (Ci) I-131 (Thyroid) 1. 0617E+00 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 1.1508E+00 Total I (Ci) 2.4235E+00 primary to Environment Transport Group Inventory:

Pathway

NEDO o9:-.'O/Rev...L....

Att / page~l'ot..LZO Time (h) - 24.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.8825E+19 Elemental I (atoms) O.OOOOE+00 1.8568E+15 Organic I (atoms) O . OOOOE+00 5.7428E+13 Aerosols (kg) O.OOOOE+00 7.9193E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) - 24.0036 Filtered Transported Noble gases (atoms) O.OOOOE+00 4.3608E+17 Elemental I (atoms) 0.000OE+00 1.1765E+13 Organic I (atoms) 0.OOOOE+00 3.6386E+11 Aerosols (kg) 0.OOOOE+00 5.0177E-11 Environment to Control Room Transport Group Inventory:

Pathway Time (h) - 24.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 5.3920E+16 Elemental I (atoms) 0.OOOOE+00 1.4547E+12 Organic I (atoms) O.OOOOE+00 4.4991E+10 Aerosols (kg) 0.OOOOE+00 6.2042E-12 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (atoms) 9.0338E+14 0.OOOOE+00 Elemental I (atoms) 2.4372E+10 0.OOOOE+00 Organic I (atoms) 7.5378E+08 0.OOOOE+00 Aerosols (kg) 1.0395E-13 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 24.0036 Ci kg Atoms Decay Br-82 1.8942E-05 1.7496E-14 1.2849E+11 6.4473E+06 Br-83 5.2085E-07 3.2970E-17 2.3922E+08 1.7735E+05 Kr-83m 4.1030E-04 1.9887E-14 1.4429E+11 1.3972E+08 Kr-85 2.4680E-02 6.2906E-08 4.4568E+17 8.4004E+09 Kr-85m 5.5991E-03 6.8037E-13 4 .8203E+12 1.9061E+09 Kr-87 9.1131E-07 3.2172E-17 2.2270E+08 3.1040E+05 Kr-88 1.7621E-03 1.4053E-13 9.6167E+ll 5.9995E+08 I-130 4.6509E-05 2.3847E-14 1.1047E+11 1.5831E+07 I-131 6.7812E-03 5.4698E-ll 2.5145E+14 2.3081E+09 I-132 5.4692E-03 5.2986E-13 2.4173E+12 1.8623E+09 I-133 4.2691E-03 3.7686E-12 1.7064E+13 1.4531E+09 I-134 2.3072E-10 8. 6487E-21 3.8868E+04 7.8610E+01 I-135 7.0199E-04 1.9989E-13 8.9168E+11 2.3897E+08 Xe-129m 6.3695E-06 5.0341E-14 2.3501E+11 2.1680E+06 Xe-131m 1.0549E-02 1.2594E-10 5.7897E+14 3.5906E+09 Xe-133 1.7159E+00 9.1672E-09 4 .1508E+16 5.8405E+1l Xe-133m 4.8886E-02 1.0895E-10 4.9331E+14 1.6639E+10 Xe-135 4.7392E-01 1.8558E-10 8.2785E+14 1.6132E+ll Xe-135m 2.4293E-02 2.6669E-13 1.1897E+12 8.2973E+09 Control Room Transport Group Inventory:

Time (h) = 24.0036 Atmosphere Sump Noble gases (atoms) 4.8909E+17 0.OOOOE+00 Elemental I (atoms) 1.3195E+13 0.OOOOE+00

AtL.L..page*l-~'Of-LZT' Organic I (atoms) 4.0809E+11 0.OOOOE+00 Aerosols (kg) 5.6276E-11 0.0000E+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.8782E-12 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 2.0358E-12 Total I (Ci) 1.7222E-02 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 4.3608E+17 Elemental I (atoms) 0.0000E+00 1.1765E+13 Organic I (atoms) 0.OOOOE+00 3.6386E+ll Aerosols (kg) 0.0000E+00 5.0177E-ll Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 5.3920E+16 Elemental I (atoms) 0.OOOOE+00 1.4547E+12 Organic I (atoms) 0.OOOOE+00 4.4991E+10 Aerosols (kg) 0.OOOOE+00 6.2042E-12 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (atoms) 9.0338E+14 0.OOOOE+00 Elemental I (atoms) 2.4372E+10 0.OOOOE+00 Organic I (atoms) 7.5378E+08 0.OOOOE+00 Aerosols (kg) 1.0395E-13 0.0000E+00 EAB Doses:

Time (h) = 24.0170 Whole Body Thyroid TEDE Delta dose (rem) 1.9724E-02 1.5162E+00 6. 6412E-02 Accumulated dose (rem) 2.2443E-02 1.7251E+00 7.5562E-02 LPZ Doses:

Time (h) = 24.0170 Whole Body Thyroid TEDE Delta dose (rem) 1.1000E-02 8.4557E-01 3.7038E-02 Accumulated dose (rem) 1.2516E-02 9.6205E-01 4.2140E-02 Control Room Doses:

Time (h) = 24.0170 Whole Body Thyroid TEDE Delta dose (rem) 9.6149E-05 1.5728E-01 4.9393E-03 Accumulated dose (rem) 9.8344E-05 1.6087E-01 5.0521E-03 primary Compartment Nuclide Inventory:

Time (h) = 24.0170 Ci kg Atoms Decay Br-82 4.0843E-01 3.7726E-10 2.7706E+15 8.8568E+ll Br-83 1.1190E-02 7.0834E-13 5.1394E+12 2.4319E+10 Kr-83m 8.8049E+00 4.2676E-10 3.0964E+15 1.9149E+13 Kr-85 5.3231E+02 1.3568E-03 9.6125E+21 1. 1541E+15 Kr-85m 1.2051E+02 1.4644E-08 1.0375E+17 2. 6162E+14 Kr-87 1.9512E-02 6.8886E-13 4.7683E+12 4.2494E+10

NEDC"OV- 0 3t Rev...L..

Aftt..Lpage2.-...otLLZ Kr-88 3.7881E+01 3.0210E-09 2.0674E+16 8.2295E+13 I-130 1.0024E+00 5.1394E-10 2.3808E+15 2.1743E+12 I-131 1.4625E+02 1.1797E-06 5.4231E+18 3.1710E+14 I-132 1.1749E+02 1.1383E-08 5.1930E+16 2.5537E+14 I-133 9.2036E+01 8. 1246E-08 3.6788E+17 1.9960E+14 I-134 4.9238E-06 1.8457E-16 8.2949E+08 1.0744E+07 I-135 1.5119E+01 4.3053E-09 1.9205E+16 3.2809E+13 Xe-129m 1.3737E-01 1.0857E-09 5.0685E+15 2.9785E+11 Xe-131m 2.2752E+02 2.7163E-06 1.2487E+19 4.9331E+14 Xe-133 3.7007E+04 1.9771E-04 8.9520E+20 8.0240E+16 Xe-133m 1.0542E+03 2.3494E-06 1.0638E+19 2.2859E+15 Xe-135 1.0212E+04 3.9988E-06 1.7838E+19 2.2153E+16 Xe-135m 5.0552E+02 5.5496E-09 2.4756E+16 1.1204E+15 primary Transport Group Inventory:

Time (h) = 24.0170 Atmosphere Sump Noble gases (atoms) 1.0549E+22 0.OOOOE+00 Elemental I (atoms) 2.8456E+17 0.OOOOE+00 Organic I (atoms) 8.8009E+15 0.OOOOE+00 Aerosols (kg) 1.2136E-06 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyr oid) 7.2276E-09 Dose Effective (Ci/cc) I-131 (ICRP:2 Thyroid) 7.8335E-09 Total I (Ci) 3.7090E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) 0.OOOOE+00 5.6848E+20 Elemental I (atoms) 0.000OE+00 1.5337E+16 Organic I (atoms) 0.OOOOE+00 4.7433E+14 Aerosols (kg) O.OOOOE+00 6.5410E-08 Environment Integral Nuclide Release:

Time (h) = 24.0170 Ci kg Atoms Bq Br-82 2.2011E-02 2.0331E-11 1.4931E+14 8.1441E+08 Br-83 6.0333E-04 3.8191E-14 2.7710E+11 2.2323E+07 Kr-83m 4 .7479E-01 2.3012E-11 1.6697E+14 1.7567E+10 Kr-85 2.8686E+01 7.3116E-05 5.1802E+20 1.0614E+12 Kr-85m 6.4961E+00 7.8936E-10 5.5925E+15 2.4036E+11 Kr-87 1.0525E-03 3.7156E-14 2.5719E+11 3.8941E+07 Kr-88 2.0422E+00 1.6287E-10 1.1146E+15 7.5563E+10 I-130 5.4022E-02 2.7699E-11 1.2831E+14 1.9988E+09 I-131 7.8815E+00 6.3574E-08 2.9225E+17 2.9162E+11 I-132 6.3348E+00 6.1371E-10 2.7999E+15 2.3439E+11 I-133 4.9601E+00 4.3786E-09 1. 9826E+16 1.8352E+11 I-134 2.6569E-07 9.9596E-18 4.4760E+07 9.8306E+03 I-135 8.1493E-01 2.3205E-10 1.0351E+15 3.0152E+10 Xe-129m 7.4031E-03 5.8510E-11 2.7314E+14 2.7391E+08 Xe-131m 1.2261E+01 1.4638E-07 6.7293E+17 4.5366E+11 Xe-133 1.9943E+03 1.0654E-05 4.8243E+19 7.3790E+13 Xe-133m 5.6812E+01 1.2661E-07 5.7329E+17 2.1020E+12 Xe-135 5.5038E+02 2.1552E-07 9.6141E+17 2.0364E+13 Xe-135m 2.7365E+01 3.004lE-10 1.3401E+15 1.0125E+12 Environment Transport Group Inventory:

Total Release Time (h) = 24.0170 Release Rate/s

NEDCO-f'-.> Rev /L Noble gases (atoms) 5.6848E+20 9.2888E+18 Elemental I (atoms) 1.5335E+16 2.5058E+14 Organic I (atoms) 4.7428E+14 7.7498E+12 Aerosols (kg) 6.5404E-08 1.0687E-09 Dose Effective (Ci) I-131 (Thyroid) 8.7684E+00 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 9.5036E+00 Total I (Ci) 1.9991E+01 primary to Environment Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) 0.OOOOE+00 5.6848E+20 Elemental I (atoms) 0.0000E+00 1.5337E+16 Organic I (atoms) 0.OOOOE+00 4.7433E+14 Aerosols (kg) O.OOOOE+00 6.5410E-08 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) O.0000E+00 3.6019E+18 Elemental I (atoms) 0.OOOOE+00 9.7174E+13 Organic I (atoms) 0.0000E+00 3.0054E+12 Aerosols (kg) 0.OOOOE+00 4.1444E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) 0.OOOOE+00 4.4537E+17 Elemental I (atoms) 0.OOOOE+00 1.2015E+13 Organic I (atoms) 0.OOOOE+00 3.7161E+11 Aerosols (kg) 0.OOOOE+00 5.1245E-11 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) 4.7552E+16 0.OOOOE+00 Elemental I (atoms) 1.2829E+12 0.OOOOE+00 Organic I (atoms) 3.9677E+10 0.OOOOE+00 Aerosols (kg) 5.4714E-12 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 24.0170 Ci kg Atoms Decay Br-82 1.5486E-04 1.4304E-13 1.0505E+12 2.8289E+08 Br-83 4.2429E-06 2.6857E-16 1.9487E+09 7.7651E+06 Kr-83m 3.3385E-03 1.6181E-13 1.1740E+12 6.1136E+09 Kr-85 2.0183E-01 5.1443E-07 3.6447E+18 3.6864E+11 Kr-85m 4.5693E-02 5.5524E-12 3.9338E+13 8.3548E+10 Kr-87 7.3983E-06 2.6119E-16 1.8079E+09 1.3564E+07 Kr-88 1.4363E-02 1. 1454E-12 7.8386E+12 2.6278E+10 I-130 3.8006E-04 1. 9487E-13 9.0270E+ll 6.9444E+08 I-131 5.5452E-02 4. 4729E-10 2.0562E+15 1.0129E+11 I-132 4.4548E-02 4.3158E-12 1.9690E+13 8. 1537E+10 I-133 3.4896E-02 3.0805E-11 1.3948E+14 6.3753E+10 I-134 1.8669E-09 6.9982E-20 3.1451E+05 3.4285E+03 I-135 5.7327E-03 1. 6324E-12 7.2818E+12 1.0478E+10

NEDC -0.;-07-rRev-Z-Aft./ page Zz of/ 70 Xe-129m 5.2086E-05 4.1166E-13 1.9218E+12 9.5138E+07 Xe-131m 8.6267E-02 1.0299E-09 4.7346E+15 1.5757E+11 Xe-133 1.4032E+01 7.4962E-08 3.3942E+17 2.5630E+13 Xe-133m 3.9971E-01 8.9080E-10 4.0335E+15 7.3013E+11 Xe-135 3.8719E+00 1.5162E-09 6.7635E+15 7.0754E+12 Xe-135m 1.9166E-01 2.1041E-12 9.3859E+12 3.5665E+11 Control Room Transport Group Inventory:

Time (h) = 24.0170 Atmosphere Sump Noble gases (atoms) 3.9997E+18 O.0000E+00 Elemental I (atoms) 1.0789E+14 O.0000E+00 Organic I (atoms) 3.3369E+12 0.OOOOE+00 Aerosols (kg) 4.6016E-10 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.5358E-11 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.6645E-11 Total I (Ci) 1.4063E-01 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) 0.000OE+00 3.6019E+18 Elemental I (atoms) 0.OOOOE+00 9.7174E+13 Organic I (atoms) 0.OOOOE+00 3.0054E+12 Aerosols (kg) 0.OOOOE+00 4.1444E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) 0.OOOOE+00 4.4537E+17 Elemental I (atoms) 0.OOOOE+00 1.2015E+13 Organic I (atoms) 0.OOOOE+00 3.7161E+11 Aerosols (kg) 0.000OE+00 5.1245E-11 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (atoms) 4.7552E+16 0.OOOOE+00 Elemental I (atoms) 1.2829E+12 0.OOOOE+00 Organic I (atoms) 3.9677E+10 0.OOOOE+00 Aerosols (kg) 5.4714E-12 0.0000E+00 EAB Doses:

Time (h) = 26.0000 Whole Body Thyroid TEDE Delta dose (rem) 4.0120E-01 3.1913E+01 1.3836E+00 Accumulated dose (rem) 4.2364E-01 3.3638E+01 1.4591E+00 LPZ Doses:

Time (h) = 26.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.2374E-01 1.7798E+01 7.7160E-01 Accumulated dose (rem) 2.3626E-01 1.8760E+01 8.1374E-01 Control Room Doses:

Time (h) = 26.0000 Whole Body Thyroid TEDE Delta dose (rem) 9.0974E-02 8. 4 654E+01 2.6948E+00

NEDC °$- 0?/Rev ./

Att -/page7!of X7°-

Accumulated dose (rem) 9.1072E-02 8.4814E+01 2.6998E+00 primary Compartment Nuclide Inventory:

Time (h) = 26. 0000 Ci kg Atoms Decay Br-82 4.1683E-04 3.8502E-13 2.8276E+12 1.3986E+13 Br-83 6.6807E-06 4.2289E-16 3.0683E+09 3.5720E+11 Kr-83m 4.4131E-03 2.1389E-13 1.5519E+12 2.7499E+14 Kr-85 5.6482E-01 1.4396E-06 1.0200E+19 1.8325E+16 Kr-85m 9.4089E-02 1.1433E-11 8.1002E+13 3.9817E+15 Kr-87 7.0249E-06 2.4801E-16 1.7167E+09 5.8564E+ll Kr-88 2.4773E-02 1.9757E-12 1.3520E+13 1.2232E+15 I-130 9.5166E-04 4.8795E-13 2.2604E+12 3.3990E+13 I-131 1.5408E-01 1.2429E-09 5.7135E+15 5.0299E+15 I-132 6.8584E-02 6.6444E-12 3.0313E+13 3.7398E+15 I-133 9.1414E-02 8.0697E-11 3.6539E+14 3.1400E+15 I-134 1.0892E-09 4.0831E-20 1.8350E+05 1.3980E+08 I-135 1.3031E-02 3.7106E-12 1. 6552E+13 5.0610E+14 Xe-129m 1.4472E-04 1.1438E-12 5.3398E+12 4.7245E+12 Xe-131m 2.4027E-01 2.8685E-09 1.3187E+16 7.8274E+15 Xe-133 3.8854E+01 2.0758E-07 9.3988E+17 1.2721E+18 Xe-133m 1.0898E+00 2.4287E-09 1.0997E+16 3.6162E+16 Xe-135 9.3304E+00 3.6536E-09 1.6298E+16 3.4459E+17 Xe-135m 4.7375E-03 5.2008E-14 2.3200E+11 1.0207E+16 primary Transport Group Inventory:

Time (h) = 26.0000 Atmosphere Sump Noble gases (atoms) 1.1180E+19 0.OOOOE+00 Elemental I (atoms) 2.9735E+14 0.OOOOE+00 Organic I (atoms) 9.1963E+12 0.OOOOE+00 Aerosols (kg) 1.2681E-09 0.0000E+00 Dose Effective (Ci/cc) I-131 (Thyr oid) 7.5553E-12 Dose Effective (Ci/cc) I-131 (ICRP 2 Thyroid) 8.0880E-12 Total I (Ci) 3.2711E-01 primary to Environment Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1098E+22 Elemental I (atoms) 0.0000E+00 2.9887E+17 Organic I (atoms) 0.OOOOE+O0 9.2433E+15 Aerosols (kg) 0.OOOOE+00 1.2746E-06 Environment Integral Nuclide Release:

Time (h) = 26.0000 Ci kg Atoms Bq Br-82 4.2730E-01 3.9468E-10 2.8986E+15 1.5810E+10 Br-83 1.0763E-02 6.8131E-13 4.9433E+12 3.9824E+08 Kr-83m 8.2490E+00 3.9982E-10 2.9009E+15 3.0521E+11 Kr-85 5.6043E+02 1.4284E-03 1.0120E+22 2.0736E+13 Kr-85m 1.2081E+02 1.4680E-08 1.0401E+17 4.4700E+12 Kr-87 1.7418E-02 6.1493E-13 4 .2566E+12 6.4448E+08 Kr-88 3.6946E+01 2.9464E-09 2.0163E+16 1.3670E+12 I-130 1.0365E+00 5.3145E-10 2.4619E+15 3.8351E+10 I-131 1.5380E+02 1.2406E-06 5.7030E+18 5.6906E+12 I-132 1.1262E+02 1.0911E-08 4.9778E+16 4.1671E+12 I-133 9.5866E+01 8.4627E-08 3.8318E+17 3.5470E+12 I-134 4.1063E-06 1.5393E-16 6.9178E+08 1.5193E+05 I-135 1.5395E+01 4.3837E-09 1.9555E+16 5.6962E+11

NEDC e'15-'* ?1Rev /-

Att....Lpage 7Yof-/LZo Xe-129m 1.4446E-01 1. 1418E-09 5.3301E+15 5.3451E+09 Xe-131m 2.3935E+02 2.8576E-06 1.3136E+19 8.8561E+12 Xe-133 3.8895E+04 2.0779E-04 9.4087E+20 1.4391E+15 Xe-133m 1.1052E+03 2.4631E-06 1.1153E+19 4.0892E+13 Xe-135 1.0500E+04 4.1116E-06 1.8341E+19 3.8850E+14 Xe-135m 2.7283E+02 2.9951E-09 1.3361E+16 1 .0095E+13 Environment Transport Group Inventory:

Total Release Time (h) = 26.0000 Release Rate/s Noble gases (atoms) 1.1104E+22 1.5422E+18 Elemental I (atoms) 2.9880E+17 4.1500E+13 Organic I (atoms) 9.2413E+15 1.2835E+12 Aerosols (kg) 1.2743E-06 1.7699E-10 Dose Effective (Ci) I-131 (Thyroid) 1.7087E+02 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 1.8477E+02 Total I (Ci) 3.7768E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1098E+22 Elemental I (atoms) 0.OOOOE+00 2.9887E+17 Organic I (atoms) 0.OOOOE+00 9.2433E+15 Aerosols (kg) 0.OOOOE+00 1.2746E-06 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 2.0317E+19 Elemental I (atoms) 4.0057E+14 1.4668E+14 Organic I (atoms) 1.2389E+13 4.5366E+12 Aerosols (kg) 1.7084E-09 6.2559E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 8.6997E+18 Elemental I (atoms) 0.0000E+00 2.3427E+14 Organic I (atoms) 0.OOOOE+00 7.2456E+12 Aerosols (kg) 0.0000E+00 9.9915E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 1.6957E+19 O.0000E+00 Elemental I (atoms) 2.2515E+14 o.OOOOE+00 Organic I (atoms) 6.9635E+12 0.OOOOE+00 Aerosols (kg) 9.6022E-10 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 26.0000 Ci kg Atoms Decay Br-82 2.1364E-04 1.9734E-13 1.4493E+12 8.3295E+10 Br-83 3.4242E-06 2. 1675E-16 1.5726E+09 1.8022E+09

Att / .. page2E'oftZ-4 Kr-83m 4.7510E-03 2.3027E-13 1. 6708E+12 2.6585E+12 Kr-85 6.0836E-01 1.5506E-06 1.0986E+19 2.2477E+14 Kr-85m 1.0134E-01 1.2315E-11 8.7247E+13 4.4152E+13 Kr-87 7.5665E-06 2.6713E-16 1.8491E+09 5.1466E+09 Kr-88 2.6683E-02 2.1280E-12 1.4562E+13 1.2825E+13 I-130 4.8777E-04 2.5009E-13 1.1585E+12 1.9777E+11 I-131 7.8975E-02 6.3702E-10 2.9284E+15 3.0267E+13 I-132 3.5152E-02 3.4055E-12 1.5537E+13 1.8745E+13 I-133 4.6854E-02 4.1361E-11 1.8728E+14 1.8537E+13 I-134 5.5829E-10 2.0928E-20 9. 4053E+04 5.4033E+05 I-135 6.6790E-03 1.9018E-12 8.4838E+12 2.8558E+12 Xe-129m 1.5588E-04 1.2320E-12 5.7515E+12 5.7811E+10 Xe-131m 2.5879E-01 3.0896E-09 1.4203E+16 9.5856E+13 Xe-133 4.184 9E+01 2.2358E-07 1.0123E+18 1.5548E+16 Xe-133m 1.1737E+00 2.6159E-09 1.1844E+16 4.3968E+14 Xe-135 1.0049E+01 3.9349E-09 1.7553E+16 4.0219E+15 Xe-135m 3.8250E-03 4.1990E-14 1.8731E+11 3.9555E+13 Control Room Transport Group Inventory:

Time (h) = 26.0000 Atmosphere Sump Noble gases (atoms) 1.2042E+19 0.OOOOE+00 Elemental I (atoms) 1.5240E+14 0.OOOOE+00 Organic I (atoms) 4.7135E+12 0.OOOOE+00 Aerosols (kg) 6.4993E-10 O.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 2. 1702E-11 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 2.3232E-11 Total I (Ci) 1. 6766E-01 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 2.0317E+19 Elemental I (atoms) 4.0057E+14 1.4668E+14 Organic I (atoms) 1.2389E+13 4.5366E+12 Aerosols (kg) 1.7084E-09 6.2559E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.6997E+18 Elemental I (atoms) 0.OOOOE+00 2.3427E+14 Organic I (atoms) 0.OOOOE+00 7.2456E+12 Aerosols (kg) 0.OOOOE+00 9.9915E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (atoms) 1.6957E+19 0.OOOOE+00 Elemental I (atoms) 2.2515E+14 0.OOOOE+00 Organic I (atoms) 6.9635E+12 0.OOOOE+00 Aerosols (kg) 9.6022E-10 0.OOOOE+00 EAB Doses:

Time (h) = 32.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.0000E+00 0.OOOOE+00 Accumulated dose (rem) 4.2364E-01 3.3638E+01 1.4591E+00

NEDCi9O3I'-Rev-Att / Page2%..of-/Lo LPZ Doses:

Time (h) = 32.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.0193E-04 1.8627E-02 7.7409E-04 Accumulated dose (rem) 2.3646E-01 1.8778E+01 8.1451E-01 Control Room Doses:

Time (h) = 32.0000 Whole Body Thyroid TEDE Delta dose (rem) 5.2733E-02 5.4555E+01 1.7270E+00 Accumulated dose (rem) 1.4381E-01 1.3937E+02 4.4269E+00 primary Compartment Nuclide Inventory:

Time (h) = 32.0000 Ci kg Atoms Decay Kr-85 5. 6579E-10 1.4421E-15 1.0217E+10 1.8343E+16 Kr-85m 3.7251E-11 4.5265E-21 3.2070E+04 3.9846E+15 I-131 1.5106E-10 1.2185E-18 5.6015E+06 5.0348E+15 I-133 7.4979E-11 6.6189E-20 2.9970E+05 3.1429E+15 Xe-131m 2.3724E-10 2.8323E-18 1.3020E+07 7.8351E+15 Xe-133 3.7694E-08 2.0138E-16 9.1183E+08 1.2734E+18 Xe-133m 1.0087E-09 2.2481E-18 1.0179E+07 3.6197E+16 Xe-135 5.9186E-09 2.3177E-18 1.0339E+07 3.4489E+17 primary Transport Group Inventory:

Time (h) = 32.0000 Atmosphere Sump Noble gases (atoms) 1.1162E+10 0.OOOOE+00 Elemental I (atoms) 2.8708E+05 0.OOOOE+00 Organic I (atoms) 8.8788E+03 0.OOOOE+00 Aerosols (kg) 1.2240E-18 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 7.2767E-21 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 7.6445E-21 Total I (Ci) 2.4426E-10 primary to Environment Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) 0.0000E+00 2.9916E+17 Organic I (atoms) 0.OOOOE+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment Integral Nuclide Release:

Time (h) 32.0000 Ci kg Atoms Bq Br-82 4.2771E-01 3.9507E-10 2.9014E+15 1.5825E+10 Br-83 1.0769E-02 6.8169E-13 4.9461E+12 3.9846E+08 Kr-83m 8.2529E+00 4.OOOOE-10 2.9023E+15 3.0536E+11 Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2090E+02 1.4691E-08 1.0408E+17 4.4733E+12 Kr-87 1.7424E-02 6.1514E-13 4.2580E+12 6.4470E+08 Kr-88 3.6968E+01 2.9482E-09 2.0176E+16 1.3678E+12 I-130 1.0375E+00 5.3193E-10 2.4 641E+15 3.8386E+10 I-131 1.5395E+02 1.2418E-06 5.7087E+18 5.6963E+12 I-132 1. 1269E+02 1.0917E-08 4.9805E+16 4.1694E+12 I-133 9.5956E+01 8.4707E-08 3.8354E+17 3.5504E+12 I-134 4 .1072E-06 1.5396E-16 6.9192E+08 1.5197E+05 I-135 1.5408E+01 4.3873E-09 1.9571E+16 5.7008E+11

NEDC205- OR/Rev-L.L..

AtL -/..Page77OU2-O-P Xe-129m 1.4461E-01 1.1429E-09 5.3354E+15 5.3504E+09 Xe-131m 2.3959E+02 2.8605E-06 1.3150E+19 8 .8650E+12 Xe-133 3.8934E+04 2.0800E-04 9.4181E+20 1.4405E+15 Xe-133m 1. 1063E+03 2.4655E-06 1.1163E+19 4.0932E+13 Xe-135 1.0509E+04 4.1152E-06 1.8357E+19 3.8883E+14 Xe-135m 2.7283E+02 2.9951E-09 1.3361E+16 1.0095E+13 Environment Transport Group Inventory:

Total Release Time (h) = 32.0000 Release Rate/s Noble gases (atoms) 1.1115E+22 3.8594E+17 Elemental I (atoms) 2.9910E+17 1.0385E+13 Organic I (atoms) 9.2504E+15 3.2120E+11 Aerosols (kg) 1.2756E-06 4.4292E-11 Dose Effective (Ci) I-131 (Thyroid) 1.7104E+02 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 1.8495E+02 Total I (Ci) 3.7800E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) 0.OOOOE+00 2.9916E+17 Organic I (atoms) 0.OOOOE+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) o.OOOE+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) 0.OOOOE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) 2.8450E+19 0.000OE+00 Elemental I (atoms) 3.6916E+14 0.OOOOE+00 Organic I (atoms) 1.1417E+13 0.OOOOE+00 Aerosols (kg) 1.5743E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 32.0000 Ci kg Atoms Decay Br-82 8.8249E-06 8.1513E-15 5.9864E+10 1.3341E+11 Br-83 2.7926E-08 1.7677E-18 1.2826E+07 2.3528E+09

Att /page ZZ of-LZ.51 Kr-83m 2.2807E-05 1.1054E-15 8.0206E+09 3.3490E+12 Kr-85 2.8279E-02 7.2078E-08 5.1066E+17 3.7219E+14 Kr-85m 1.8618E-03 2.2624E-13 1.6029E+12 6.3561E+13 Kr-87 1.3363E-08 4.7175E-19 3.2654E+06 6.0757E+09 Kr-88 2.8680E-04 2.2872E-14 1.5652E+11 1.7366E+13 I-130 1. 6191E-05 8.3015E-15 3.8456E+10 3.0575E+11 I-131 3.5918E-03 2.8972E-11 1.3319E+14 4.9286E+13 I-132 2.6782E-04 2.5946E-14 1.1837E+11 2.4321E+13 I-133 1.7828E-03 1.5737E-12 7.1258E+12 2.9288E+13 I-135 1.6544E-04 4.7109E-14 2.1015E+11 4 .2291E+12 Xe-129m 7.0910E-06 5.6044E-14 2. 6163E+11 9.5360E+10 Xe-131m 1.1857E-02 1.4155E-10 6.5072E+14 1.5832E+14 Xe-133 1.8839E+00 1.0065E-08 4.5572E+16 2.5600E+16 Xe-133m 5.0412E-02 1.1235E-10 5.0871E+14 7.1799E+14 Xe-135 2.9570E-01 1.1579E-10 5.1653E+14 6.1791E+15 Xe-135m 2.9488E-05 3.2371E-16 1.4440E+09 3.9876E+13 Control Room Transport Group Inventory:

Time (h) = 32.0000 Atmosphere Sump Noble gases (atoms) 5.5791E+17 0.OOOOE+00 Elemental I (atoms) 6.8258E+12 0.OOOOE+00 Organic I (atoms) 2.1111E+ll 0.OOOOE+00 Aerosols (kg) 2.9104E-11 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 9.6960E-13 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.0186E-12 Total I (Ci) 5.8078E-03 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) O.OOOOE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (atoms) 2.8450E+19 0.0000E+00 Elemental I (atoms) 3.6916E+14 0.OOOOE+00 Organic I (atoms) 1.1417E+13 0.OOOOE+00 Aerosols (kg) 1.5743E-09 0.OOOOE+00 EAB Doses:

Time (h) = 48.0000 Whole Body Thyroid TEDE Delta dose (rem) o.OOOOE+00 o.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 4.2364E-01 3.3638E+01 1.4591E+00

NEDCO 3_ev...L...

LPZ Doses:

Time (h) = 48.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.7020E-14 2.3228E-12 1.0816E-13 Accumulated dose (rem) 2.3646E-01 1.8778E+01 8.1451E-01 Control Room Doses:

Time (h) = 48.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.9039E-03 2.5557E+00 8.0147E-02 Accumulated dose (rem) 1.4571E-01 1.4193E+02 4.5070E+00 primary Compartment Nuclide Inventory:

Time (h) = 48.0000 Ci kg Atoms Decay primary Transport Group Inventory:

Time (h) = 48.0000 Atmosphere Sump Noble gases (atoms) 1.1129E-14 0.OOOOE+00 Elemental I (atoms) 2.6647E-19 0.0000E+00 Organic I (atoms) 8.2415E-21 0.OOOOE+00 Aerosols (kg) 1.1358E-42 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 6.6938E-45 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 6.8951E-45 Total I (Ci) 1.8889E-34 primary to Environment Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) O.OOOOE+00 2.9916E+17 Organic I (atoms) 0.OOOOE+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment Integral Nuclide Release:

Time (h) = 48.0000 Ci kg Atoms Bq Br-82 4 .2771E-01 3.9507E-10 2. 9014E+15 1.5825E+10 Br-83 1.0769E-02 6.8169E-13 4 .9461E+12 3.9846E+08 Kr-83m 8.2529E+00 4.OOOOE-10 2.9023E+15 3.0536E+11 Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2090E+02 1.4691E-08 1.0408E+17 4.4733E+12 Kr-87 1.7424E-02 6.1514E-13 4.2580E+12 6.4470E+08 Kr-88 3.6968E+01 2.9482E-09 2.0176E+16 1.3678E+12 I-130 1.0375E+00 5.3193E-10 2.4641E+15 3.8386E+10 I-131 1.5395E+02 1.2418E-06 5.7087E+18 5.6963E+12 I-132 1.1269E+02 1.0917E-08 4.9805E+16 4.1694E+12 I-133 9.5956E+01 8.4707E-08 3. 8354E+17 3.5504E+12 I-134 4.1072E-06 1.5396E-16 6.9192E+08 1.5197E+05 I-135 1.5408E+01 4.3873E-09 1.9571E+16 5.7008E+11 Xe-129m 1.4461E-01 1.1429E-09 5.3354E+15 5.3504E+09 Xe-131m 2.3959E+02 2.8605E-06 1.3150E+19 8.8650E+12 Xe-133 3.8934E+04 2.0800E-04 9.4181E+20 1.4405E+15 Xe-133m 1.1063E+03 2.4655E-06 1.1163E+19 4.0932E+13 Xe-135 1.0509E+04 4.1152E-06 1.8357E+19 3.8883E+14 Xe-135m 2.7283E+02 2.9951E-09 1.3361E+16 1.0095E+13 Environment Transport Group Inventory:

NEDCOA-.EeZ Rev /

AtL -/pagel-c-of /7°0 Total Release Time (h) = 48.0000 Release Rate/s Noble gases (atoms) 1.1115E+22 1.2865E+17 Elemental I (atoms) 2.9910E+17 3.4618E+12 Organic I (atoms) 9.2504E+15 1.0707E+11 Aerosols (kg) 1.2756E-06 1.4764E-11 Dose Effective (Ci) I-131 (Thyroid) 1.7104E+02 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 1.8495E+02 Total I (Ci) 3.7800E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) 0.OOOOE+00 2.9916E+17 Organic I (atoms) 0.OOOOE+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) 0.OOOOE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 2. 9007E+19 0.000OE+00 Elemental I (atoms) 3.7592E+14 0.OOOOE+00 Organic I (atoms) 1. 1626E+13 0.OOOOE+00 Aerosols (kg) 1.6031E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 48.0000 Ci kg Atoms Decay Br-82 1.7911E-09 1.6543E-18 1. 2150E+07 1.3553E+11 Kr-85 7.8569E-06 2.0026E-11 1. 4188E+14 3.7924E+14 Kr-85m 4.3519E-08 5.2882E-18 3.7466E+07 6.3921E+13 Kr-88 1.6050E-09 1.2800E-19 8.7593E+05 1.7415E+13 I-130 1.8341E-09 9.4041E-19 4.3563E+06 3.0940E+11 I-131 9.4231E-07 7.6008E-15 3.4 941E+10 5.0174E+13 I-132 5.9919E-10 5.8049E-20 2.6483E+05 2.4364E+13 I-133 2.9065E-07 2.5658E-16 1.1618E+09 2.9706E+13 I-135 8.5866E-09 2.4450E-18 1.0907E+07 4.2635E+12 Xe-129m 1.8598E-09 1.4699E-17 6.8619E+07 9.7114E+10 Xe-131m 3.1695E-06 3.7840E-14 1.7395E+1l 1.6126E+14

AtL....L~PageY-LLofL7Zo Xe-133 4.8044E-04 2.5667E-12 1.1622E+13 2. 6065E+16 Xe-133m 1.1343E-05 2.5280E-14 1.1446E+11 7.3024E+14 Xe-135 2.4270E-05 9.5039E-15 4.2395E+10 6.2436E+15 Xe-135m 3.9852E-09 4.3749E-20 1. 9516E+05 3.9882E+13 Control Room Transport Group Inventory:

Time (h) = 48.0000 Atmosphere Sump Noble gases (atoms) 1.5383E+14 0.OOOOE+00 Elemental I (atoms) 1.7523E+09 0.OOOOE+00 Organic I (atoms) 5.4196E+07 0.OOOOE+00 Aerosols (kg) 7.4694E-15 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 2.4668E-16 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 2.5410E-16 Total I (Ci) 1.2421E-06 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) 0.OOOOE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (atoms) 2.9007E+19 0.OOOOE+00 Elemental I (atoms) 3.7592E+14 0.OOOOE+00 Organic I (atoms) 1.1626E+13 0.OOOOE+00 Aerosols (kg) 1.6031E-09 0.OOOOE+00 EAB Doses:

Time (h) = 120.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 4.2364E-01 3.3638E+01 1.4591E+00 LPZ Doses:

Time (h) - 120.0000 Whole Body Thyroid TEDE Delta dose (rem) 7.4459E-39 9.3609E-37 3.6044E-38 Accumulated dose (rem) 2.3646E-01 1.8778E+01 8.1451E-01 Control Room Doses:

Time (h) = 120.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.9559E-07 3.9934E-04 1.2394E-05 Accumulated dose (rem) 1.4571E-01 1.4193E+02 4.5070E+00

'Et iv 0* 3 I Rev .L.

Att / page.Izof12o primary Compartment Nuclide Inventory:

Time (h) = 120.0000 Ci kg Atoms Decay primary Transport Group Inventory:

Time (h) = 120.0000 Atmosphere Sump Noble gases (atoms) 1.1073-122 0.OOOOE+00 Elemental I (atoms) 2.0402-127 0.OOOOE+00 Organic I (atoms) 6.3100-129 0.OOOOE+00 Aerosols (kg) 8.6934-151 O.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 5.04 95-153 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 5.0679-153 Total I (Ci) 1.1709-142 primary to Environment Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) 0.OOOOE+00 2.9916E+17 Organic I (atoms) 0.OOOOE+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment Integral Nuclide Release:

Time (h) = 120.0000 Ci kg Atoms Bq Br-82 4.2771E-01 3.9507E-10 2.9014E+15 1.5825E+10 Br-83 1.0769E-02 6.8169E-13 4.9461E+12 3.9846E+08 Kr-83m 8.2529E+00 4.OOOOE-10 2.9023E+15 3.0536E+11 Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2090E+02 1.4691E-08 1.0408E+17 4 .4733E+12 Kr-87 1.7424E-02 6.1514E-13 4.2580E+12 6.4470E+08 Kr-88 3.6968E+01 2.9482E-09 2.0176E+16 1.3678E+12 I-130 1.0375E+00 5.3193E-10 2.4641E+15 3.8386E+10 I-131 1.5395E+02 1.2418E-06 5.7087E+18 5.6963E+12 I-132 1.1269E+02 1.0917E-08 4.9805E+16 4. 1694E+12 I-133 9.5956E+01 8.4707E-08 3.8354E+17 3.5504E+12 I-134 4.1072E-06 1.5396E-16 6.9192E+08 1.5197E+05 1-135 1.5408E+01 4.3873E-09 1.9571E+16 5.7008E+11 Xe-129m 1.4461E-01 1.1429E-09 5.3354E+15 5.3504E+09 Xe-131m 2.3959E+02 2.8605E-06 1.3150E+19 8.8650E+12 Xe-133 3.8934E+04 2.0800E-04 9.4181E+20 1.4405E+15 Xe-133m 1.1063E+03 2.4655E-06 1.1163E+19 4.0932E+13 Xe-135 1.0509E+04 4.1152E-06 1.8357E+19 3.8883E+14 Xe-135m 2.7283E+02 2.9951E-09 1.3361E+16 1.0095E+13 Environment Transport Group Inventory:

Total Release Time (h) = 120.0000 Release Rate/s Noble gases (atoms) 1.1115E+22 3.2162E+16 Elemental I (atoms) 2.9910E+17 8.6544E+11 Organic I (atoms) 9.2504E+15 2.6766E+10 Aerosols (kg) 1.2756E-06 3.6910E-12 Dose Effective (Ci) I-131 (Thyroid) 1.7104E+02 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 1.8495E+02 Total I (Ci) 3.7800E+02 primary to Environment Transport Group Inventory:

AtL.L-page.jI-LOt 70 Pathway Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) 0.OOOOE+00 2.9916E+17 Organic I (atoms) O.OOOOE+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) 0.OOOOE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 2.9007E+19 0.OOOOE+00 Elemental I (atoms) 3.7592E+14 0.OOOOE+00 Organic I (atoms) 1.1626E+13 0.OOOOE+00 Aerosols (kg) 1.6031E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) - 120.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 120.0000 Atmosphere Sump Noble gases (atoms) - l.4894E-02 0.OOOOE+00 Elemental I (atoms) 1.3055E-07 0.OOOOE+00 Organic I (atoms) 4.0378E-09 0.OOOOE+00 Aerosols (kg) 5.5629E-31 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.8108E-32 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.8174E-32 Total I (Ci) 7.4926E-23 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway

NEDCRS-07LRev.L-Aft-L-page S"Y'd L70 Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) 0.000OE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (atoms) 2.9007E+19 0.OOOOE+00 Elemental I (atoms) 3.7592E+14 0.OOOOE+00 Organic I (atoms) 1.1626E+13 0.OOOOE+00 Aerosols (kg) 1.6031E-09 0.OOOOE+00 EAB Doses:

Time (h) = 744.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 4.2364E-01 3.3638E+01 1.4591E+00 LPZ Doses:

Time (h) = 744.0000 Whole Body Thyroid TEDE Delta dose (rem) 7.7703-148 1.4687-145 5.2504-147 Accumulated dose (rem) 2.3646E-01 1.8778E+01 8.1451E-01 Control Room Doses:

Time (h) = 744.0000 Whole Body Thyroid TEDE Delta dose (rem) 6.5128E-24 1.9576E-20 6.0274E-22 Accumulated dose (rem) 1.4571E-01 1.4193E+02 4.5070E+00 primary Compartment Nuclide Inventory:

Time (h) = 744.0000 Ci kg Atoms Decay primary Transport Group Inventory:

Time (h) - 744.0000 Atmosphere Sump Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 primary to Environment Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) 0.OOOOE+00 2.9916E+17 Organic I (atoms) 0.OOOOE+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment Integral Nuclide Release:

Time (h) = 744.0000 Ci kg Atoms Bq Br-82 4.2771E-01 3.9507E-10 2.9014E+15 1.5825E+10

NLD O5-/Revj....-.

At-pgy-- U-Br-83 1.0769E-02 6.8169E-13 4.9461E+12 3.9846E+08 Kr-83m 8.2529E+00 4.OOOOE-10 2. 9023E+15 3.0536E+11 Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2090E+02 1.4691E-08 1.0408E+17 4.4733E+12 Kr-87 1.7424E-02 6.1514E-13 4.2580E+12 6.4470E+08 Kr-88 3. 6968E+01 2.9482E-09 2.0176E+16 1.3678E+12 I-130 1.0375E+00 5.3193E-10 2.4641E+15 3.8386E+10 I-131 1.5395E+02 1.2418E-06 5.7087E+18 5.6963E+12 I-132 1.1269E+02 1.0917E-08 4. 9805E+16 4.1694E+12 I-133 9.5956E+01 8.4707E-08 3.8354E+17 3.5504E+12 I-134 4 .1072E-06 1.5396E-16 6.9192E+08 1.5197E+05 I-135 1.5408E+01 4.3873E-09 1. 9571E+16 5.7008E+11 Xe-129m 1.4461E-01 1.1429E-09 5. 3354E+15 5.3504E+09 Xe-131m 2.3959E+02 2.8605E-06 1.3150E+19 8.8650E+12 Xe-133 3.8934E+04 2.0800E-04 9.4181E+20 1.4405E+15 Xe-133m 1. 1063E+03 2.4655E-06 1. 1163E+19 4.0932E+13 Xe-135 1.0509E+04 4.1152E-06 1.8357E+19 3.8883E+14 Xe-135m 2.7283E+02 2.9951E-09 1.3361E+16 1.0095E+13 Environment Transport Group Inventory:

Total Relea.se Time (h) = 744.0000 Release Rate/ s Noble gases (atoms) 1.1115E+22 4.2882 E+15 Elemental I (atoms) 2.9910E+17 1.1539 E+11 Organic I (atoms) 9.2504E+15 3.5688 E+09 Aerosols (kg) 1.2756E-06 4.9213 E-13 Dose Effective (Ci) I-131 (Thyroid) 1.7104E+02 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 1.8495E+02 Total I (Ci) 3.7800E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1110E+22 Elemental I (atoms) 0.000OE+00 2.9916E+17 Organic I (atoms) 0.0000E+00 9.2525E+15 Aerosols (kg) 0.OOOOE+00 1.2759E-06 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) 0.OOOOE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

NEDCG*_O-)/Rev /

AtL / page ffe-f_°7c Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 2.9007E+19 o.OOOOE+00 Elemental I (atoms) 3.7592E+14 0.0000E+00 Organic I (atoms) 1.1626E+13 o.OOOOE+00 Aerosols (kg) 1.6031E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 744.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 744.0000 Atmosphere Sump Noble gases (atoms) 2.8691-141 0.OOOOE+00 Elemental I (atoms) 2.8212-147 0.OOOOE+00 Organic I (atoms) 8.7254-149 0.OOOOE+00 Aerosols (kg) 1.2021-170 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 3.9052-172 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 3.9052-172 Total I (Ci) 1.5687-162 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.0331E+19 Elemental I (atoms) 4.0089E+14 1.4672E+14 Organic I (atoms) 1.2399E+13 4.5378E+12 Aerosols (kg) 1.7098E-09 6.2576E-10 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.7065E+18 Elemental I (atoms) 0.OOOOE+00 2.3446E+14 Organic I (atoms) 0.OOOOE+00 7.2512E+12 Aerosols (kg) 0.OOOOE+00 9.9993E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (atoms) 2.9007E+19 0.OOOOE+00 Elemental I (atoms) 3.7592E+14 0.OOOOE+00 Organic I (atoms) 1.1626E+13 0.OOOOE+00 Aerosols (kg) 1.6031E-09 0.OOOOE+00 839 I-131 Summary

1. 1. 1. 1. 11 *1111*11 1*1 1141 1##

1. f1111ff#41*#111*41**#####1#

primary Environment Control Room Time (hr) I-131 (Curies) I-131 (Curies) I-131 (Curies) 24.000 2.3765E+01 2.2805E-02 1.6231E-04 24.004 1.5319E+02 9.5425E-01 6.7812E-03 24.017 1.4625E+02 7.8815E+00 5.5452E-02 24.417 3.6688E+01 1.1731E+02 1.3770E-01

NEDC O*-o3/Rev 1 Alt / pagem-oftfL° 24.717 1.3005E+01 1.4096E+02 1.3870E-01 25.017 4.6096E+00 1.4935E+02 1.2617E-01 25.317 1.6339E+00 1.5232E+02 1.1070E-01

25. 617 5.7917E-01 1.5337E+02 9.5768E-02

25. 917 2.0529E-01 1.5375E+02 8.2376E-02 26.000 1.5408E-01 1.5380E+02 7.8975E-02 26.300 5.4617E-02 1.5390E+02 6.7730E-02 26.600 1. 9360E-02 1.5393E+02 5.8051E-02

26. 900 6.8623E-03 1.5395E+02 4.9744E-02 27.200 2.4324E-03 1.5395E+02 4.2621E-02 27.500 8.6220E-04 1.5395E+02 3.6517E-02 27.800 3.0562E-04 1.5395E+02 3.128 6E-02 28.100 1.0833E-04 1.5395E+02 2.6805E-02 28.400 3.8399E-05 1.5395E+02 2.2965E-02 28.700 1.3611E-05 1.5395E+02 1.9675E-02 29.000 4.8246E-06 1.5395E+02 1.6857E-02 29.300 1.7101E-06 1.5395E+02 1.4442E-02

29. 600 6.0618E-07 1.5395E+02 1.2373E-02 29.900 2.1487E-07 1.5395E+02 1.0601E-02 30.200 7.6162E-08 1.5395E+02 9.0821E-03 30.500 2.6997E-08 1.5395E+02 7.7811E-03 30.800 9.5693E-09 1.5395E+02 6.6665E-03 31.100 3.3920E-09 1.5395E+02 5.7115E-03 31.400 1.2023E-09 1.5395E+02 4.8933E-03 31.700 4.2618E-10 1.5395E+02 4.1924E-03 32.000 1.5106E-10 1.5395E+02 3.5918E-03 32.300 5.3546E-11 1.5395E+02 3.0773E-03

32. 600 1.8980E-11 1.5395E+02 2.6365E-03

32. 900 6.7278E-12 1.5395E+02 2.2588E-03 33.200 2.3847E-12 1.5395E+02 1.9352E-03 33.500 8.4530E-13 1.5395E+02 1.6580E-03 33.800 2.9963E-13 1.5395E+02 1. 4205E-03 34.100 1.0621E-13 1.5395E+02 1.2170E-03 34.400 3.7646E-14 1.5395E+02 1.0427E-03 48.000 1.4329E-34 1.5395E+02 9.4231E-07 120.000 1.1299-142 1.5395E+02 7.2304E-23 744.000 O.OOOOE+00 1.5395E+02 1.5687-162

II$I#t+tfi#f#IU #ftt**Ii#ftI*IHCumu a iv###e*fiDose# fiSummary### s Cumulative Dose Summary EAB LPZ Control Room Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem)

(rem) 24.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 24.004 2.0885E-01 9.1494E-03 1.1648E-01 5.1026E-03 3.5896E-03 1.1273E-04 24.017 1.7251E+00 7.5562E-02 9.6205E-01 4.2140E-02 1.6087E-01 5.0521E-03 24.417 2.5671E+01 1.1182E+00 1.4316E+01 6.2363E-01 1.6566E+01 5.268lE-Ol 24.717 3.0839E+01 1.3402E+00 1.7199E+01 7.4740E-01 3.2366E+01 1.0305E+00 25.017 3.2669E+01 1.4181E+00 1.8219E+01 7.9089E-01 4.7356E+01 1.5081E+00 25.317 3.3317E+01 1.4456E+00 1.8580E+01 8.0619E-01 6.0703E+01 1.9331E+00

NEDC^-c7S/ RevJ.1 Aft -- PagB ITo 25.617 3.3546E+01 1.4552E+00 1.8708E+01 8.1158E-01 7.2310E+01 2.3024E+00 25.917 3.3627E+01 1.4586E+00 1.8754E+01 8. 1348E-01 8.2307E+01 2.6202E+00 26.000 3.3638E+01 1.4591E+00 1.8760E+01 8.1374E-01 8.4814E+01 2.6998E+00 26.300 3.3638E+01 1.4591E+00 1.8772E+01 8.1424E-01 9.3034E+01 2.9609E+00 26.600 3.3638E+01 1.4591E+00 1.8776E+01 8.1441E-01 1.0007E+02 3.1842E+00 26.900 3.3638E+01 1.4591E+00 1.8778E+01 8.1448E-01 1.0610E+02 3.3754E+00 27.200 3.3638E+01 1.4591E+00 1. 8778E+01 8. 1450E-01 1.1126E+02 3.5388E+00 27.500 3.3638E+01 1.4591E+00 1. 8778E+01 8. 1451E-01 1. 1567E+02 3.6787E+00 27.800 3.3638E+01 1. 4591E+00 1.8778E+01 8.1451E-01 1. 1945E+02 3.7983E+00 28.100 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.2269E+02 3.9006E+00 28.400 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.2546E+02 3.9881E+00 28.700 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.2783E+02 4.0630E+00 29.000 3.3638E+01 1.4591E+00 1. 8778E+01 8.1451E-01 1.2986E+02 4.1271E+00 29.300 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.3159E+02 4.1819E+00 29.600 3.3638E+01 1.4591E+00 1. 8778E+01 8.1451E-01 1.3308E+02 4.2288E+00 29.900 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.3435E+02 4.2689E+00 30.200 3.3638E+01 1. 4591E+00 1. 8778E+01 8.1451E-01 1.3544E+02 4.3032E+00 30.500 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.3637E+02 4.3326E+00 30.800 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.3717E+02 4.3577E+00 31.100 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.3786E+02 4.3792E+00 31.400 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.3844E+02 4.3976E+00 31.700 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.3894E+02 4.4134E+00 32.000 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.3937E+02 4.4269E+00 32.300 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.3974E+02 4.4384E+00 32.600 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.4005E+02 4.4483E+00 32.900 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.4032E+02 4.4567E+00 33.200 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.4055E+02 4.4639E+00 33.500 3.3638E+01 1.4591E+00 1.8778E+01 8. 1451E-01 1.4075E+02 4.4701E+00 33.800 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4092E+02 4.4754E+00 34.100 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4106E+02 4.4800E+00

NEDC °S°71Rev {L_

Att- _page gnOf S7_5 34.400 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4118E+02 4.4838E+00 48.000 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4193E+02 4.5070E+00 120.000 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4193E+02 4.5070E+00 744.000 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4193E+02 4.5070E+00 Worst Two-Hour Doses EAB Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 24.0 4.2364E-01 3.3638E+01 1.4591E+00

NED COe.5~07LR ev /L-Aft-Lpage 7...ofL-L2 Page: Fl of_F30_

CaIc. No.: ALION-CAL-NPPD-3236-001 1cA. L 1:7tN#0. Rev. Number: 1 ATTACHMENT F RADTRAD CASE I Detailed Output File (oO)

NEDGE -,PJ- Rev /-

AtL/- pageQ8.ZL.otL

1. 1. 1. 1. $###44#####1########## #################################41###$#####

RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:30:35

1. 1. 1. 1. ####### 4#####$################4*#####################*1###### 4#####

File information 1*1#144#1###*14#4*111*144#####1#**#4#1#41#4#11#4**1#**14#*4****#### ####

Plant file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHACooper 9-21-05 NoCREFS.psf Inventory file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nif Release file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\RG1 183FHA.RFT Dose Conversion file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inp

*1 1 1 ## 1 4 * # 1 *

* # # # 4## 4 1 * #

1 4 Radrad3*0 4*115 2**0014 44* **44 Radtrad 3.03 4/15/2001 Case 1- 168 hour0.00194 days 0.0467 hours 2.777778e-4 weeks 6.3924e-5 months decay Nuclide Inventory File:

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nif Plant Power Level:

1.5329E+01 Compartments:

3 Compartment 1:

primary 3

7.9500E+05 0

0 0

Compartment 2:

Environment 2

O.OOOOE+00 0

0 0

Compartment 3:

Control Room 1

wme~.0j1f71Rev, I Att I -page-T of >°-

1.4186E+05 0

0 0

Pathways:

4 Pathway 1:

primary to Environment 1

2 2

Pathway 2:

Environment tto Control Room 2

3 2

Pathway 3:

Environment t:o Control Room 2

3 2

Pathway 4:

Control Room to Environment 3

2 2

End of Plant Model File Scenario Description Name:

Plant Model Filename:

Source Term:

1 1 l.OOOOE+00 C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inp C:\Cooper FRA Analysis\Cooper FHA Files\Rev 1 9-21-05\RG1_183FHA.RFT 1.6800E+02 1

9.5000E-01 4.8500E-02 1.50OOE-03 1.OOOOE+0O Overlying Pool:

0 O.OOOOE+O0 0

0 0

0 Compartments:

3 Compartment 1:

1 1

0 0

0

NEDCj2LOcJ/Rev....L AtL....page-Z~f-ltL270 Compartment 2:

1 1

0 0

0 Compartment 3:

1 1

0 0

0 Pathways:

4 Pathway 1:

0 0

0 1

1 1.6800E+02 4.5760E+04 0.OOOOE+00 0.OOOOE+00 O.O000E+00 0

0 0

0 Pathway 2:

0 0

0 1

1 1 .6800E+02 3.2350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

0 0

0 Pathway 3:

0 0

0 1

1

NEDCos-g3RRev L.

Att I page..-of -/70 1.6800E+02 4.OOOOE+02 0.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

0 0

0 Pathway 4:

0 0

0 1

1 1.6800E+02 3.6350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

0 0

0 Dose Locations:

3 Location 1:

EAB 2

1 2

1. 6800E+02 5.2000E-04

1. 7000E+02 O.OOOOE+00 1

4 1 .6800E+02 3.5000E-04

1. 7600E+02 1.8000E-04 1 .9200E+02 2.3000E-04

8. 8800E+02 O.OOOOE+00 0

Location 2:

LPZ 2

1 5

1.6800E+02 2.9000E-04

1. 7600E+02 7.300OE-05 1.9200E+02 2.5000E-05

2. 6400E+02 5.2000E-06

8. 8800E+02 O.OOOOE+00 1

4

1. 6800E-i02 3.5000E-04

1. 7600E+02 1.8000E-04 1 .9200E+02 2.3000E-04 8.8800E+02 O.OOOOE+00 0

Location 3:

Control Room 3

0 1

NEDC!& -°2) ^Rev /-

AtLL-page of/L° 2

1.6800E+02 3.5000E-04 8.8800E+02 O.OOOOE+O0 1

4 1.6800E+02 l.OOOOE+00 1.9200E+02 6.OOOOE-01 2.6400E+02 4.OOOOE-01 8.8800E+02 O.OOOOE+O0 Effective Volume Location:

1 6

1.6800E+02 4.1500E-03 1.7000E+02 3.2400E-03 1.7600E+02 1.3200E-03 1.9200E+02 9.O100E-04 2.6400E+02 7.2200E-04 8.8800E+02 O.OOOOE+OO Simulation Parameters:

1 1.6800E+02 O.OOOOE+00 Output Filename:

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHACooper 9-21-05 NoCREFS.oO 1

1 1

0 0

End of Scenario File

NEDOr -oS-o RevY .

Att / page 96 of.L270 This page intentionally left blank.

NEDC°t22L/Rev /

Att LIpageiZof7 ofL RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:30:35 Plant Description

ttt*4#itt*##H###ti**i#f#t###t#*#t##*+##**#t#*1t*#1tf1I*##4H**#1Ifflh##f i Number of Nuclides = 29 Inventory Power = 1.OOOOE+00 MWth Plant Power Level = 1.5329E+01 MWth Number of compartments = 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: primary Compartment volume = 7.9500E+05 (Cubic feet)

Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: primary to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: primary to Environment Inlet Pathway Number 4: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 1.4186E+05 (Cubic feet)

Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Inlet Pathway Number 3: Environment to Control Room Exit Pathway Number 4: Control Room to Environment Total number of pathways = 4

NEDO o5-./ Rev4/

ALpage ?'tLZ70_

RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:30:35 Scenario Description Time between shutdown and first release = 1.6800E+02 (Hours)

Radioactive Decay is enabled Calculation of Daughters is enabled Release Fractions and Timings GAP EARLY IN-VESSEL LATE RELEASE RELEASE MASS 0.003600 hr 0.0000 hrs 0.0000 hrs (gm)

NOBLES 5.OOOOE-02 0.OOOOE+00 0.OOOOE+00 1.659E+00 IODINE 2.5000E-04 0.OOOOE+00 0.OOOOE+00 1.615E-03 CESIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 TELLURIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 STRONTIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 BARIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 RUTHENIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 CERIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 LANTHANUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 Inventory Power = 15. MWt Nuclide Group Specific half Whole Body Inhaled Inhaled Name Inventory life DCF Thyroid Effective (Ci/MWt) (s) (Sv-m3/Bq-s) (Sv/Bq) (Sv/Bq)

Br-82 2 1.800E+02 1.271E+05 1.300E-13 2.380E-10 3.310E-10 Br-83 2 3.260E+03 8. 604E+03 3.820E-16 3.290E-12 2.330E-11 Br-84 2 5.610E+03 1.908E+03 9.410E-14 3.120E-12 2.610E-11 Kr-83m 1 3.270E+03 6.588E+03 1.500E-18 0.OOOE+00 0.OOOE+00 Kr-85 1 7.320E+02 3.383E+08 1.190E-16 0. OOOE+00 0.OOOE+00 Kr-85m 1 6.810E+03 1. 613E+04 7.480E-15 0.OOOE+00 0.OOOE+00 Kr-87 1 1.300E+04 4. 578E+03 4.120E-14 0.OOOE+00 0.OOOE+00 Kr-88 1 1.830E+04 1. 022E+04 1.020E-13 0.OOOE+00 0.OOOE+00 I-128 2 4.190E+02 1. 499E+03 4.160E-15 5.340E-11 1.280E-11 I-130 2 1.060E+03 4.450E+04 1.040E-13 1. 990E-08 7.140E-10 I-131 2 4.352E+04 6. 947E+05 1.820E-14 2.920E-07 8.890E-09 I-132 2 3.930E+04 8.280E+03 1.120E-13 1.740E-09 1.030E-10 I-133 2 5.510E+04 7.4 88E+04 2.940E-14 4.860E-08 1.580E-09 I-134 2 6.040E+04 3. 156E+03 1.300E-13 2. 880E-10 3.550E-11 I-135 2 5.160E+04 2. 380E+04 8.294E-14 8. 460E-09 3.320E-10 Xe-129m 1 2.060E-01 6. 912E+05 1.060E-15 0.OOOE+00 0.OOOE+00 Xe-131m 1 3.040E+02 1.028E+06 3.890E-16 0.OOOE+00 0.OOOE+00 Xe-133 1 5.260E+04 4. 532E+05 1.560E-15 0. OOOE+00 0.OOOE+00 Xe-133m 1 1.580E+03 1.890E+05 1.370E-15 0.OOOE+00 0.OOOE+00 Xe-135 1 1.860E+04 3.272E+04 1.190E-14 0.OOOE+00 0.OOOE+00 Xe-135m 1 1.090E+04 9. 174E+02 2.040E-14 0. OOOE+00 0.OOOE+00 Xe-138 1 4.500E+04 8. 502E+02 5.770E-14 0. OOOE+00 0.OOOE+00 Nuclide Daughter Fraction Daughter Fraction Daughter Fraction Br-83 Kr-83m 1.00 none 0.00 none 0.00 Kr-85m Kr-85 0.21 none 0.00 none 0.00 Kr-87 Rb-87 1.00 none 0.00 none 0.00

NEDC Of-07/Rev Att Z page VYof two0 Kr-88 Rb-88 1.00 none 0.00 none 0.00 I-131 Xe-131m 0.01 none 0.00 none 0.00 I-133 Xe-133m 0.03 Xe-133 0.97 none 0.00 I-135 Xe-135m 0.15 Xe-135 0.85 none 0.00 Te-129 I-129 1.00 none 0.00 none 0.00 Te-131 I-131 1.00 none 0.00 none 0.00 Te-131m I-131 0.78 Te-131 0.22 none 0.00 Te-132 I-132 1.00 none 0.00 none 0.00 Te-133 I-133 1.00 none 0.00 none 0.00 Te-133m I-133 0.87 Te-133 0.13 none 0.00 Te-134 I-134 1.00 none 0.00 none 0.00 Xe-133m Xe-133 1.00 none 0.00 none 0.00 Xe-135 Cs-135 1.00 none 0.00 none 0.00 Xe-135m Cs-135 0.00 Xe-135 1.00 none 0.00 Xe-138 Cs-138 1.00 none 0.00 none 0.00 Iodine fractions Aerosol = 9.5000E-01 Elemental = 4.8500E-02 Organic = 1.5000E-03 COMPARTMENT DATA Compartment number 1: primary Compartment number 2: Environment Compartment number 3: Control Room PATHWAY DATA Pathway number 1: primary to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filtere Efficiencies s(%)

(cfm) Aerosol Elemental Organic 1.6800E+02 4.5760E+04 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 1.6800E+02 3.2350E+03 0.OOOOE+00 0.OOOOE+00 O.OOOOE+00 Pathway number 3: Environment to Control Room Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 1.6800E+02 4.OOOOE+02 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 4: Control Room to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

NEOC ei-O-71 RevL./-

Al -1page/ooof.L290 (cfm) Aerosol Elemental Organic 1.6800E+02 3.6350E+03 0.OOOOE+00 0.OOOOE+00 O.OOOOE+00 LOCATION DATA Location EAB is in compartment 2 Location X/Q Data Time (hr) X/Q (s

m^-3) 1.6800E+02 5.2000E-04 1.7000E+02 0.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing Rate (mA3

sec^-1) 1.6800E+02 3.5000E-04 1.7600E+02 1.8000E-04 1.9200E+02 2.3000E-04 8.8800E+02 0.OOOOE+00 Location LPZ is in compartment 2 Location X/Q Data Time (hr) X/Q (s

mA-3) 1.6800E+02 2.9000E-04 1.7600E+02 7.3000E-05 1.9200E+02 2.5000E-05 2.6400E+02 5.2000E-06 8.8800E+02 0.0000E+00 Location Breathing Ra1te Da ita Time (hr) Br4eathi.ng Rate (mA3

seiCA_1) 1.6800E+02 3.5000E-04 1.7600E+02 1.8000E-04 1.9200E+02 2.3000E-04 8.8800E+02 0.0000E+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr) X/Q (S

mA-3) 1.6800E+02 4.1500E-03 1.7000E+02 3.2400E-03 1.7600E+02 1.3200E-03 1.9200E+02 9.0 l00E-04 2.6400E+02 7.2200E-04 8.8800E+02 0.0000E+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-l) 1.6800E+02 3.5000E-04 8.8800E+02 0.0000E+00 Location Occupancy Factor Data Time (hr) Occupancy Factor 1.6800E+02 1.OOOOE+00 1.9200E+02 6.OOO0E-0l 2.6400E+02 4.0000E-01 8.8800E+02 0.0000E+00 USER SPECIFIED TIME STEP DATA - SUPPLEMENTAL TIME STEPS Time Time step 0.OOOOE+00 0.OOOOE+00

NEDOC Or-o/ Rev- J1..

AIttL/ page o/aofLZ79 RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:30:35 5555 5

ititititit titlist it it 5*5*1

its it it it sit it it its it it

it it it it it it it it it sitititit it it it

its it it it it

sit it 5 it it it it titus situ it it its##i it Dose, Detailed model and Detailed Inventory Output EAB Doses:

Time (h) = 168.0036 Whole Body Thyroid TEDE Delta dose (rem) 4.3640E-04 1.1337E-01 3.8956E-03 Accumulated dose (rem) 4.3640E-04 1.1337E-01 3.8956E-03 LPZ Doses:

Time (h) = 168.0036 Whole Body Thyroid TEDE Delta dose (rem) 2.4338E-04 6.3226E-02 2. 1726E-03 Accumulated dose (rem) 2.4338E-04 6.3226E-02 2. 1726E-03 Control Room Doses:

Time (h) = 168.0036 Whole Body Thyroid TEDE Delta dose (rem) 3.5245E-07 1.9485E-03 5.9807E-05 Accumulated dose (rem) 3.5245E-07 1.9485E-03 5.9807E-05 primary Compartment Nuclide Inventory:

Time (h) = 168.0036 Ci kg Atoms Decay Br-82 2.5312E-02 2.3380E-11 1.7171E+14 9.2630E+09 Kr-85 5.5693E+02 1.4195E-03 1.0057E+22 2.0380E+14 Kr-85m 2.6673E-08 3.2411E-18 2.2963E+07 9.7627E+03 I-130 3.2682E-04 1.6757E-13 7.7625E+11 1.1960E+08 I-131 9.2217E+01 7.4384E-07 3.4195E+18 3.3746E+13 I-132 3.4478E+01 3.3402E-09 1.5239E+16 1.2622E+13 I-133 7.94 69E-01 7.0152E-10 3.1764E+15 2. 9082E+11 I-135 4.3879E-06 1.2494E-15 5.5736E+09 1.6059E+06 Xe-129m 8.5555E-02 6.7619E-10 3.1567E+15 3. 1308E+10 Xe-131m 2.4500E+02 2.9249E-06 1.3446E+19 8.9653E+13 Xe-133 1.9474E+04 1.0404E-04 4 .7107E+20 7.1262E+15 Xe-133m 2.1688E+02 4.8335E-07 2.1886E+18 7.9367E+13 Xe-135 3.2535E-01 1.2740E-10 5.6832E+14 1.1907E+11 Xe-135m 1.5192E-04 1.6677E-15 7.4395E+09 5.5795E+07 primary Transport Group Inventory:

Time (h) = 168.0036 Atmosphere Sump

NED C O-!7c*/_Rev.L...

M-L..Lpage/7of LoTll&

Noble gases (atoms) 1.0544E+22 0.0000E+00 Elemental I (atoms) 1.6675E+17 0.OOOOE+00 Organic I (atoms) 5.1571E+15 O.OOOOE+00 Aerosols (kg) 7.1051E-07 O.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 4.1114E-09 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 4.1610E-09 Total I (Ci) 1.2749E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 168.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.5681E+19 Elemental I (atoms) 0.OOOOE+00 1.0387E+15 Organic I (atoms) 0.OOOOE+00 3.2126E+13 Aerosols (kg) O.OOOOE+00 4.4261E-09 Environment Integral Nuclide Release:

Time (h) = 168.0036 Ci kg Atoms Bq Br-82 1.5768E-04 1.4564E-13 1.0696E+12 5.8342E+06 Kr-85 3.4693E+00 8.8427E-06 6.2649E+19 1.2836E+ll Kr- 85m 1.6616E-10 2.0191E-20 1.4305E+05 6.1479E+00 I-130 2.0359E-06 1.0439E-15 4.8356E+09 7.5328E+04 I-131 5.7445E-01 4.6336E-09 2.1301E+16 2.1255E+10 I-132 2.1478E-01 2.0808E-11 9.4930E+13 7.9469E+09 I-133 4.9504E-03 4 .3700E-12 1.978iE+13 1.8317E+08 I-135 2.7334E-08 7.7834E-18 3.4721E+07 1.0114E+03 Xe-129m 5.3295E-04 4.2122E-12 1.9664E+13 1.9719E+07 Xe-131m 1.5262E+00 1.8220E-08 8.3760E+16 5.6468E+10 Xe-133 1.2131E+02 6.4807E-07 2.9344E+18 4.4884E+12 Xe-133m 1.3510E+00 3.OllOE-09 1.3634E+16 4.9989E+10 Xe-135 2.0268E-03 7.9365E-13 3.5403E+12 7.4990E+07 Xe-135m 9.4656E-07 1.0391E-17 4.6354E+07 3.5023E+04 Environment Transport Group Inventory:

Total Release Time (h) = 168.0036 Release Rate/s Noble gases (atoms) 6.5681E+19 5.0680E+18 Elemental I (atoms) 1.0387E+15 8.0148E+13 Organic I (atoms) 3.2125E+13 2.4788E+12 Aerosols (kg) 4.4260E-09 3.4151E-10 Dose Effective (Ci) I-131 (Thyroid) 5.7656E-01 Dose Effective (Ci) 1-131 (ICRP2 Thyroid) 5.8352E-O1 Total I (Ci) 7.9418E-01 primary to Environment Transport Group Inventory:

Pathway Time (h) = 168.0036 Filtered Transported Noble gases (atoms) O.0000E+00 6.5681E+19 Elemental I (atoms) 0.OOOOE+00 1.0387E+15 Organic I (atoms) 0.OOOOE+00 3.2126E+13 Aerosols (kg) 0.OOOOE+00 4.4261E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 168.0036 Filtered Transported

NED C23SLR6G--

.AtL. lpge~e.aof-L12P Noble gases (atoms) o.0000E+00 4.1616E+17 Elemental I (atoms) 0.OOOOE+00 6.5814E+12 Organic I (atoms) 0.OOOOE+00 2.0355E+ll Aerosols (kg) 0.OOOOE+00 2.8044E-ll Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 168.0036 Filtered Transported Noble gases (atoms) O.OOOOE+00 5.1457E+16 Elemental I (atoms) 0.OOOOE+00 8.1377E+11 Organic I (atoms) 0.OOOOE+00 2.5168E+10 Aerosols (kg) O.0000E+00 3.4675E-12 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 168.0036 Filtered Transported Noble gases (atoms) 8.6211E+14 0.OOOOE+00 Elemental I (atoms) 1.3634E+10 0.OOOOE+00 Organic I (atoms) 4.2167E+08 0.OOOOE+00 Aerosols (kg) 5.8095E-14 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 168.0036 Ci kg Atoms Decay Br-82 1.1205E-06 1.0350E-15 7.6011E+09 3.8140E+05 Kr-85 2.4654E-02 6.2839E-08 4.4521E+17 8.3915E+09 I-130 1.4467E-08 7.4179E-18 3.4363E+07 4.9246E+03 I-131 4.0822E-03 3.2928E-11 1.5137E+14 1.3895E+09 I-132 1.5262E-03 1.4786E-13 6.7455E+ll 5.1967E+08 I-133 3.5179E-05 3.1055E-14 1.4061E+11 1.1974E+07 I-135 1.9424E-10 5.5310E-20 2.4673E+05 6.6122E+01 Xe-129m 3.7873E-06 2.9933E-14 1.3974E+11 1.2891E+06 Xe-131m 1.0845E-02 1.2948E-10 5. 9522E+14 3.6914E+09 Xe-133 8.6205E-01 4.6054E-09 2.0853E+16 2.9342E+11 Xe-133m 9.6009E-03 2.1397E-l1 9.6884E+13 3.2679E+09 Xe-135 1.4402E-05 5.6398E-15 2.5158E+10 4.9026E+06 Xe-135m 6.7220E-09 7.3793E-20 3.2918E+05 2.2959E+03 Control Room Transport Group Inventory:

Time (h) = 168.0036 Atmosphere Sump Noble gases (atoms) 4.6675E+17 0.OOOOE+00 Elemental I (atoms) 7.3814E+12 0.OOOOE+00 Organic I (atoms) 2.2829E+11 0.OOOOE+00 Aerosols (kg) 3.1453E-11 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.0200E-12 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.0323E-12 Total I (Ci) 5.6436E-03 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 168.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 4.1616E+17 Elemental I (atoms) 0.OOOOE+00 6.5814E+12 Organic I (atoms) 0.OOOOE+00 2.0355E+11 Aerosols (kg) 0.OOOOE+00 2.8044E-11 Environment to Control Room Transport Group Inventory:

NEDCjeY26I0ev- /

AtL....IPageL9-YofJ.L-e Pathway Time (h) = 168.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 5.1457E+16 Elemental I (atoms) 0.OOOOE+00 8.1377E+11 Organic I (atoms) 0.OOOOE+00 2.5168E+10 Aerosols (kg) 0.0000E+00 3.4675E-12 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 168.0036 Filtered Transported Noble gases (atoms) 8.6211E+14 0.OOOOE+00 Elemental I (atoms) 1.3634E+10 0.OOOOE+00 Organic I (atoms) 4.2167E+08 0.OOOOE+00 Aerosols (kg) 5.8095E-14 0.OOOOE+00 EAB Doses:

Time (h) = 170.0000 Whole Body Thyroid TEDE Delta dose (rem) 6.9402E-02 1.8162E+01 6.2350E-01 Accumulated dose (rem) 6.9838E-02 1.8276E+01 6.2740E-01 LPZ Doses:

Time (h) = 170.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.8705E-02 1.0129E+01 3. 4772E-01 Accumulated dose (rem) 3.8948E-02 1.0192E+01 3.4989E-01 Control Room Doses:

Time (h) = 170.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.3553E-02 1.3299E+02 4.0797E+00 Accumulated dose (rem) 2.3553E-02 1.3299E+02 4.0798E+00 primary Compartment Nuclide Inventory:

Time (h) = 170.0000 Ci kg Atoms Decay Br-82 2.4658E-05 2.2776E-14 1. 6727E+11 8.2118E+11 Kr-85 5.6422E-01 1.4381E-06 1.0189E+19 1.8170E+16 Kr-85m 1.9842E-11 2.4110E-21 1.7082E+04 8.3315E+05 I-130 2.9603E-07 1.5178E-16 7.0313E+08 1.0493E+10 I-131 9.2758E-02 7.4820E-10 3.4395E+15 3.0054E+15 1-132 1.9138E-02 1.8541E-12 8.4589E+12 1.0352E+15 I-133 7.5328E-04 6.6497E-13 3.0109E+12 2.5681E+13 I-135 3.6057E-09 1.0267E-18 4.5800E+06 1.3897E+08 Xe-129m 8.6054E-05 6.8013E-13 3.1751E+12 2.7883E+12 Xe-131m 2.4701E-01 2.9490E-09 1.3557E+16 7.9873E+15 Xe-133 1.9515E+01 1.0426E-07 4 .7208E+17 6.3432E+17 Xe-133m 2.1401E-01 4.7695E-10 2.1596E+15 7.0490E+15 Xe-135 2.8307E-04 1.1085E-13 4. 9447E+11 1.0387E+13 Xe-135m 1.3130E-09 1.4414E-20 6.4297E+04 2.7863E+09 primary Transport Group Inventory:

Time (h) = 170.0000 Atmosphere Sump Noble gases (atoms) 1.0677E+19 0.OOOOE+00 Elemental I (atoms) 1.6738E+14 0.OOOOE+00 Organic I (atoms) 5.1767E+12 0.OOOOE+00 Aerosols (kg) 7.1321E-10 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 4.1310E-12

NEDC,0E- 0 7/Rev.J...

Am / pageo / 7o Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 4.1600E-12 Total I (Ci) 1.1265E-01 primary to Environment Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 1.0592E+22 Elemental I (atoms) 0.OOOOE+00 1.6732E+17 Organic I (atoms) 0.OOOOE+00 5.1750E+15 Aerosols (kg) 0.OOOOE+00 7.1297E-07 Environment Integral Nuclide Release:

Time (h) = 170.0000 Ci kg Atoms Bq Br-82 2.5276E-02 2.3347E-11 1.7146E+14 9.3523E+08 Kr-85 5.5983E+02 1.4269E-03 1.0110E+22 2.0714E+13 Kr-85m 2.5468E-08 3.0947E-18 2.1926E+07 9.4232E+02 I-130 3.2239E-04 1. 6530E-13 7.6573E+11 1.1928E+07 I-131 9.2586E+01 7.4681E-07 3.4331E+18 3.4257E+12 I-132 3.14 06E+01 3.0426E-09 1.3881E+16 1.1620E+12 I-133 7.8992E-01 6. 9731E-10 3.1573E+15 2.9227E+10 I-135 4.2588E-06 1.2127E-15 5.4097E+09 1.5758E+05 Xe-129m 8.5897E-02 6.7888E-10 3.1693E+15 3.1782E+09 Xe-131m 2.4607E+02 2.9378E-06 1.3505E+19 9.1047E+12 Xe-133 1.9539E+04 1.0439E-04 4.7265E+20 7.2295E+14 Xe-133m 2.1705E+02 4.8371E-07 2.1902E+18 8.0307E+12 Xe-135 3.1879E-01 1.2483E-10 5.5687E+14 1.1795E+10 Xe-135m 7.4699E-05 8.2004E-16 3.6581E+09 2.7639E+06 Environment Transport Group Inventory:

Total Release Time (h) = 170.0000 Release Rate/s Noble gases (atoms) 1.0598E+22 1.4719E+18 Elemental I (atoms) 1.6734E+17 2.3242E+13 Organic I (atoms) 5.1755E+15 7.1882E+ll Aerosols (kg) 7.1305E-07 9.9034E-11 Dose Effective (Ci) I-131 (Thyroid) 9.2904E+01 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 9.3929E+01 Total I (Ci) 1.2478E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0592E+22 Elemental I (atoms) 0.OOOOE+00 1.6732E+17 Organic I (atoms) 0.OOOOE+00 5.1750E+15 Aerosols (kg) 0.OOOOE+00 7.1297E-07 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7150E+19 Elemental I (atoms) 0.OOOOE+00 1.0608E+15 Organic I (atoms) 0.OOOOE+00 3.2808E+13 Aerosols (kg) 0.OOOOE+00 4.5200E-09

NEDCeZ=-°0URev /Z Att./ page ofL Z4' Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3030E+18 Elemental I (atoms) 0.OOOOE+00 1.3116E+14 Organic I (atoms) 0.OOOOE+00 4.0566E+12 Aerosols (kg) 0.OOOOE+00 5.5889E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) 6.9304E+19 0.OOOOE+00 Elemental I (atoms) 1. 0924E+15 0.OOOOE+00 Organic I (atoms) 3.3786E+13 0.OOOOE+00 Aerosols (kg) 4.6547E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 170.0000 Ci kg Atoms Decay Br-82 1.4242E-05 1.3154E-14 9.6607E+10 1.4223E+10 Kr-85 3.2587E-01 8.3058E-07 5.8846E+18 3.1754E+14 I-130 1.7097E-07 8.7663E-17 4.0609E+08 1.7877E+08 I-131 5.3573E-02 4.3213E-10 1.9865E+15 5.2438E+13 I-132 1.1053E-02 1.0709E-12 4. 8855E+12 1.5862E+13 I-133 4.3506E-04 3.8406E-13 1.7390E+12 4.4203E+11 I-135 2.0825E-09 5.9298E-19 2.6452E+06 2.3164E+06 Xe-129m 4 .9701E-05 3.9281E-13 1.8338E+12 4.8649E+10 Xe-131m 1.4266E-O1 1.7032E-09 7.8297E+15 1.3943E+14 Xe-133 1.1271E+01 6.0215E-08 2.7265E+17 1.1058E+16 Xe-133m 1.2360E-01 2.7547E-10 1.2473E+15 1.2245E+14 Xe-135 1. 6349E-04 6.4020E-14 2.8558E+11 1.7536E+11 Xe-135m 7.5831E-10 8.3246E-21 3.7135E+04 2.1722E+07 Control Room Transport Group Inventory:

Time (h) = 170.0000 Atmosphere Sump Noble gases (atoms) 6.1663E+18 0.00OOE+00 Elemental I (atoms) 9.6672E+13 0.OOOOE+00 Organic I (atoms) 2.9898E+12 0.0000E+00 Aerosols (kg) 4.1191E-10 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.3371E-11 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.3465E-11 Total I (Ci) 6.5061E-02 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7150E+19 Elemental I (atoms) 0.OOOOE+00 1.0608E+15 Organic I (atoms) 0.OOOOE+00 3.2808E+13 Aerosols (kg) 0.OOOOE+00 4.5200E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) O.OOOOE+00 8.3030E+18 Elemental I (atoms) 0.0000E+00 1.3116E+14

NEDO 6*O2-71Rev-L-AuL...iPageLZe.Z-of.L7-d Organic I (atoms) 0.0000E+00 4 . 0566E+12 Aerosols (kg) 0.0000E+00 5.5889E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 170.0000 Filtered Transported Noble gases (atoms) 6.9304E+19 0.OOOOE+00 Elemental I (atoms) 1.0924E+15 0.OOOOE+00 Organic I (atoms) 3.3786E+13 0.OOOOE+00 Aerosols (kg) 4.6547E-09 0.OOOOE+00 EAB Doses:

Time (h) = 176.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 6.9838E-02 1.8276E+01 6.2740E-01 LPZ Doses:

Time (h) = 176.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.7098E-05 1.0188E-02 3.4765E-04 Accumulated dose (rem) 3.8985E-02 1.0202E+01 3.5024E-01 Control Room Doses:

Time (h) = 176.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.0324E-03 1.1946E+01 3.6613E-01 Accumulated dose (rem) 2.5585E-02 1.4494E+02 4.4459E+00 primary Compartment Nuclide Inventory:

Time (h) = 176.0000 Ci kg Atoms Decay Kr-85 5.6519E-10 1. 4406E-15 1.0206E+10 1.8188E+16 I-131 9.0940E-11 7.3353E-19 3.3721E+06 3.0084E+15 Xe-131m 2.4388E-10 2.9116E-18 1.3385E+07 7. 9953E+15 Xe-133 1.8921E-08 1.0108E-16 4.5770E+08 6.3495E+17 Xe-133m 1.9807E-10 4 .4141E-19 1.9987E+06 7.0559E+15 primary Transport Group Inventory:

Time (h) = 176.0000 Atmosphere Sump Noble gases (atoms) 1.0679E+10 0.OOOOE+00 Elemental I (atoms) 1.6374E+05 0.OOOOE+00 Organic I (atoms) 5.0642E+03 0.OOOOE+00 Aerosols (kg) 6.9768E-19 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 4.0450E-21 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 4.0520E-21 Total I (Ci) 9.4701E-11 primary to Environment Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0603E+22 Elemental I (atoms) 0.OOOOE+00 1.6749E+17 Organic I (atoms) 0.OOOOE+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment Integral Nuclide Release:

NEDC _05Oc'7Rev/L AtLt....page Av )ofL70 Time (h) = 176.0000 Ci kg Atoms Bq Br-82 2.5301E-02 2.3370E-11 1.7163E+14 9.3613E+08 Kr-85 5.6040E+02 1.4284E-03 1.0120E+22 2.0735E+13 Kr-85m 2.5487E-08 3.0970E-18 2. 1942E+07 9.4302E+02 I-130 3.2268E-04 1.6545E-13 7.6642E+1l 1.1939E+07 I-131 9.2678E+01 7.4756E-07 3.4366E+18 3.4291E+12 I-132 3.1424E+01 3.0443E-09 1.3889E+16 1.1627E+12 I-133 7.9066E-01 6.9796E-10 3.1603E+15 2.9254E+10 I-135 4.2623E-06 1.2137E-15 5.4141E+09 1.5771E+05 Xe-129m 8.5983E-02 6.7956E-10 3.1724E+15 3.1814E+09 Xe-131m 2.4632E+02 2.9407E-06 1.3519E+19 9.1138E+12 Xe-133 1.9559E+04 1.0449E-04 4 .7312E+20 7.2367E+14 Xe-133m 2.1726E+02 4.8419E-07 2. 1924E+18 8.0386E+12 Xe-135 3.1907E-01 1.2494E-10 5. 5735E+14 1.1806E+10 Xe-135m 7.4700E-05 8.2005E-16 3.6581E+09 2.7639E+06 Environment Transport Group Inventory:

Total Release Time (h) = 176.0000 Release Rate/s Noble gases (atoms) 1.0609E+22 3.6835E+17 Elemental I (atoms) 1.6751E+17 5.8163E+12 Organic I (atoms) 5.1807E+15 1.7988E+11 Aerosols (kg) 7.1376E-07 2.4783E-11 Dose Effective (Ci) I-131 (Thyroid) 9.2997E+01 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 9.4023E+01 Total I (Ci) 1.2489E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0603E+22 Elemental I (atoms) 0.OOOOE+00 1.6749E+17 Organic I (atoms) 0.OOOOE+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14 Organic I (atoms) 0.OOOOE+00 4.0598E+12 Aerosols (kg) 0.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 7.5528E+19 0.OOOOE+00

NEDCj2jas-LRev.JI..

Att 4 --pageze-T-ofL2m' Elemental I (atoms) 1.1897E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 O.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 176.0000 Ci kg Atoms Decay Br-82 1.2696E-09 1.1727E-18 8.6124E+06 1.5361E+10 Kr-85 3.2681E-05 8.3300E-11 5.9017E+14 3.4392E+14 I-130 1.2248E-11 6.2801E-21 2.9092E+04 1. 9212E+08 I-131 5.2585E-06 4.2416E-14 1.9499E+11 5. 6765E+13 I-132 1.8175E-07 1.7608E-17 8.0333E+07 1.6609E+13 I-133 3.5727E-08 3.1538E-17 1.4280E+08 4.7651E+11 Xe-129m 4.8779E-09 3.8553E-17 1.7998E+08 5.2664E+10 Xe-131m 1.4102E-05 1.6836E-13 7.7398E+11 1.5097E+14 Xe-133 1.0941E-03 5.8451E-12 2.6466E+13 1.1967E+16 Xe-133m 1.1453E-05 2.5524E-14 1.1557E+11 1.3237E+14 Xe-135 1.0377E-08 4.0635E-18 1.8127E+07 1.8797E+11 Control Room Transport Group Inventory:

Time (h) = 176.0000 Atmosphere Sump Noble gases (atoms) 6.1753E+14 0.OOOOE+00 Elemental I (atoms) 9.4682E+09 0.OOOOE+00 Organic I (atoms) 2.9283E+08 0.OOOOE+00 Aerosols (kg) 4.0343E-14 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.3108E-15 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.3131E-15 Total I (Ci) 5.4760E-06 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 0.000OE+00 8.3095E+18 Elemental I (atoms) 0.0000E+00 1.3127E+14 Organic I (atoms) 0.OOOOE+00 4.0598E+12 Aerosols (kg) 0.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 176.0000 Filtered Transported Noble gases (atoms) 7.5528E+19 0.OOOOE+00 Elemental I (atoms) 1.1897E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 EAB Doses:

Time (h) = 192.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

AftL.L.paget&o-otLZa Accumulated dose (rem) 6.9838E-02 1.8276E+01 6.2740E-01 LPZ Doses:

Time (h) = 192.0000 Whole Body Thyroid TEDE Delta dose (rem) 8.6205E-15 1.2916E-12 4 .7954E-14 Accumulated dose (rem) 3.8985E-02 1.0202E+01 3.5024E-01 Control Room Doses:

Time (h) = 192.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.8689E-07 1.1605E-03 3.5527E-05 Accumulated dose (rem) 2.5586E-02 1.4494E+02 4.4460E+00 primary Compartment Nuclide Inventory:

Time (h) = 192.0000 Ci kg Atoms Decay primary Transport Group Inventory:

Time (h) = 192.0000 Atmosphere Sump Noble gases (atoms) 1.0689E-14 0.OOOOE+C 0 Elemental I (atoms) 1.5521E-19 0.0000E+C 0 Organic I (atoms) 4.8004E-21 O.OOOOE+0 0 Aerosols (kg) 6.6134E-43 0.OOOOE+C 0 Dose Effective (Ci/cc) I-131 (Thyr oid) 3.8346E-45 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 3.8363E-45 Total I (Ci) 8.6653E-35 primary to Environment Transport Group Inventory:

Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0603E+22 Elemental I (atoms) 0.OOOOE+00 1.6749E+17 Organic I (atoms) 0.OOOOE+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment Integral Nuclide Release:

Time (h) 5 192.0000 Ci kg Atoms Bq Br-82 2.5301E-02 2.3370E-11 1.7163E+14 9.3613E+08 Kr-85 5.6040E+02 1.4284E-03 1.0120E+22 2.0735E+13 Kr-85m 2.5487E-08 3.0970E-18 2.1942E+07 9.4302E+02 I-130 3.2268E-04 1.6545E-13 7.6642E+11 1.1939E+07 I-131 9.2678E+01 7.4756E-07 3.4366E+18 3.4291E+12 I-132 3.1424E+01 3.0443E-09 1.3889E+16 1.1627E+12 I-133 7.9066E-01 6.9796E-10 3.1603E+15 2.9254E+10 I-135 4.2623E-06 1.2137E-15 5.4141E+09 1.5771E+05 Xe-129m 8.5983E-02 6.7956E-10 3.1724E+15 3.1814E+09 Xe-131m 2.4632E+02 2.9407E-06 1.3519E+19 9.1138E+12 Xe-133 1.9559E+04 1.0449E-04 4.7312E+20 7.2367E+14 Xe-133m 2.1726E+02 4.8419E-07 2.1924E+18 8.0386E+12 Xe-135 3.1907E-01 1.2494E-10 5.5735E+14 1.1806E+10 Xe-135m 7.4700E-05 8.2005E-16 3.6581E+09 2.7639E+06 Environment Transport Group Inventory:

Total Release Time (h) = 192.0000 Release Rate/s Noble gases (atoms) 1.0609E+22 1.2278E+17

AftL.L..page ///of129O Elemental I (atoms) 1.6751E+17 1.9388E+12 Organic I (atoms) 5.1807E+15 5.9962E+10 Aerosols (kg) 7.1376E-07 8.2611E-12 Dose Effective (Ci) I-131 (Thyroid) 9.2997E+01 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 9.4023E+01 Total I (Ci) 1.2489E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0603E+22 Elemental I (atoms) 0.0000E+00 1.6749E+17 Organic I (atoms) 0.OOOOE+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7203E+19 Elemental I (atoms) 0.0000E+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14 Organic I (atoms) 0.OOOOE+00 4.0598E+12 Aerosols (kg) 0.0000E+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.0000E+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 192.0000 Ci kg Atoms Decay Kr-85 6.7777E-16 1.7275E-21 1.2239E+04 3.4392E+14 Control Room Transport Group Inventory:

Time (h) = 192.0000 Atmosphere Sump Noble gases (atoms) 1.2760E+04 0.OOOOE+00 Elemental I (atoms) 1.8528E-01 0.OOOOE+00 Organic I (atoms) 5.7304E-03 0.OOOOE+00 Aerosols (kg) 7.8948E-25 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 2.5653E-26 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 2.5664E-26 Total I (Ci) 1.0344E-16 Environment to Control Room Transport Group Inventory:

NEDA°5L-L7a RevLo Att I -pageL12 of /?° Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14 Organic I (atoms) 0.OOOOE+00 4.0598E+12 Aerosols (kg) 0.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 192.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.OOOOE+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 EAB Doses:

Time (h) = 264.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 6.9838E-02 1.8276E+01 6.2740E-01 LPZ Doses:

Time (h) = 264.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.6954E-39 5.3621E-37 1. 9021E-38 Accumulated dose (rem) 3.8985E-02 1.0202E+01 3.5024E-01 Control Room Doses:

Time (h) = 264.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.5131E-18 1.6197E-14 4.9566E-16 Accumulated dose (rem) 2.5586E-02 1.4494E+02 4.4460E+00 primary Compartment Nuclide Inventory:

Time (h) = 264.0000 Ci kg Atoms Decay primary Transport Group Inventory:

Time (h) = 264.0000 Atmosphere Sump Noble gases (atoms) 1.0768-122 0.OOOOE+00 Elemental I (atoms) 1.2234-127 0.OOOOE+00 Organic I (atoms) 3.7836-129 0.OOOOE+00 Aerosols (kg) 5.2127-151 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 3.0218-153 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 3. 0220-153 Total I (Ci) 6.8055-143 primary to Environment Transport Group Inventory:

Pathway

NEDO. ~f5fk;4Rev-L..

Att / -agefll3ofJ-LZ Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0603E+22 Elemental I (atoms) 0.OOOOE+00 1.6749E+17 Organic I (atoms) 0.OOOOE+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment Integral Nuclide Release:

Time (h) = 264.0000 Ci kg Atoms Bq Br-82 2.5301E-02 2.3370E-11 1.7163E+14 9.3613E+08 Kr-85 5.6040E+02 1.4284E-03 1.0120E+22 2.0735E+13 Kr-85m 2.5487E-08 3.0970E-18 2.1942E+07 9.4302E+02 I-130 3.2268E-04 1. 6545E-13 7.6642E+ll 1.1939E+07 I-131 9.2678E+01 7.4756E-07 3.4366E+18 3.4291E+12 I-132 3.1424E+01 3.0443E-09 1.3889E+16 1.1627E+12 I-133 7.9066E-01 6. 9796E-10 3.1603E+15 2.9254E+10 I-135 4.2623E-06 1.2137E-15 5.4141E+09 1.5771E+05 Xe-129m 8.5983E-02 6.7956E-10 3.1724E+15 3.1814E+09 Xe-131m 2.4632E+02 2.9407E-06 1.3519E+19 9.1138E+12 Xe-133 1.9559E+04 1.0449E-04 4.7312E+20 7.2367E+14 Xe-133m 2.1726E+02 4 .8419E-07 2.1924E+18 8.0386E+12 Xe-135 3.1907E-01 1.2494E-10 5.5735E+14 1.1806E+10 Xe-135m 7.4700E-05 8.2005E-16 3.6581E+09 2.7639E+06 Environment Transport Group Inventory:

Total Release Time (h) = 264.0000 Release Rate/s Noble gases (atoms) 1.0609E+22 3.0696E+16 Elemental I (atoms) 1.6751E+17 4.8469E+11 Organic I (atoms) 5.1807E+15 1.4990E+10 Aerosols (kg) 7.1376E-07 2.0653E-12 Dose Effective (Ci) I-131 (Thyroid) 9.2997E+01 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 9.4023E+01 Total I (Ci) 1.2489E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0603E+22 Elemental I (atoms) 0.OOOOE+00 1.6749E+17 Organic I (atoms) 0.OOOOE+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14

NEMED 00* 3/I3ev.....

Att - / page //roUg.-

Organic I (atoms) 0.OOOOE+00 4.0598E+12 Aerosols (kg) 0.0000E+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.OOOOE+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 264.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 264.0000 Atmosphere Sump Noble gases (atoms) 1.0608E-44 0.OOOOE+00 Elemental I (atoms) 1.2053E-49 0.OOOOE+00 Organic I (atoms) 3.7276E-51 0.OOOOE+00 Aerosols (kg) 5.1355E-73 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.6684E-74 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.6685E-74 Total I (Ci) 6.7047E-65 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14 Organic I (atoms) 0.OOOOE+00 4.0598E+12 Aerosols (kg) 0.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.OOOOE+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 EAB Doses:

Time (h) = 888.0000 Whole Body Thyroid TEDE Delta dose (rem) O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 6.9838E-02 1.8276E+01 6.2740E-01 LPZ Doses:

NEDC o-0.'-*/R8vLZ Att /pageeroLL~fZ90 Organic I (atoms) 0.OOOOE+00 4 .0598E+12 Aerosols (kg) o.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.OOOOE+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 264.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 264.0000 Atmosphere Sump Noble gases (atoms) 1.0608E-44 0.OOOOE+00 Elemental I (atoms) 1.2053E-49 0.OOOOE+00 Organic I (atoms) 3.7276E-51 0.OOOOE+00 Aerosols (kg) 5.1355E-73 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.6684E-74 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.6685E-74 Total I (Ci) 6.7047E-65 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14 Organic I (atoms) 0.0000E+00 4.0598E+12 Aerosols (kg) 0.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 264.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.OOOOE+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 O.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 EAB Doses:

Time (h) = 888.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 6.9838E-02 1.8276E+01 6.2740E-01 LPZ Doses:

NEDO £'5:. 07/RevLZ../

AtL...LpageA4~ ofiL Time (h) = 888.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.8856-148 8.7891-146 3.0644-147 Accumulated dose (rem) 3.8985E-02 1.0202E+01 3.5024E-01 Control Room Doses:

Time (h) = 888.0000 Whole Body Thyroid TEDE Delta dose (rem) 9.5828E-67 7.0226E-63 2.1476E-64 Accumulated dose (rem) 2.5586E-02 1.4494E+02 4.4460E+00 primary Compartment Nuclide Inventory:

Time (h) = 888.0000 Ci kg Atoms Decay primary Transport Group Inventory:

Time (h) = 888.0000 Atmosphere Sump Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.0000E+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 primary to Environment Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 0.000OE+00 1.0603E+22 Elemental I (atoms) 0.OOOOE+00 1.6749E+17 Organic I (atoms) o.0000E+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment Integral Nuclide Release:

Time (h) = 888.0000 Ci kg Atoms Bq Br-82 2.5301E-02 2.3370E-11 1.7163E+14 9.3613E+08 Kr-85 5.6040E+02 1.4284E-03 1.0120E+22 2.0735E+13 Kr-85m 2.5487E-08 3.0970E-18 2. 1942E+07 9.4302E+02 I-130 3.2268E-04 1.6545E-13 7. 6642E+1l 1.1939E+07 I-131 9.2678E+01 7.4756E-07 3.4366E+18 3.4291E+12 I-132 3.1424E+01 3.0443E-09 1.3889E+16 1.1627E+12 I-133 7.9066E-01 6.9796E-10 3.1603E+15 2.9254E+10 I-135 4.2623E-06 1.2137E-15 5.4141E+09 1.5771E+05 Xe-129m 8.5983E-02 6.7956E-10 3.1724E+15 3.1814E+09 Xe-131m 2.4632E+02 2.9407E-06 1.3519E+19 9.1138E+12 Xe-133 1.9559E+04 1.0449E-04 4.7312E+20 7.2367E+14 Xe-133m 2.1726E+02 4.8419E-07 2.1924E+18 8.0386E+12 Xe-135 3.1907E-01 1.2494E-10 5.5735E+14 1.1806E+10 Xe-135m 7.4700E-05 8.2005E-16 3.6581E+09 2.7639E+06 Environment Transport Group Inventory:

Total Release Time (h) = 888.0000 Release Rate/s Noble gases (atoms) 1.0609E+22 4.0928E+15 Elemental I (atoms) 1. 6751E+17 6.4625E+10 Organic I (atoms) 5.1807E+15 1.9987E+09 Aerosols (kg) 7.1376E-07 2.7537E-13

Aft -L/page //7of / 4g Dose Effective (Ci) I-131 (Thyroid) 9.2997E+01 Dose Effective (Ci) I-131 (ICRP2 Thyroid) 9.4023E+01 Total I (Ci) 1.2489E+02 primary to Environment Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.0603E+22 Elemental I (atoms) 0.OOOOE+00 1.6749E+17 Organic I (atoms) 0.OOOOE+00 5.1801E+15 Aerosols (kg) 0.OOOOE+00 7.1368E-07 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15 Organic I (atoms) 0.OOOOE+00 3.2833E+13 Aerosols (kg) 0.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14 Organic I (atoms) 0.OOOOE+00 4.0598E+12 Aerosols (kg) 0.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.OOOOE+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.OOOOE+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 Control Room Compartment Nuclide Inventory:

Time (h) = 888.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 888.0000 Atmosphere Sump Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.000OE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.7203E+19 Elemental I (atoms) 0.OOOOE+00 1.0616E+15

NEDC~!e2ev.JZ.

Att..... Page /'-of.L7Z0 Organic I (atoms) 0.0000E+O0 3.2833E+13 Aerosols (kg) O.OOOOE+00 4.5236E-09 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 8.3095E+18 Elemental I (atoms) 0.OOOOE+00 1.3127E+14 Organic I (atoms) 0.0000E+00 4.0598E+12 Aerosols (kg) 0.OOOOE+00 5.5933E-10 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 888.0000 Filtered Transported Noble gases (atoms) 7.5529E+19 0.OOOOE+00 Elemental I (atoms) 1.1898E+15 0.OOOOE+00 Organic I (atoms) 3.6796E+13 0.0000E+00 Aerosols (kg) 5.0695E-09 0.OOOOE+00 838 I-131 Summary primary Environment Control Room Time (hr) I-131 (Curies) 1-131 (Curies) I-131 (Curies) 168.000 1.4306E+01 1.3729E-02 9.7713E-05 168.004 9.2217E+01 5.7445E-01 4.0822E-03 168.404 2.3133E+01 6.9573E+01 3.4421E-01 168.704 8.1999E+00 8.4489E+01 2.9853E-01 169. 004 2.9066E+00 8.9775E+01 2.1700E-01 169.304 1.0303E+00 9.1649E+01 1.4694E-01 169.604 3. 6519E-01 9.2314E+01 9.6188E-02 169. 904 1.2945E-01 9.2549E+01 6.1873E-02 170. 000 9.2758E-02 9.2586E+01 5.3573E-02 170.300 3.2879E-02 9.2646E+01 3.3998E-02 170.600 1.1654E-02 9.2667E+01 2.1503E-02 170.900 4.1311E-03 9.2674E+01 1.3576E-02 171.200 1.4643E-03 9.2677E+01 8.5617E-03 171.500 5.1904E-04 9.2678E+01 5.3964E-03 171.800 1. 8398E-04 9.2678E+01 3.4003E-03 172.100 6.5214E-05 9.2678E+01 2.1421E-03 172.400 2.3116E-05 9.2678E+01 1.3493E-03 172. 700 8.1937E-06 9.2678E+01 8.4991E-04 173.000 2.9044E-06 9.2678E+01 5.3532E-04 173.300 1.0295E-06 9.2678E+01 3.3717E-04 173.600 3.6492E-07 9.2678E+01 2.1236E-04 173.900 1.2935E-07 9.2678E+01 1.3375E-04 174.200 4.5849E-08 9.2678E+01 8.4242E-05 174.500 1.6252E-08 9.2678E+01 5.3058E-05 174.800 5.7607E-09 9.2678E+01 3.3417E-05 175.100 2.0419E-09 9.2678E+01 2.1047E-05 175. 400 7.2379E-10 9.2678E+01 1.3256E-05 175.700 2.5656E-10 9.2678E+01 8.3491E-06 176. 000 9.0940E-11 9.2678E+01 5.2585E-06 176.300 3.2235E-11 9.2678E+01 3.3120E-06 176. 600 1.1426E-11 9.2678E+01 2.0860E-06

NEDC 2-L71Rev-L-AtLt / page&ZfofL27° 176.900 4.0501E-12 9.2678E+01 1.3138E-06 177.200 1.4356E-12 9.2678E+01 8.2747E-07 177.500 5.0887E-13 9.2678E+01 5.2117E-07 177.800 1.8037E-13 9.2678E+01 3.2825E-07 178.100 6.3936E-14 9.2678E+01 2.0674E-07 178.400 2.2663E-14 9.2678E+01 1.3021E-07 192.000 8.6263E-35 9.2678E+01 1.0298E-16 264.000 6.8021-143 9.2678E+01 6.7013E-65 888.000 O.OOOOE+00 9.2678E+01 O.OOOOE+00 Cumulative Dose Summary EAB LPZ Control Room Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem)

(rem) 168.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 168.004 1.1337E-01 3.8956E-03 6.3226E-02 2. 1726E-03 1.9485E-03 5.9807E-05 168.404 1.3734E+01 4.7173E-01 7.6596E+00 2.6308E-01 3.2749E+01 1.0050E+00 168.704 1.6678E+01 5.7268E-01 9.3012E+00 3.1938E-01 6.6183E+01 2.0308E+00 169.004 1.7721E+01 6.0843E-01 9.8830E+00 3.3932E-01 9.2477E+01 2.8374E+00 169.304 1.8091E+01 6.2108E-01 1.0089E+01 3.4637E-01 1.1089E+02 3.4022E+00 169.604 1.8222E+01 6.2556E-01 1.0162E+01 3. 4887E-01 1.2315E+02 3.7781E+00 169.904 1.8269E+01 6.2715E-01 1.0188E+01 3.4976E-01 1.3110E+02 4.0218E+00 170.000 1.8276E+01 6.2740E-01 1.0192E+01 3.4989E-01 1.3299E+02 4.0798E+00 170.300 1.8276E+01 6.2740E-01 1. 0199E+01 3.5012E-01 1.3739E+02 4.2146E+00 170.600 1.8276E+01 6.2740E-01 1.0201E+01 3.5020E-01 1.4018E+02 4.3000E+00 170.900 1.8276E+01 6.2740E-01 1.0202E+01 3.5023E-01 1.4194E+02 4.3540E+00 171.200 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4305E+02 4.3880E+00 171.500 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4375E+02 4.4095E+00 171.800 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4419E+02 4.4230E+00 172.100 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4447E+02 4.4315E+00 172.400 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4464E+02 4.4368E+00 172.700 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4475E+02 4.4402E+00 173.000 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4482E+02 4.4424E+00 173.300 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4486E+02 4.4437E+00 173.600 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4489E+02 4.4445E+00

NEDoc 9.jE /Rev (

Aft- - pageL1oof L7c 173.900 1.8276E+01 6.274OE-01 1.0202E+01 3.5024E-01 1.44 91E+02 4.4451E+00 174.200 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4492E+02 4.4454E+00 174.500 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4493E+02 4.4456E+00 174.800 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4493E+02 4.4457E+00 175.100 1.8276E+01 6.274OE-01 1.0202E+01 3.5024E-01 1.4493E+02 4.4458E+00 175.400 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4459E+00 175.700 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4459E+00 176.000 1.8276E+01 6.274OE-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4459E+00 176.300 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 176.600 1.8276E+01 6.2740E-01 1.0202E+Ol 3.5024E-01 1.4494E+02 4.4460E+00 176.900 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 177.200 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 177.500 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 177.800 1.8276E+01 6.274OE-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 178.100 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 178.400 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 192.000 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 264.000 1.8276E+01 6.2740E-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 888.000 1.8276E+01 6.274OE-01 1.0202E+01 3.5024E-01 1.4494E+02 4.4460E+00 Worst Two-Hour Doses EAB Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 168.0 6.9838E-02 1.8276E+01 6.274OE-01

NEDCO5-°O ev L.

a) AtL /I page /z{/off 70 Page:_GI_ ofG45_

A L I O 1<@et@8 04I4CE9 Ao5" t

N Caic. No.: ALION-CAL-NPPD-3236-001 Rev. Number: 1 ATTACHMENT G RADTRAD v 3.10 Detailed Output File (oO)

Qualitative CREFS Shine Analysis

NEDC Oe-o7fRev-/

Att-pagelfL-of.LZ?

ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:33 File information if#14*1 itl#ti#tttii 111*1* liii IiuI#lii#ittfif utiiliii##ttttitii#ttti##

Input File Name = C:\Documents and Settings\Jan Bostelman\My Documents\FHAcooper 9-21-05.psf Output File Name = C:\Documents and Settings\Jan Bostelman\My Documents\FHAcooper 9-21-05.o5 Inventory file = c:\radtrad\nuclides 103\defaults\cooper29fha.nif Release file = c:\radtrad\radtrad_310\defaults\rgl_183.rft Dose Conversion file = C:\RADTRAD\Nuclides_103\Defaults

\cooper29fha.inp

t it #t #t ##

f# #*

Dose

fovrionFator11File:11 1 1fi C:RATRD\ucide 103De1uls 1co*r29hainpI Radtrad 3.10 9/13/2004 Nuclid Invetor filites: 14f Dose Conversion Factor File:

C::\RADTRAD\Nuclides_103\Defaults\cooper29fha.inp Release Fraction & Timing Files:

1 c: \radtrad\radtrad_310\defaults\rgl 183. rft Nuclide Inventory Files:

1 1 c: \radtrad\nuclides_103\defaults\cooper29fha.nif Plant Power Level:

1.5329E+01 Number of Compartments:

3 Compartment 1:

containment 3

7.9500E+05 0

0 0

Compartment 2:

environment 2

0.OOOOE+00

NEDC OS-c7yRevL AtLe/ pageansof LZ70 0

0 0

Compartment 3:

control room 1

1.4186E+05 0

0 0

Number of Pathways:

4 Pathway 1:

containment to environment 1

2 2

Pathway 2:

environment to control room 2

3 2

Pathway 3:

environment to control room 2

3 2

Pathway 4:

control room to environment 3

2 2

End of Plant Model Source Term Input:

I 1 1 1 1 2.4000E+01 2.4000E+01 7.4400E+02 1

1 5.OOOOE-02 9.10OOE-01 4.OOOOE-02 Overlying Pool:

0 O.OOOOE+00 0

0 0

0 Compartments:

3 Compartment 1:

1 1

0 0

NEDC Offfll Rev /L Aft-- / pageLnofJ-7-o 0

0 0

Compartment 2:

1 1

0 0

0 Compartment 3:

1 1

0 0

Pathways:

4 Pathway 1:

2 1

0 0

0 1

1 2.4000E+01 4.5760E+04 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

7.4400E+02 0.0000E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 7.4400E+02 0

0 0

0 Pathway 2:

2 1

0 0

0 1

2 2.4000E+01 3.2350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 8.1000E+02 8.9000E+01 8.9000E+01 8. 9000E+01 0

7.4400E+02 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 7.4400E+02 0

0 0

0

EDC N. pev I/LZ Att / pagezz -5otf-o 0

0 Pathway 3:

2 1

0 0

0 1

1 2.4000E+01 4.0000E+02 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

7.4400E+02 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 7.4400E+02 0

0 0

0 Pathway 4:

2 1

0 0

0 1

2 2.4000E+01 3.6350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 1.2100E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0

7.4400E+02 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 7.4400E+02 0

0 0

0 Dose Locations:

3 Location 1:

Exclusion Area Boundary 2

1 3

2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 0

Location 2:

Low Population Zone 2

1 3

2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 0

Location 3:

NEDCP5-e73 /.Rev.L/

AtLL/page/ 2 otLZ90 control room 3

1 2

2.4000E+01 3.5000E-04 7.4400E+02 O.OOOOE+00 1

4 2.4000E+01 l.OOOOE+00 4.8000E+01 6.OOOOE-01 1.2000E+02 4.OOOOE-01 7.4400E+02 O.OOOOE+00 X/Q Tables:

3 Exclusion Area Boundary 3

2.4000E+01 5.2000E-04 2.6000E+01 O.OOOOE+00 7.4400E+02 O.OOOOE+00 Low Population Zone 5

2.4000E+01 2.9000E-04 3.2000E+01 7.3000E-05 4.8000E+01 2.5000E-05 1.2000E+02 5.2000E-06 7.4400E+02 O.OOOOE+00 cr 6

2.4000E+01 4.1500E-03 2.6000E+01 3.2400E-03 3.2000E+01 1.3200E-03 4.8000E+01 9.0100E-04 1.2000E+02 7.2200E-04 7.4400E+02 O.OOOOE+00 Inflow Pathways:

2 2 3 Exhaust Pathways:

2 1 4 X/Q table ID for Exhaust-Inflow paths:

3 3 0 0 Simulation Parameters:

1 2.4000E+01 O.OOOOE+00 Output Filename:

C:\Documents and Settings\Jan Bostelman\My Documents\FHAcooper 9 05.o4 1

1 0

1 1

End of Scenario File

NEDC !5S- 4TRev /Z AtL.&.pageLzo7bf_1_po control room 3

1 2

2.4000E+01 3.5000E-04 7.4400E+02 O.OOOOE+00 1

4 2.4000E+01 l.OOOOE+00 4.8000E+01 6.OOOOE-01 1.2000E+02 4.OOOOE-01 7.4400E+02 O.OOOOE+00 X/Q Tables:

3 Exclusion Area Boundary 3

2.4000E+01 5.2000E-04 2.6000E+01 O.OOOOE+00 7.4400E+02 O.OOOOE+00 Low Population Zone 5

2.4000E+01 2.9000E-04 3.2000E+01 7.3000E-05 4.8000E+01 2.5000E-05 1.2000E+02 5.2000E-06 7.4400E+02 O.OOOOE+00 cr 6

2.4000E+01 4.1500E-03 2.6000E+01 3.2400E-03 3.2000E+01 1.3200E-03 4.8000E+01 9.0100E-04 1.2000E+02 7.2200E-04 7.4400E+02 O.OOOOE+00 Inflow Pathways:

2 2 3 Exhaust Pathways:

2 1 4 X/Q table ID for Exhaust-Inflow paths:

3 3 0 0 Simulation Parameters:

1 2.4000E+01 O.OOOOE+00 Output Filename:

C:\Documents and Settings\Jan Bostelman\My Documents\FHAcooper 9 05.o4 1

1 0

1 1

End of Scenario File

NEDC O$.3/Rev J Att / pageLzofL/70 This page intentionally left blank.

NEDC° 57a-e9/ Rev Att_...Cpageo.LzfofLL7Z°

41411111*l1*11#11114#1#1*141#####*#1#111#t1111111#t1#11141##111444111*#

ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:33 1t11#1###1l 11*41 14 11 11 111#11*4 111*11411#11*1411*1 *111 11**#44####1##1#

Plant Description Number of Nuclides = 29 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.5329E+01 MWth Number of compartments = 3 Compartment information Compartment number 1 Name: containment Compartment volume = 7.9500E+05 (Cubic feet)

Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: containment to environment Compartment number 2 Name: environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: containment to environment Inlet Pathway Number 4: control room to environment Exit Pathway Number 2: environment to control room Exit Pathway Number 3: environment to control room Compartment number 3 Name: control room Compartment volume = 1.4186E+05 (Cubic feet)

Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: environment to control room Inlet Pathway Number 3: environment to control room Exit Pathway Number 4: control room to environment Total number of pathways = 4

NEDC °S- 07/, Rev /

Att / pageL.otL/7° ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:33 Scenario Description Inventory Power = 15. MWt Time between shutdown and accident start = 2.4000E+01 (Hours)

Time between shutdown and first release = 2.4000E+01 (Hours)

End Time = 7.4400E+02 (Hours)

Radioactive Decay is enabled Calculation of Daughters is enabled Inventory 1 from file c:\radtrad\nuclides_103\defaults\cooper29fha.nif Release Table 1 from file c:\radtrad\radtrad 310\defaults\rgl_183.rft Dose Conversion file = C:\RADTRAD\Nuclides_103\Defaults

\cooper29fha.inp Nuclide Group Specific half Whole Body Inhaled Inhaled Name Inventory life DCF Thyroid Effective (Ci/MWt) (s) (Sv-m3/Bq-s) (Sv/Bq) (Sv/Bq)

Br-82 2 1.800E+02 1.271E+05 1.300E-13 2.380E-10 3.310E-10 Br-83 2 3.260E+03 8.604E+03 3.820E-16 3.290E-12 2.330E-11 Br-84 2 5.610E+03 1.908E+03 9.410E-14 3.120E-12 2.610E-11 Kr-83m 1 3.270E+03 6.588E+03 1.500E-18 0.OOOE+00 O.OOOE+00 Kr-85 1 7.320E+02 3.383E+08 1.190E-16 0.OOOE+0O O.OOOE+00 Kr-85m 1 6.810E+03 1.613E+04 7.480E-15 O.OOOE+O0 O.OOOE+00 Kr-87 1 1.300E+04 4.578E+03 4.120E-14 0.OOOE+00 O.OOOE+00 Kr-88 1 1.830E+04 1.022E+04 1.020E-13 0.OOOE+00 O.OOOE+00 I-128 2 4.190E+02 1.499E+03 4.160E-15 5.340E-11 1.280E-11 I-130 2 1.060E+03 4.450E+04 1.040E-13 1.990E-08 7.140E-10 I-131 2 4.352E+04 6.947E+05 1.820E-14 2.920E-07 8.890E-09 I-132 2 3.930E+04 8.28OE+03 1.120E-13 1.740E-09 1.030E-10 I-133 2 5.510E+04 7.488E+04 2.940E-14 4.860E-08 1.580E-09 I-134 2 6.040E+04 3.156E+03 1.300E-13 2.880E-10 3.550E-11 I-135 2 5.160E+04 2.380E+04 8.294E-14 8.460E-09 3.320E-10 Te-129 4 8.790E+03 4.176E+03 2.750E-15 5.090E-13 2.090E-11 Te-131 4 2.420E+04 1.500E+03 2.040E-14 2.660E-09 1.240E-10 Te-131m 4 3.960E+03 1.080E+05 7.463E-14 3.669E-08 1.758E-09 Te-132 4 3.850E+04 2.815E+05 1.030E-14 6.28OE-08 2.550E-09 Te-133 4 3.240E+04 7.470E+02 4.600E-14 5.910E-10 2.390E-11 Te-133m 4 1.980E+04 3.324E+03 1.140E-13 2.630E-09 1.100E-10 Te-134 4 4.500E+04 2.508E+03 4.240E-14 5.560E-10 3.230E-11 Xe-129m 1 2.060E-01 6.912E+05 1.060E-15 0.OOOE+00 O.OOOE+00 Xe-131m 1 3.040E+02 1.028E+06 3.890E-16 O.OOOE+00 O.OOOE+00 Xe-133 1 5.260E+04 4.532E+05 1.560E-15 0.OOOE+00 O.OOOE+00

AtLJ*...PageL3LofLLZP_

Xe-133m 1 1.580E+03 1.890E+05 1.370E-15 0.OOOE+00 0.OOOE+00 Xe-135 1 1.860E+04 3.272E+04 1.190E-14 0.OOOE+00 0.OOOE+00 Xe-135m 1 1.090E+04 9.174E+02 2.040E-14 0.OOOE+00 0.OOOE+00 Xe-138 1 4.500E+04 8. 502E+02 5.770E-14 0.OOOE+00 0.OOOE+00 Nuclide Daughter Fraction Daughter Fractior n Daughter Fraction Br-83 Kr-83m 1.00 none 0.00 none 0.00 Kr-85m Kr-85 0.21 none 0.00 none 0.00 Kr-87 Rb-87 1.00 none 0.00 none 0.00 Kr-88 Rb-88 1.00 none 0.00 none 0.00 I-131 Xe-131m 0.01 none 0.00 none 0.00 I-133 Xe-133m 0.03 Xe-133 0.97 none 0.00 I-135 Xe-135m 0.15 Xe-135 0.85 none 0.00 Te-129 I-129 1.00 none 0.00 none 0.00 Te-131 I-131 1.00 none 0.00 none 0.00 Te-131m I-131 0.78 Te-131 0.22 none 0.00 Te-132 I-132 1.00 none 0.00 none 0.00 Te-133 I-133 1.00 none 0.00 none 0.00 Te-133m I-133 0.87 Te-133 0.13 none 0.00 Te-134 I-134 1.00 none 0.00 none 0.00 Xe-133m Xe-133 1.00 none 0.00 none 0.00 Xe-135 Cs-135 1.00 none 0.00 none 0.00 Xe-135m Cs-135 0.00 Xe-135 1.00 none 0.00 Xe-138 Cs-138 1.00 none 0.00 none 0.00 Release Fractions and Timings RG 1.183, Tables 3 with DF iodine=200 Duration (h:): NON-LOCA Accident chk i GAP EARLY IN-VESSEL LATE RELEASE RELEASE MASS 0.003600 hr 0.0000 hrs 0.0000 hrs (Ci)

NOBLES 5.OOOOE-02 0.OOOOE+00 0.OOOOE+00 1.311E+05 IODINE 2.5000E-04 0.OOOOE+00 0.OOOOE+00 9.981E+02 CESIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 TELLURIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 STRONTIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 BARIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 RUTHENIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 CERIUM 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOE+00 LANTHANUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 AEROSOL 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 Source Number 1 is used in Compartment 1 Nuclide Distribution from Inventory File 1 Nuclide Distribution given in Ci/MWt Release File Number 1 Fraction of Nuclide Distribution in this Compartment 1.00000 Iodine fractions Aerosol 5.OOOOE-02 Elemental 9.10OOE-01 Organic 4.OOOOE-02 COMPARTMENT DATA Compartment number 1: containment Compartment number 2: environment Compartment number 3: control room

NEDCO 5-07/Rev-..L AI.L/.page 13 zofl Z7 PATHWAY DATA Pathway number 1: containment to environment Radioactive decay is enabled for this pathway.

Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 4.5760E+04 O.OOOOE+00 O.OOQOE+00 O.OOOOE+00 Pathway number 2: environment to control room Radioactive decay is enabled for this pathway.

Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 3.2350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 8.1000E+02 8.9000E+01 8.9000E+01 8.9000E+01 Pathway number 3: environment to control room Radioactive decay is enabled for this pathway.

Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 4.OOOOE+02 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Pathway number 4: control room to environment Radioactive decay is enabled for this pathway.

Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 2.4000E+01 3.6350E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 2.4017E+01 1.2100E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 DOSE INFORMATION NumberDoseLocations = 3 Dose Location Name = Exclusion Area Boundary Located in compartment 2 the environment Exclusion Area Boundary Breathing Rate Data Time (hr) Breathing Rate (mA3

secA^-)

2.4000E+01 3.5000E-04 3.2000E+01 1.80OOE-04 4.BOOOE+01 2.3000E-04 Dose Location Name = Low Population Zone Located in compartment 2 the environment Low Population Zone Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-l) 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04

NED

'*-31Rev..L....

AftLL..page/i2.of-L7?

Dose Location Name = control room Located in compartment 3 the control room control room Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-1) 2.4000E+01 3.5000E-04 7.4400E+02 O.0000E+00 control room Occupancy Factor Data Time (hr) Occupancy Factor 2.4000E+01 1.0000E+00 4.8000E+01 6.0000E-01 1.2000E+02 4.OOOOE-01 7.4400E+02 0.0000E+00 X/Q, ATMOSPHERIC DISPERSION INFORMATION X/Q Table Name = Exclusion Area Boundary Location X/Q Data Time (hr) X/Q (s

m^-3) 2.4000E+01 5.2000E-04 2.6000E+01 0.OOOOE+00 7.4400E+02 0.000OE+00 X/Q Table Name = Low Population Zone Location X/Q Data Time (hr) X/Q (s

m^-3) 2.4000E+01 2.9000E-04 3.2000E+01 7.3000E-05 4.8000E+01 2.5000E-05 1.2000E+02 5.2000E-06 7.4400E+02 0.OOOOE+00 X/Q Table Name = cr Location X/Q Data Time (hr) X/Q (s

m^-3) 2.4000E+01 4.1500E-03 2.6000E+01 3.2400E-03 3.2000E+01 1.3200E-03 4.8000E+01 9.O100E-04 1.2000E+02 7.2200E-04 7.4400E+02 0.OOOOE+00 This X/Q Table is used for these connected pathways Path 1 containment to environment and Path 2 environment to control room Path 1 containment to environment and Path 3 environment to control room USER SPECIFIED TIME STEP DATA - SUPPLEMENTAL TIME STEPS Time (hr) Time step (hr) 0.OOOOE+00 0.OOOOE+00 EDIT EACH MAJOR TIME STEP EDIT SUPPLEMENTAL TIME STEPS DO NOT EDIT MODEL DECONTAMINATION

NEDC o.S-O 5Rev.

L Att L pagel!bo 0 1

Masses in Curies in detailed output

NEDC - 03/Rev (

Att / pageL3.f LL DTR Vers##4o4####40####(###u##me##05#####4#ru##n9*##2#2#2#0#5#a###4583 ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:33 4##4##*##4#44**#44#44*####4#44#*###44#####4###44444##4#4*#4#############

1. 1. 1. # I ####4 #####

4 #44 44

#4 # * # # # # *

4 #4 # 4 # # # # 4 4

#4 # * # 4#4#4 4 4 4

# # I # * #

4

# # * # #4

4 4444 44*4 # # 4

44#44*#44#44#4oe#4D##tie##4*oel*a#*d4eta##l#edIn#e###tory Outpu*#t Dose, Detailed model and Detailed Inventory Output

4 #444*4444 44*14 #444 4*1*444444444 *44 *444444 4 *4444*4 44 1*4 4*1 4444 Exclusion Area Boundary Doses:

Time (h) - 24.0006 Whole Body Thyroid TEDE Delta dose (rem) 6.4970E-05 4. 9913E-03 2.1867E-04 Accumulated dose (rem) 6.4970E-05 4.9913E-03 2.1867E-04 Low Population Zone Doses:

Time (h) = 24.0006 Whole Body Thyroid TEDE Delta dose (rem) 3.6233E-05 2.7836E-03 1.2195E-04 Accumulated dose (rem) 3.6233E-05 2.7836E-03 1.2195E-04 control room Doses:

Time (h) = 24.0006 Whole Body Thyroid TEDE Skin Delta dose (rem) 1.0403E-08 1.7007E-05 5.3410B-07 5.8867E-07 Accumulated dose (rem) 1.0403E-08 1.7007E-05 5.3410E-07 5.8867E-07 containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 24.0006 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Br-82 6.6384E-02 3.6880E-05 Br-83 1.8269E-03 1.0149E-06 Br-84 7.7368E-14 4.2982E-17 Kr-83m 1.4394E+00 7.9969E-04 Kr-85 8.6490E+01 4.8050E-02 Kr-85m 1.9631E+01 1.0906E-02 Kr-87 3.1989E-03 1.7772E-06 Kr-88 6.1797E+00 3.4332E-03 1-130 1.6302E-01 9.0564E-05 I-131 2.3765E+01 1.3203E-02

NEDC9o5-/ ~Rev-.J.

Att-L...Page/3 cot-L.Z7 I-132 1.9181E+01 1.0656E-02 I-133 1.4962E+01 8.3124E-03 I-134 8.1049E-07 4.5027E-10 I-135 2.4609E+00 1.3671E-03 Xe-129m 2.2322E-02 1.2401E-05 Xe-131m 3.6969E+01 2.0539E-02 Xe-133 6.0135E+03 3.3408E+00 Xe-133m 1.7132E+02 9.5179E-02 Xe-135 1.6612E+03 9.2288E-01 Xe-135m 8.5707E+01 4.7615E-02 Total 8.1430E+03 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 1.1745E-09 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.2731E-09 Total I (Ci) 6.0368E+01 containment Compartment Group Inventory Distribution:

Time (h) = 24.0006 Atmosphere Sump Noble gases (Ci) 8.0824E+03 0.0000E+00 Elemental I (Ci) 5.5146E+01 0.OOOOE+00 Organic I (Ci) 2.4240E+00 0.OOOOE+00 Aerosol I (Ci) 3.0300E+00 0.OOOOE+00 Aerosols (Ci) 3.0300E+00 0.000OE+00 Aerosols (kg) 1.0380E-08 0.OOOOE+00 environment Integral Nuclide Release:

Time (h) = 24.0006 Ci kg Atoms Bq Br-82 6.3705E-05 5.8842E-14 4.3214E+11 2.3571E+06 Br-83 1.7532E-06 1.1098E-16 8.0519E+08 6.4867E+04 Kr-83m 1.3813E-03 6.6951E-14 4.8577E+11 5.1110E+07 Kr-85 8.2999E-02 2.1155E-07 1.4988E+18 3.0710E+09 Kr-85m 1.8839E-02 2.2891E-12 1.6218E+13 6.9703E+08 Kr-87 3.0698E-06 1.0838E-16 7.5018E+08 1.1358E+05 Kr-88 5.9303E-03 4.7294E-13 3.2365E+12 2.1942E+08 I-130 1.5644E-04 8.0210E-14 3.7156E+11 5.7881E+06 I-131 2.2805E-02 1.8395E-10 8.4563E+14 8.4380E+08 I-132 1.8406E-02 1.7832E-12 8.1353E+12 6.8104E+08 I-133 1.4358E-02 1.2675E-11 5.7392E+13 5.3126E+08 I-134 7.7778E-10 2.9156E-20 1.3103E+05 2.8778E+01 I-135 2.3615E-03 6.7245E-13 2.9997E+12 8.7377E+07 Xe-129m 2.1421E-05 1.6930E-13 7.9034E+1l 7.9257E+05 Xe-131m 3.5477E-02 4.2355E-10 1.9471E+15 1.3127E+09 Xe-133 5.7707E+00 3.0830E-08 1.3959E+17 2.1352E+11 Xe-133m 1.6441E-01 3.6640E-10 1.6590E+15 6.0831E+09 Xe-135 1.5941E+00 6.2424E-10 2.7846E+15 5.8983E+10 Xe-135m 8.2248E-02 9.0291E-13 4.0277E+12 3.0432E+09 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 24.0006 Release Rate/s Noble gases (Ci) 7.7562E+00 3.8781E+00 Elemental I (Ci) 5.2920E-02 2.6460E-02 Organic I (Ci) 2.3261E-03 1.1631E-03 Aerosol I (Ci) 2.9077E-03 1.4538E-03 Aerosols (Ci) 2.9077E-03 1.4538E-03 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

24.0006

NEDC 0- Tev-Z AtLL.-page /-b-L22tfi.ZG Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Br-82 4.5341E-07 2.5190E-10 Br-83 1.2478E-08 6.9322E-12 Kr-83m 9.8316E-06 5.4620E-09 Kr-85 5.9074E-04 3.2819E-07 Kr-85m 1.3408E-04 7.4490E-08 Kr-87 2.1849E-08 1.2138E-11 Kr-88 4.2208E-05 2.3449E-08 I-130 1.1134E-06 6.1857E-10 I-131 1.6231E-04 9.0175E-08 I-132 1.3101E-04 7.2781E-08 I-133 1.0220E-04 5.6775E-08 I-134 5.5358E-12 3.0754E-15 I-135 1.6808E-05 9.3378E-09 Xe-129m 1.5246E-07 8.4701E-11 Xe-131m 2.5251E-04 1.4028E-07 Xe-133 4.1073E-02 2.2818E-05 Xe-133m 1.1702E-03 6.5009E-07 Xe-135 1.1346E-02 6.3034E-06 Xe-135m 5.8539E-04 3.2522E-07 Total 5.5618E-02 0.0000E+00 Dose Effective (Ci/cc) I-131 (Thyroid) 4.4 956E-14 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 4.8731E-14 Total I (Ci) 4. 1232E-04 control room Compartment Group Inventory Distribution:

Time (h) = 24.0006 Atmosphere Sump Noble gases (Ci) 5.5204E-02 0.0000E+00 Elemental I (Ci) 3.7665E-04 0.0000E+00 Organic I (Ci) 1.6556E-05 0.OOOOE+00 Aerosol I (Ci) 2.0695E-05 0.0000E+00 Aerosols (Ci) 2.0695E-05 0.0000E+00 Aerosols (kg) 7.0897E-14 0.OOOOE+00 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

= 24.0006 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 24.0006 Filtered Transported Noble gases (Ci) 0.OOOOE+00 7.7539E+00 Elemental I (Ci) 0.OOOOE+00 5.2906E-02 Organic I (Ci) 0.OOOOE+00 2.3255E-03 Aerosol I (Ci) 0.OOOOE+00 2.9069E-03 Aerosols (Ci) 0.0000E+00 2.9069E-03 Aerosols (kg) o.OOOOE+00 9.9611E-12 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0006 Nuclide Filter environment to control room Transport Group Inventory:

NEDC e~FclRevLf AinL.L.pag0Le f.Z Pathway Time (h) = 24.0006 Filtered Transported Noble gases (Ci) 0.OOOOE+00 9.8258E-02 Elemental I (Ci) 0.OOOOE+00 6.7043E-04 Organic I (Ci) O.0000E+00 2.9469E-05 Aerosol I (Ci) 0.OOOOE+00 3.6837E-05 Aerosols (Ci) 0.OOOOE+00 3.6837E-05 Aerosols (kg) 0.OOOOE+00 6.3093E-14 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0006 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 24.0006 Filtered Transported Noble gases (Ci) 0.OOOOE+00 1.2149E-02 Elemental I (Ci) 0.OOOOE+00 8.2897E-05 Organic I (Ci) 0.OOOOE+00 3.6438E-06 Aerosol I (Ci) 0.OOOOE+00 4.5548E-06 Aerosols (Ci) 0.OOOOE+00 4.5548E-06 Aerosols (kg) 0.OOOOE+00 7.8013E-15 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0006 Nuclide Filter Br-82 1.9364E-10 Kr-83m 4.1987E-09 Kr-85 2.5228E-07 Kr-85m 5.7262E-08 Kr-88 1.8026E-08 I-130 4.7550E-10 I-131 6.9319E-08 I-132 5.5948E-08 I-133 4.3644E-08 I-135 7.1781E-09 Xe-129m 6.5111E-11 Xe-131m 1.0784E-07 Xe-133 1.7541E-05 Xe-133m 4.9973E-07 Xe-135 4.8455E-06 Xe-135m 2.5000E-07 control room to environment Transport Group Inventory:

Pathway Time (h) = 24.0006 Filtered Transported Noble gases (Ci) 0.OOOOE+00 -0.OOOOE+00 Elemental I (Ci) 0.OOOOE+00 0.OOOOE+00 Organic I (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosol I (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosols (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 2.0185E-17 0.OOOOE+00 Exclusion Area Boundary Doses:

NEDCO YE-1, RevL./..

AftLL~pag e / Z'of 7-0 Time (h) = 24.0036 Whole Body Thyroid TEDE Delta dose (rem) 2.6531E-03 2.0386E-01 8.9306E-03 Accumulated dose (rem) 2.7181E-03 2.0885E-01 9.1492E-03 Low Population Zone Doses:

Time (h) = 24.0036 Whole Body Thyroid TEDE Delta dose (rem) 1.4796E-03 1. 1369E-01 4.9805E-03 Accumulated dose (rem) 1.5159E-03 1.1648E-01 5.1025E-03 control room Doses:

Time (h) = 24.0036 Whole Body Thyroid TEDE Skin Delta dose (rem) 2.0964E-06 3.4281E-03 1.0766E-04 1. 1864E-04 Accumulated dose (rem) 2.1068E-06 3.4451E-03 1.0819E-04 1. 1923E-04 containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 24.0036 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Br-82 4.2789E-01 1.1055E-03 Br-83 1.1766E-02 3.0403E-05 Br-84 4.9674E-13 1.2842E-15 Kr-83m 9.2690E+00 2.3951E-02 Kr-85 5.5752E+02 1.4404E+00 Kr-85m 1.2648E+02 3.2681E-01 Kr-87 2.0586E-02 5.3201E-05 Kr-88 3.9805E+01 1.0285E-01 I-130 1.0506E+00 2.7145E-03 I-131 1.5319E+02 3.9577E-01 I-132 1.2356E+02 3.1926E-01 I-133 9.6439E+01 2.4916E-01 I-134 5.2119E-06 1.3471E-08 I-135 1.5858E+01 4.0973E-02 Xe-129m 1.4389E-01 3.7175E-04 Xe-131m 2.3831E+02 6.1569E-01 Xe-133 3.8763E+04 1.0015E+02 Xe-133m 1.1043E+03 2.8532E+00 Xe-135 1.0706E+04 2.7661E+01 Xe-135m 5.4924E+02 1.4201E+00 Total 5.2484E+04 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 7.5708E-09 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 8.2063E-09 Total I (Ci) 3.8904E+02 containment Compartment Group Inventory Distribution:

Time (h) = 24.0036 Atmosphere Sump Noble gases (Ci) 5.2094E+04 0.OOOOE+00 Elemental I (Ci) 3.5539E+02 0.000OE+00 Organic I (Ci) 1.5621E+01 0.OOOOE+00 Aerosol I (Ci) 1.9527E+01 0.OOOOE+00 Aerosols (Ci) 1.9527E+01 0.OOOOE+00 Aerosols (kg) 6.6909E-08 0.OOOOE+00 environment Integral Nuclide Release:

AttL/p ageZL-'o;fj.L2.

Time (h) = 24.0036 Ci kg Atoms Bq Br-82 2.6655E-03 2.4620E-12 1.8081E+13 9.8623E+07 Br-83 7.3303E-05 4.6401E-15 3.3667E+10 2.7122E+06 Kr-83m 5.7748E-02 2.7989E-12 2.0308E+13 2.1367E+09 Kr-85 3.4730E+00 8.8521E-06 6.2716E+19 1.2850E+11 Kr-85m 7.8796E-01 9.574BE-11 6.7836E+14 2. 9154E+10 Kr-87 1.2827E-04 4.5284E-15 3.1346E+10 4.7460E+06 Kr-88 2.4799E-01 1.9777E-11 1.3534E+14 9.1756E+09 I-130 6.5449E-03 3.3558E-12 1.5545E+13 2.4216E+08 I-131 9.5425E-01 7.6971E-09 3.5384E+16 3.5307E+10 I-132 7. 6974E-01 7.4572E-11 3.4021E+14 2. 8480E+10 I-133 6.0076E-01 5.3033E-10 2.4013E+15 2.2228E+10 I-134 3.2478E-08 1.2175E-18 5.4715E+06 1.2017E+03 I-135 9.8789E-02 2.8130E-11 1.2548E+14 3.6552E+09 Xe-129m 8.9632E-04 7.0840E-12 3.3071E+13 3.3164E+07 Xe-131m 1.4845E+00 1.7723E-08 8.1473E+16 5.4926E+10 Xe-133 2.4147E+02 1.2900E-06 5.8410E+18 8.9342E+12 Xe-133m 6.8792E+00 1.5331E-08 6.9419E+16 2.5453E+11 Xe-135 6.6693E+01 2.6116E-08 1.1650E+17 2.4676E+12 Xe-135m 3.4229E+00 3.7576E-11 1.6762E+14 1.2665E+11 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 24.0036 Release Rate/s Noble gases (Ci) 3.2451E+02 2.5040E+01 Elemental I (Ci) 2.2139E+00 1.7082E-01 Organic I (Ci) 9.7313E-02 7.5087E-03 Aerosol I (Ci) 1.2164E-01 9.3859E-03 Aerosols (Ci) 1.2164E-01 9.3859E-03 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

24.0036 Nuclide COMPARTMENT EXPOSURE PATHWAY 4 Atomsphere (Ci-hr) Filter Br-82 1.8942E-05 4.2413E-08 3.9223E-08 Br-83 5.2085E-07 1.1664E-09 1.0785E-09 Kr-83m 4.1030E-04 9.1883E-07 8.4961E-07 Kr-85 2.4680E-02 5.5262E-05 5.1105E-05 Kr-85m 5.5991E-03 1.2538E-05 1.1594E-05 Kr-87 9.1131E-07 2.0409E-09 1.8871E-09 Kr-88 1.7621E-03 3.9459E-06 3.6488E-06 I-130 4.6509E-05 1.0414E-07 9.6307E-08 I-131 6.7812E-03 1.5184E-05 1.4042E-05 I-132 5.4693E-03 1.2247E-05 1.1325E-05 I-133 4.2691E-03 9.5593E-06 8.8401E-06 I-134 2.3072E-10 5.1674E-13 4.7775E-13 I-135 7.0199E-04 1.5719E-06 1.4536E-06 Xe-129m 6.3695E-06 1.4262E-08 1.3189E-08 Xe-131m 1.0549E-02 2.3621E-05 2.1844E-05 Xe-133 1.7159E+00 3.8422E-03 3.5532E-03 Xe-133m 4.8886E-02 1.0946E-04 1.0123E-04 Xe-135 4.7392E-01 1.0612E-03 9.8135E-04 Xe-135m 2.4294E-02 5.4436E-05 5.0294E-05 Total 2.3233E+00 0.OOOOE+00 4.8109E-03 Dose Effective (Ci/cc) I-131 (Thyroid) 1.8782E-12 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 2.0358E-12 Total I (Ci) 1.7222E-02

NEOC 05'7/Rev .

AtLt/ pageZLYZot.L.Z control room Compartment Group Inventory Distribution:

Time (h) = 24.0036 Atmosphere Sump Noble gases (Ci) 2.3060E+00 0.0000E+00 Elemental I (Ci) 1.5732E-02 0.OOOOE+00 Organic I (Ci) 6.9150E-04 0.0000E+00 Aerosol I (Ci) 8.6438E-04 0.OOOOE+00 Aerosols (Ci) 8.6438E-04 0.0000E+00 Aerosols (kg) 2.9619E-12 0.0000E+00 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

= 24.0036 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (Ci) 0.0000E+00 3.2438E+02 Elemental I (Ci) 0.0000E+00 2.2132E+00 Organic I (Ci) 0.000OE+00 9.7283E-02 Aerosol I (Ci) 0.OOOOE+00 1.2160E-01 Aerosols (Ci) 0.0000E+00 1.2160E-01 Aerosols (kg) 0.OOOOE+00 4.1680E-10 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0036 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (Ci) 0.0000E+00 2.9454E+00 Elemental I (Ci) 0.OOOOE+00 2.0096E-02 Organic I (Ci) 0.0000E+00 8.8336E-04 Aerosol I (Ci) 0.0000E+00 1.1042E-03 Aerosols (Ci) 0.0000E+00 1.1042E-03 Aerosols (kg) 0.0000E+00 2.6396E-12 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0036 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (Ci) 0.0000E+00 3.6419E-01 Elemental I (Ci) 0.0000E+00 2.4849E-03 Organic I (Ci) 0.OOOOE+00 1.0922E-04 Aerosol I (Ci) 0.0000E+00 1.3653E-04 Aerosols (Ci) 0.0000E+00 1.3653E-04 Aerosols (kg) 0.0000E+00 3.2637E-13 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0036

NEOC4 r -7/ Re-v.L ..

AttL...LPage&*z otu-o Nuclide Filter Br-82 3.9223E-08 Br-83 1.0785E-09 Kr-83m 8.4961E-07 Kr-85 5.1105E-05 Kr-85m 1.1594E-05 Kr-87 1.8871E-09 Kr-88 3.6488E-06 I-130 9.6307E-08 I-131 1.4042E-05 I-132 1.1325E-05 I-133 8.8401E-06 I-135 1.4536E-06 Xe-129m 1.3189E-08 Xe-131m 2.184 4E-05 Xe-133 3.5532E-03 Xe-133m 1.0123E-04 Xe-135 9.8135E-04 Xe-135m 5.0294E-05 control room to environment Transport Group Inventory:

Pathway Time (h) = 24.0036 Filtered Transported Noble gases (Ci) 4.7751E-03 0.OOOOE+00 Elemental I (Ci) 3.2575E-05 0.OOOOE+00 Organic I (Ci) 1.4319E-06 0.OOOOE+00 Aerosol I (Ci) 1.7899E-06 0.OOOOE+00 Aerosols (Ci) 1.7899E-06 0.OOOOE+00 Aerosols (kg) 5.4715E-15 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 24.0170 Whole Body Thyroid TEDE Delta dose (rem) 1.9711E-02 1.5162E+00 6.6397E-02 Accumulated dose (rem) 2.2429E-02 1.7250E+00 7.5546E-02 Low Population Zone Doses:

Time (h) = 24.0170 Whole Body Thyroid TEDE Delta dose (rem) 1.0993E-02 8.4555E-01 3.7029E-02 Accumulated dose (rem) 1.2509E-02 9.6203E-01 4.2132E-02 control room Doses:

Time (h) = 24.0170 Whole Body Thyroid TEDE Skin Delta dose (rem) 9.6701E-05 1.5832E-01 4.9717E-03 5.4751E-03 Accumulated dose (rem) 9.8807E-05 1.6176E-01 5.0799E-03 5.5943E-03 containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 24.0170 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Br-82 4.0843E-01 6.6471E-03 Br-83 1.1190E-02 1.8238E-04

Att /pageZ22ofJL7_

Br-84 4 . 6604E-13 7.6370E-15 Kr-83m 8. 8051E+00 1.4357E-01 Kr-85 5.3231E+02 8.6622E+00 Kr-85m 1.2051E+02 1.9627E+00 Kr-87 1.9512E-02 3.1845E-04 Kr-88 3.7881E+01 6.1724E-01 I-130 1.0024E+00 1.6316E-02 I-131 1.4625E+02 2.3800E+00 I-132 1. 1750E+02 1.9151E+00 I-133 9.2036E+01 1.4980E+00 I-134 4.9238E-06 8.0463E-08 I-135 1. 5119E+01 2.4618E-01 Xe-129m 1.3737E-01 2.2355E-03 Xe-131m 2.2752E+02 3.7025E+00 Xe-133 3.7007E+04 6.0223E+02 Xe-133m 1.0542E+03 1.7156E+01 Xe-135 1.0212E+04 1.6624E+02 Xe-135m 5.0572E+02 8.3493E+00 Total 5.0078E+04 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 7.2276E-09 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 7.8335E-09 Total I (Ci) 3.7091E+02 containment Compartment Group Inventory Distribution:

Time (h) = 24.0170 Atmosphere Sump Noble gases (Ci) 4.9706E+04 0.OOOOE+00 Elemental I (Ci) 3.3882E+02 O.OOOOE+00 Organic I (Ci) 1.4893E+01 0.OOOOE+00 Aerosol I (Ci) 1.8616E+01 0.OOOOE+00 Aerosols (Ci) 1.8616E+01 0.OOOOE+00 Aerosols (kg) 6.3876E-08 0.OOOOE+00 environment Integral Nuclide Release:

Time (h) = 24.0170 Ci kg Atoms Bq Br-82 2.2012E-02 2.0332E-ll 1.4932E+14 8.1446E+08 Br-83 6.0389E-04 3.8226E-14 2.7735E+ll 2.2344E+07 Kr-83m 4.7538E-01 2.3041E-ll 1. 6717E+14 1.7589E+10 Kr-85 2.8686E+01 7.3116E-05 5.1802E+20 1.0614E+12 Kr-85m 6.4993E+00 7.8975E-10 5.5953E+15 2.4047E+l1 Kr-87 1.0543E-03 3.7221E-14 2.5764E+11 3.9009E+07 Kr-88 2.0438E+00 1.6299E-10 1.1154E+15 7.5622E+10 I-130 5.4032E-02 2.7704E-ll 1.2834E+14 1.9992E+09 I-131 7.8816E+00 6.3574E-08 2.9225E+17 2.9162E+ll I-132 6.3412E+00 6.1433E-10 2.8027E+15 2.3462E+11 I-133 4.9606E+00 4.3791E-09 1.9828E+16 1.8354E+ll I-134 2.6636E-07 9. 9848E-18 4.4873E+07 9.8554E+03 I-135 8.1520E-01 2.3213E-10 1.0355E+15 3.0162E+10 Xe-129m 7.4031E-03 5.8511E-l1 2.7315E+14 2.7392E+08 Xe-131m 1.2261E+01 1.4638E-07 6.7293E+17 4.5367E+ll Xe-133 1.9944E+03 1.0655E-05 4.8244E+19 7.3791E+13 Xe-133m 5.6814E+01 1.2662E-07 5.7332E+17 2.1021E+12 Xe-135 5.5053E+02 2. 1558E-07 9.6166E+17 2.0370E+13 Xe-135m 2.7616E+01 3.0316E-10 1.3524E+15 1.0218E+12 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 24.0170 Release Rate/s

AttL/pageL~yft.LP Noble gases (Ci) 2.6793E+03 4.3779E+01 Elemental I (Ci) 1.8269E+01 2.9851E-01 Organic I (Ci) 8.0301E-01 1.3121E-02 Aerosol I (Ci) 1.0038E+00 1. 6401E-02 Aerosols (Ci) 1.0038E+00 1. 6401E-02 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

24.0170 Nuclide COMPARTMENT EXPOSURE PATHWAY 4 Atomsphere (Ci-hr) Filter Br-82 1.5486E-04 1.6401E-06 1.8413E-06 Br-83 4.2429E-06 4.4962E-08 5.0448E-08 Kr-83m 3.3385E-03 3.5385E-05 3.9694E-05 Kr-85 2.0183E-01 2.1374E-03 2.3997E-03 Kr-85m 4.5693E-02 4.8407E-04 5.4329E-04 Kr-87 7.3983E-06 7.8442E-08 8.7965E-08 Kr-88 1.4363E-02 1.5219E-04 1.7078E-04 I-130 3.8006E-04 4.0254E-06 4.5189E-06 I-131 5.5452E-02 5.8727E-04 6.5933E-04 I-132 4.4550E-02 4.7211E-04 5.2970E-04 I-133 3.4896E-02 3.6959E-04 4.1492E-04 I-134 1.8669E-09 1.9805E-11 2.2197E-11 I-135 5.7327E-03 6.0725E-05 6.8161E-05 Xe-129m 5.2086E-05 5.5161E-07 6.1930E-07 Xe-131m 8.6267E-02 9.1360E-04 1.0257E-03 Xe-133 1.4032E+01 1.4860E-01 1.6683E-01 Xe-133m 3.9971E-01 4.2332E-03 4.7525E-03 Xe-135 3.8719E+00 4.1012E-02 4.6036E-02 Xe-135m 1.9173E-01 2.0424E-03 2.2792E-03 Total 1.8988E+01 0.0000E+00 2.2576E-01 Dose Effective (Ci/cc) I-131 (Thyroid) 1.5358E-11 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1. 6645E-11 Total I (Ci) 1. 4063E-01 control room Compartment Group Inventory Distribution:

Time (h) = 24.0170 Atmosphere Sump Noble gases (Ci) 1.8846E+01 0.OOOOE+00 Elemental I (Ci) 1.2847E-01 0.OOOOE+00 Organic I (Ci) 5.6468E-03 0.OOOOE+00 Aerosol I (Ci) 7.0586E-03 0.OOOOE+00 Aerosols (Ci) 7.0586E-03 0.OOOOE+00 Aerosols (kg) 2.4219E-11 0.OOOOE+00 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

- 24.0170 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (Ci) 0.OOOOE+00 2.6799E+03 Elemental I (Ci) 0.OOOOE+00 1.8280E+01 Organic I (Ci) 0.OOOOE+00 8.0350E-01 Aerosol I (Ci) 0.OOOOE+00 1.0044E+00 Aerosols (Ci) 0.OOOOE+00 1.0044E+00 Aerosols (kg) 0.OOOOE+00 3.4426E-09

fNEDG4- evZ AtL.... .PageLr2Cof.L7.ZP environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0170 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (Ci) 0.OOOOE+00 1.7709E+01 Elemental I (Ci) 0.OOOOE+00 1.2079E-01 Organic I (Ci) 0.OOOOE+00 5.3095E-03 Aerosol I (Ci) 0.OOOOE+00 6.6368E-03 Aerosols (Ci) 0.OOOOE+00 6.6368E-03 Aerosols (kg) 0.OOOOE+00 2.1812E-11 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0170 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 24.0170 Filtered Transported Noble gases (Ci) 0.OOOOE+00 2.1896E+00 Elemental I (Ci) 0.OOOOE+00 1.4935E-02 Organic I (Ci) 0.OOOOE+00 6.5650E-04 Aerosol I (Ci) O.OOOOE+00 8.2063E-04 Aerosols (Ci) 0.OOOOE+00 8.2063E-04 Aerosols (kg) 0.OOOOE+00 2.6970E-12 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 24.0170 Nuclide Filter Br-82 1.8413E-06 Br-83 5.0448E-08 Kr-83m 3.9694E-05 Kr-85 2.3997E-03 Kr-85m 5.4329E-04 Kr-87 8.7965E-08 Kr-88 1.7078E-04 I-130 4.5189E-06 I-131 6.5933E-04 I-132 5.2970E-04 I-133 4.1492E-04 I-135 6.8161E-05 Xe-129m 6.1930E-07 Xe-131m 1.0257E-03 Xe-133 1.6683E-01 Xe-133m 4.7525E-03 Xe-135 4.6036E-02 Xe-135m 2.2792E-03 control room to environment Transport Group Inventory:

Pathway T'ime (h) = 24.0170 Filtered Transported

__ _r _ _ _

NEDCA~.2Rev~i-.

Att I.LpageL2Lof-Z2-Noble gases (Ci) 2.2408E-01 0.OOOOE+00 Elemental I (Ci) 1.5274E-03 0.OOOOE+00 Organic I (Ci) 6.7141E-05 o.OOOOE+00 Aerosol I (Ci) 8.3926E-05 o.OOOOE+00 Aerosols (Ci) 8.3926E-05 0.OOOOE+00 Aerosols (kg) 2.8794E-13 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 26.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.9979E-01 3.1907E+01 1.3819E+00 Accumulated dose (rem) 4.2222E-01 3.3632E+01 1.4575E+00 Low Population Zone Doses:

Time (h) = 26.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.2296E-01 1.7794E+01 7.7069E-01 Accumulated dose (rem) 2.3547E-01 1.8756E+01 8.1282E-01 control room Doses:

Time (h) = 26.0000 Whole Body Thyroid TEDE Skin Delta dose (rem) 9.0952E-02 8.4757E+01 2.6978E+00 5.4102E+00 Accumulated dose (rem) 9.1051E-02 8 .4918E+01 2.7029E+00 5.4158E+00 containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 26.0000 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Br-82 4.1683E-04 1.1457E-01 Br-83 6.6807E-06 2.9092E-03 Kr-83m 4.4131E-03 2.2356E+00 Kr-85 5.6482E-01 1.5017E+02 Kr-85m 9.4089E-02 3.2523E+01 Kr-87 7.0249E-06 4.7441E-03 Kr-88 2.4773E-02 9.9724E+00 I-130 9.5166E-04 2.7821E-01 I-131 1.5408E-01 4.1217E+01 I-132 6.8588E-02 3.0453E+01 I-133 9.1414E-02 2.5714E+01 I-134 1.0892E-09 1.1267E-06 I-135 1.3031E-02 4.1382E+00 Xe-129m 1.4472E-04 3.8715E-02 Xe-131m 2.4027E-01 6.4143E+01 Xe-133 3.8854E+01 1.0424E+04 Xe-133m 1.0898E+00 2.9627E+02 Xe-135 9.3304E+00 2.8198E+03 Xe-135m 4.6012E-03 7.9290E+01 Total 5.0536E+01 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 7.5553E-12 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 8.0880E-12 Total I (Ci) 3.2712E-01 containment Compartment Group Inventory Distribution:

Time (h) = 26.0000 Atmosphere Sump

NEDO O-eL-1-"/ Rev./Z.

Att / Ipagej!!2ofLZ?7 Noble gases (Ci) 5.0208E+01 0.OOOOE+00 Elemental I (Ci) 2. 9893E-01 o.OOOOE+00 Organic I (Ci) 1.3140E-02 0.OOOOE+00 Aerosol I (Ci) 1.6425E-02 0.OOOOE+00 Aerosols (Ci) 1.6425E-02 0.0000E+00 Aerosols (kg) 6.6740E-11 0.OOOOE+00 environment Integral Nuclide Release:

Time (h) = 26. 0000 Ci kg Atoms Bq Br-82 4.2752E-01 3. 9489E-10 2.9001E+15 1.5818E+10 Br-83 1.0847E-02 6.8664E-13 4.9819E+12 4.0135E+08 Kr-83m 8.3391E+00 4. 0418E-10 2.9326E+15 3.0855E+11 Kr-85 5.6043E+02 1.4284E-03 1.0120E+22 2.0736E+13 Kr-85m 1.2131E+02 1.4741E-08 1.0444E+17 4.4886E+12 Kr-87 1.7676E-02 6.2401E-13 4.3194E+12 6.5400E+08 Kr-88 3.7189E+01 2.9658E-09 2.0296E+16 1.3760E+12 I-130 1.0381E+00 5.3225E-10 2. 4656E+15 3.8409E+10 I-131 1.5381E+02 1.2407E-06 5.7035E+18 5.6911E+12 I-132 1.1354E+02 1.1000E-08 5.0185E+16 4.2012E+12 I-133 9.5952E+01 8.4702E-08 3.8353E+17 3.5502E+12 I-134 4.1947E-06 1.5724E-16 7.0667E+08 1.5520E+05 I-135 1.5438E+01 4.3961E-09 1.9610E+16 5.7122E+1l Xe-129m 1.4448E-01 1.1419E-09 5.3306E+15 5.3456E+09 Xe-131m 2.3938E+02 2.8579E-06 1.3138E+19 8.8570E+12 Xe-133 3.8912E+04 2.0788E-04 9.4128E+20 1.4397E+15 Xe-133m 1.1056E+03 2.4641E-06 1.1157E+19 4.0909E+13 Xe-135 1.0532E+04 4. 1241E-06 1.8397E+19 3.8968E+14 Xe-135m 3.0359E+02 3.3328E-09 1.4867E+16 1.1233E+13 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 26.0000 Release Rate/s Noble gases (Ci) 5.1820E+04 7.1972E+00 Elemental I (Ci) 3.4601E+02 4.8056E-02 Organic I (Ci) 1.5209E+01 2.1124E-03 Aerosol I (Ci) 1.9011E+01 2.6405E-03 Aerosols (Ci) 1.9011E+01 2.6405E-03 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

26.0000 Nuclide COMPARTMENT EXPOSURE PATHWAY 2 PATHWAY 4 Atomsphere (Ci-hr) Filter Filter Br-82 2.1364E-04 6.2324E-04 5.0925E-04 3.1285E-04 Br-83 3.4242E-06 1.3356E-05 8.1619E-06 5. 0142E-06 Kr-83m 4.7545E-03 1.9571E-02 0.OOOOE+00 6.6812E-03 Kr-85 6.0836E-01 1.6783E+00 0.OOOOE+00 8.5556E-01 Kr-85m 1.0134E-01 3.2775E-01 0.0000E+00 1.4252E-01 Kr-87 7.5665E-06 3.7631E-05 0.OOOOE+00 1.0641E-05 Kr-88 2.6683E-02 9.4883E-02 0.OOOOE+00 3.7525E-02 I-130 4.8777E-04 1.4779E-03 1.1627E-03 7.1427E-04 1-131 7.8975E-02 2.2660E-01 1.8825E-01 1.1565E-01 I-132 3.5154E-02 1.3887E-01 8.3794E-02 5.1478E-02 I-133 4.6854E-02 1.3864E-01 1.1168E-01 6.8611E-02 I-134 5.5829E-10 3.9317E-09 1.3307E-09 8.1754E-10 I-135 6.6790E-03 2.1304E-02 1.5920E-02 9.7804E-03 Xe-129m 1.5588E-04 4.3159E-04 0.OOOOE+00 2.1922E-04 Xe-131m 2.5880E-01 7.1566E-01 0.OOOOE+00 3. 6394E-01

NEDC 05- 07 fRev..L...

AtLL.(.page /V~ofJ-LZ9 Xe-133 4.1850E+01 1.1607E+02 0.OOOOE+00 5.8844E+01 Xe-133m 1.1738E+00 3.2813E+00 0.0000E+00 1.6507E+00 Xe-135 1.0050E+01 2.9948E+01 O.OOOE+00 1.4128E+01 Xe-135m 5.9845E-03 2. 6855E-01 o.OOOOE+00 4.3249E-03 Total 5.4248E+01 0.OOOOE+00 4.0132E-01 7.6280E+01 Dose Effective (Ci/cc) I-131 (Thyroid) 2.1702E-11 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 2.3232E-11 Total I (Ci) 1.6766E-01 control room Compartment Group Inventory Distribution:

Time (h) = 26.0000 Atmosphere Sump Noble gases (Ci) 5.4080E+01 0.OOOOE+00 Elemental I (Ci) 1.5321E-01 0.OOOOE+00 Organic I (Ci) 6.7346E-03 0.OOOOE+00 Aerosol I (Ci) 8.4183E-03 0.OOOOE+00 Aerosols (Ci) 8.4183E-03 0.OOOOE+00 Aerosols (kg) 3.4207E-11 O.OOOOE+00 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

= 26.0000 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 5.1986E+04 Elemental I (Ci) 0.OOOOE+00 3.4843E+02 Organic I (Ci) 0.OOOOE+00 1.5316E+01 Aerosol I (Ci) 0.OOOOE+00 1.9145E+01 Aerosols (Ci) 0.OOOOE+00 1.9145E+01 Aerosols (kg) 0.OOOOE+00 6.7107E-08 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 26.0000 Nuclide Filter Br-82 5.0925E-04 Br-83 8.1619E-06 I-130 1.1627E-03 I-131 1.8825E-01 I-132 8.3794E-02 I-133 1.1168E-01 I-134 1.3307E-09 I-135 1.5920E-02 environment to control room Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 8.9437E+01 Elemental I (Ci) 3.6520E-01 1.7363E-01 Organic I (Ci) 1.6053E-02 7.6319E-03 Aerosol I (Ci) 2.0066E-02 9.5399E-03 Aerosols (Ci) 2.0066E-02 9.5399E-03 Aerosols (kg) 9.0107E-11 3.2948E-11 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time

NEDC v~-Po/Rev-1-..

Am Z.pageZYL~LLZP (h) = 26.0000 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 3.7611E+01 Elemental I (Ci) 0.OOOOE+00 2.5213E-01 Organic I (Ci) 0.OOOOE+00 1.1083E-02 Aerosol I (Ci) 0.OOOOE+00 1.3853E-02 Aerosols (Ci) 0.OOOOE+00 1.3853E-02 Aerosols (kg) 0.OOOOE+00 5.2694E-11 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 26.0000 Nuclide Filter Br-82 3.1285E-04 Br-83 5.0142E-06 Kr-83m 6.6812E-03 Kr-85 8.5556E-01 Kr-85m 1.4252E-01 Kr-87 1.0641E-05 Kr-88 3.7525E-02 I-130 7. 1427E-04 I-131 1.1565E-01 I-132 5.1478E-02 I-133 6.8611E-02 I-134 8.1754E-10 1-135 9.7804E-03 Xe-129m 2.1922E-04 Xe-131m 3. 6394E-01 Xe-133 5.8844E+01 Xe-133m 1.6507E+00 Xe-135 1.4128E+01 Xe-135m 4.3249E-03 control room to environment Transport Group Inventory:

Pathway Time (h) = 26.0000 Filtered Transported Noble gases (Ci) 7.6034E+01 0.OOOOE+00 Elemental I (Ci) 2.2436E-01 0.OOOOE+00 Organic I (Ci) 9.8620E-03 0.OOOOE+00 Aerosol I (Ci) 1.2327E-02 0.OOOOE+00 Aerosols (Ci) 1.2327E-02 0.OOOOE+00 Aerosols (kg) 5.0523E-11 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 32.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 4.2222E-01 3.3632E+01 1.4575E+00 Low Population Zone Doses:

NEDO ,'VRevJ....

Att.L.-pageLE-0of.L72.?

Time (h) = 32.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.0164E-04 1.8624E-02 7.7369E-04 Accumulated dose (rem) 2.3567E-01 1.8775E+01 8. 1360E-01 control room Doses:

Time (h) = 32.0000 Whole Body Thyroid TEDE Skin Delta dose (rem) 5.2703E-02 5.4537E+01 1.7264E+00 3.2170E+00 Accumulated dose (rem) 1.4375E-01 1.3946E+02 4.4294E+00 8.6328E+00 containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 32.0000 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Br-82 3.7116E-13 1.1468E-01 Br-83 1.1745E-15 2.9108E-03 Kr-83m 4.5763E-13 2.2366E+00 Kr-85 5.6579E-10 1.5032E+02 Kr-85m 3.7251E-11 3.2546E+01 Kr-88 5.7381E-12 9. 9785E+00 I-130 6.8095E-13 2.7846E-01 I-131 1.5106E-10 4.1258E+01 I-132 1.1265E-11 3.0470E+01 I-133 7.4979E-11 2.5738E+01 I-135 6.9581E-12 4.1416E+00 Xe-129m 1.4187E-13 3.8753E-02 Xe-131m 2.3724E-10 6.4207E+01 Xe-133 3.7694E-08 1.0434E+04 Xe-133m 1.0087E-09 2.9655E+02 Xe-135 5.9186E-09 2.8222E+03 Xe-135m 1.1611E-12 7.9291E+01 Total 4.5715E-08 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 7.2767E-21 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 7. 6445E-21 Total I (Ci) 2.4427E-10 containment Compartment Group Inventory Distribution:

Time (h) = 32.0000 Atmosphere Sump Noble gases (Ci) 4.5470E-08 0.OOOOE+00 Elemental I (Ci) 2.2324E-10 0.OOOOE+00 Organic I (Ci) 9.8127E-12 0.OOOOE+00 Aerosol I (Ci) 1.2266E-11 O.OOOOE+00 Aerosols (Ci) 1.2266E-11 0.OOOOE+00 Aerosols (kg) 6.4423E-20 O.OOOOE+00 environment Integral Nuclide Release:

Time (h) = 32.0000 Ci kg Atoms Bq Br-82 4.2794E-01 3. 9527E-10 2. 9029E+15 1.5834E+10 Br-83 1.0853E-02 6.8702E-13 4. 9848E+12 4.0158E+08 Kr-83m 8.3502E+00 4.0472E-10 2.9365E+15 3.0896E+11 Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2140E+02 1.4752E-08 1.0452E+17 4.4919E+12 Kr-87 1.7682E-02 6.2422E-13 4.3209E+12 6.5422E+08 Kr-88 3.7212E+01 2.9676E-09 2.0308E+16 1.3768E+12 I-130 1.0390E+00 5.3273E-10 2. 4678E+15 3.8443E+10 I-131 1.5397E+02 1.2419E-06 5.7092E+18 5.6968E+12

NEDC 02- Rev /!~

Att-L pageLrZoLLU-0 I-132 1.1361E+02 1. 1006E-08 5.0213E+16 4.2035E+12 I-133 9.6042E+01 8.4782E-08 3. 8389E+17 3.5536E+12 I-134 4.1956E-06 1.5727E-16 7.0681E+08 1.5524E+05 I-135 1.5451E+01 4.3997E-09 1. 9626E+16 5.7169E+11 Xe-129m 1.4462E-01 1.1430E-09 5.3359E+15 5.3509E+09 Xe-131m 2.3964E+02 2.8610E-06 1.3152E+19 8.8667E+12 Xe-133 3.8988E+04 2.0829E-04 9.4311E+20 1.4425E+15 Xe-133m 1.1069E+03 2.4669E-06 1.1170E+19 4.0956E+13 Xe-135 1.0545E+04 4.1295E-06 1. 8421E+19 3.9018E+14 Xe-135m 3.2714E+02 3.5913E-09 1. 6020E+16 1.2104E+13 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 32.0000 Release Rate/s Noble gases (Ci) 5.1935E+04 1.8033E+00 Elemental I (Ci) 3.4630E+02 1.2024E-02 Organic I (Ci) 1.5222E+01 5.2854E-04 Aerosol I (Ci) 1. 9027E+01 6.6067E-04 Aerosols (Ci) 1. 9027E+01 6.6067E-04 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

32.0000 Nuclide COMPARTMENT EXPOSURE PATHWAY PATHWAY 4 Atomsphere (Ci-hr) Filter Filter Br-82 8.8249E-06 1.0042E-03 4.5302E-04 4.5945E-04 Br-83 2.7926E-08 1.7514E-05 1.4336E-06 1.4539E-06 Kr-83m 2.3723E-05 2.4786E-02 0.0000E+00 1.1583E-03 Kr-85 2.8279E-02 2.7993E+00 0.0000E+00 1.4367E+00 Kr-85m 1.8618E-03 4.7479E-01 0.OOOOE+00 9.4588E-02 Kr-87 1.3363E-08 4.4601E-05 o.0000E+00 6.7886E-07 Kr-88 2.8680E-04 1.2921E-01 0.OOOOE+00 1.4570E-02 I-130 1.6191E-05 2.2979E-03 8.3115E-04 8.4293E-04 I-131 3.5918E-03 3.7122E-01 1.8438E-01 1.8700E-01 I-132 2.6783E-04 1.8096E-01 1.3749E-02 1.3944E-02 I-133 1.7828E-03 2.2032E-01 9.1517E-02 9.2815E-02 I-134 2.2582E-13 4.3469E-09 1.1592E-11 1.1757E-11 I-135 1.6544E-04 3.1721E-02 8.4929E-03 8.6133E-03 Xe-129m 7.0910E-06 7.1711E-04 0.0000E+00 3.6025E-04 Xe-131m 1.1866E-02 1.1907E+00 0.0000E+00 6.0235E-01 Xe-133 1.8849E+00 1.9251E+02 0.0000E+00 9.5624E+01 Xe-133m 5.0483E-02 5.3975E+00 0.OOOOE+00 2.5611E+00 Xe-135 2.9700E-01 4.6331E+01 0.0000E+00 1.5020E+01 Xe-135m 1.2278E-03 2.8103E-01 0.0000E+00 2.2336E-04 Total 2.2818E+00 0.OOOOE+00 2.9943E-01 1.1566E+02 Dose Effective (Ci/cc) I-131 (Thyroid) 9.6960E-13 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.0186E-12 Total I (Ci) 5.8078E-03 control room Compartment Group Inventory Distribution:

Time (h) = 32.0000 Atmosphere Sump Noble gases (Ci) 2.2760E+00 0.0000E+00 Elemental I (Ci) 5.3079E-03 0.0000E+00 Organic I (Ci) 2.3331E-04 0.OOOOE+00 Aerosol I (Ci) 2.9164E-04 0.0000E+00 Aerosols (Ci) 2.9164E-04 0.0000E+00 Aerosols (kg) 1.5318E-12 0.0000E+00

NEDGCAO*-0743e At / pagezo-Lf-7-0 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

= 32.0000 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 5.2036E+04 Elemental I (Ci) 0.OOOOE+00 3.4873E+02 Organic I (Ci) 0.OOOOE+00 1.5329E+01 Aerosol I (Ci) 0.OOOOE+00 1.9161E+01 Aerosols (Ci) 0.0000E+00 1.9161E+01 Aerosols (kg) 0.0000E+00 6.7174E-08 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 32.0000 Nuclide Filter Br-82 4.5302E-04 Br-83 1.4336E-06 I-130 8.3115E-04 I-131 1.8438E-01 I-132 1.3749E-02 I-133 9.1517E-02 I-135 8.4929E-03 environment to control room Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 8.9494E+01 Elemental I (Ci) 2.7248E-01 1.7366E-01 Organic I (Ci) 1.1977E-02 7.6335E-03 Aerosol I (Ci) 1.4971E-02 9.5419E-03 Aerosols (Ci) 1.4971E-02 9.5419E-03 Aerosols (kg) 9.0180E-11 3.2958E-11 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 32.0000 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 3.7639E+01 Elemental I (Ci) o.OOOOE+00 2.5230E-01 Organic I (Ci) 0.OOOOE+00 1.1090E-02 Aerosol I (Ci) 0.OOOOE+00 1.3862E-02 Aerosols (Ci) 0.0000E+00 1.3862E-02 Aerosols (kg) 0.OOOOE+00 5.2735E-11 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) - 32.0000 Nuclide Filter Br-82 4.5945E-04

NEDC FO7Aev- /

Att/. pagee/M-1Of2 -O Br-83 1.4539E-06 Kr-83m 1.1583E-03 Kr-85 1.4367E+00 Kr-85m 9.4588E-02 Kr-87 6.7886E-07 Kr-88 1.4570E-02 I-130 8.4293E-04 I-131 1.8700E-01 I-132 1.3944E-02 I-133 9.2815E-02 I-135 8.6133E-03 Xe-129m 3.6025E-04 Xe-131m 6.0235E-01 Xe-133 9.5624E+01 Xe-133m 2.5611E+00 Xe-135 1.5020E+01 Xe-135m 2.2336E-04 control room to environment Transport Group Inventory:

Pathway Time (h) = 32.0000 Filtered Transported Noble gases (Ci) 1.1535E+02 0.OOOOE+00 Elemental I (Ci) 2.7634E-01 0.OOOOE+00 Organic I (Ci) 1.2147E-02 0.OOOOE+00 Aerosol I (Ci) 1.5184E-02 0.OOOOE+00 Aerosols (Ci) 1.5184E-02 0.OOOOE+00 Aerosols (kg) 8.2839E-11 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 48.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 4.2222E-01 3.3632E+01 1.4575E+00 Low Population Zone Doses:

Time (h) = 48.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.6981E-14 2.3225E-12 1.0811E-13 Accumulated dose (rem) 2.3567E-01 1.8775E+01 8.1360E-01 control room Doses:

Time (h) = 48.0000 Whole Body Thyroid TEDE Skin Delta dose (rem) 1.9551E-03 2.5552E+00 8.0185E-02 1.2283E-01 Accumulated dose (rem) 1.4571E-01 1.4201E+02 4.5095E+00 8.7556E+00

- - - - Y*************a*****i*e**********

containment COMPARTMENT NVCLIDE INVENTORY (Ci) at Time (h) = 48.0000 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Total 3.8328E-32 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 6.6938E-45 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 6.8951E-45 Total I (Ci) 1.8889E-34

NEDGE5E~L-0Rev /j~-

AftL..L~pageeTZfbt-Lz-0 containment Compartment Group Inventory Distribution:

Time (h) = 48.0000 Atmosphere Sump Noble gases (Ci) 3.8139E-32 0.OOOOE+00 Elemental I (Ci) 1.7239E-34 0.OOOOE+00 Organic I (Ci) 7.5777E-36 0.OOOOE+00 Aerosol I (Ci) 9.4721E-36 0.OOOOE+00 Aerosols (Ci) 9.4721E-36 0.0000E+00 Aerosols (kg) 5.9782E-44 0.OOOOE+00 environment Integral Nuclide Release:

Time (h) = 48. 0000 Ci kg Atoms Bq Br-82 4.2794E-01 3.9527E-10 2. 9029E+15 1.5834E+10 Br-83 1.0853E-02 6.8702E-13 4. 9848E+12 4.0158E+08 Kr-83m 8.3517E+00 4.0479E-10 2.9370E+15 3.0901E+11 Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2140E+02 1.4752E-08 1.0452E+17 4.4919E+12 Kr-87 1.7682E-02 6.2422E-13 4. 3209E+12 6.5422E+08 Kr-88 3.7212E+01 2.9676E-09 2.0308E+16 1.3768E+12 I-130 1.0390E+00 5.3273E-10 2.4678E+15 3.8443E+10 I-131 1.5397E+02 1.2419E-06 5.7092E+18 5.6968E+12 I-132 1.1361E+02 1.1006E-08 5.0213E+16 4.2035E+12 I-133 9.6042E+01 8.4782E-08 3. 8389E+17 3.5536E+12 I-134 4.1956E-06 1.5727E-16 7.0681E+08 1.5524E+05 I-135 1.5451E+01 4.3997E-09 1. 9626E+16 5.7169E+11 Xe-129m 1.4462E-01 1.1430E-09 5.3359E+15 5.3509E+09 Xe-131m 2.3970E+02 2.8618E-06 1.3156E+19 8.8690E+12 Xe-133 3.9072E+04 2.0874E-04 9. 4516E+20 1.4457E+15 Xe-133m 1. 1073E+03 2.4677E-06 1.1173E+19 4.0969E+13 Xe-135 1.0550E+04 4.1311E-06 1.8428E+19 3.9034E+14 Xe-135m 3.4239E+02 3.7587E-09 1.6767E+16 1.2669E+13 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 48.0000 Release Rate/s Noble gases (Ci) 5.2039E+04 6.0231E-01 Elemental I (Ci) 3.4630E+02 4.0081E-03 Organic I (Ci) 1. 5222E+01 1.7618E-04 Aerosol I (Ci) 1.9027E+01 2.2022E-04 Aerosols (Ci) 1.9027E+01 2.2022E-04 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

48.0000 Nuclide COMPARTMENT EXPOSURE PATHWAY 2 PATHWAY 4 Atomsphere (Ci-hr) Filter Filter Br-82 1.7911E-09 1.0202E-03 3.3088E-04 3.4203E-04 Br-83 7.4920E-14 1.7548E-05 1.384lE-08 1.4307E-08 Kr-83m 1.1530E-08 2.4814E-02 0.0000E+00 2.7941E-06 Kr-85 7.8569E-06 2.8528E+00 0.0000E+00 1.4648E+00 Kr-85m 4.3519E-08 4.7751E-01 0.OOOOE+00 8.1135E-03 Kr-87 6.0562E-16 4.4614E-05 0.0000E+00 1.1291E-10 Kr-88 1.6050E-09 1.2958E-01 0.0000E+00 2.9923E-04 1-130 1.8341E-09 2.3255E-03 3.3884E-04 3.5025E-04 I-131 9.4231E-07 3.7796E-01 1.7409E-01 1.7995E-01 I-132 5.9922E-10 1.8128E-01 1.1070E-04 1.1443E-04 I-133 2.9065E-07 2.2349E-01 5.3696E-02 5.5505E-02 I-135 8.5866E-09 3.1981E-02 1.5863E-03 1.6398E-03

NED o: /!

G;/Rv AttL.Lpag~e4E~tLZ-P Xe-129m 1.8598E-09 7.3042E-04 0.OOOOE+00 3.4673E-04 Xe-131m 1.4824E-05 1.2132E+00 0.OOOOE+00 5.9091E-01 Xe-133 1.2410E-03 1.9605E+02 0.OOOOE+00 8.9294E+01 Xe-133m 6.4977E-05 5.4915E+00 0.OOOOE+00 2.1148E+00 Xe-135 3.4027E-04 4.6830E+01 0.OOOOE+00 4.5241E+00 Xe-135m 3.0627E-04 2.9171E-01 0.OOOOE+00 1.0643E-05 Total 1.9765E-03 0.OOOOE+00 2.3015E-01 9.8235E+01 Dose Effective (Ci/cc) I-131 (Thyroid) 2.4668E-16 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 2.5410E-16 Total I (Ci) 1.2421E-06 control room Compartment Group Inventory Distribution:

Time (h) = 48.0000 Atmosphere Sump Noble gases (Ci) 1.9753E-03 0.OOOOE+00 Elemental I (Ci) 1.1337E-06 O.OOOOE+00 Organic I (Ci) 4.9831E-08 O.0000E+00 Aerosol I (Ci) 6.2289E-08 0.OOOOE+00 Aerosols (Ci) 6.2289E-08 0.OOOE+00 Aerosols (kg) 3.9312E-16 0.OOOOE+00 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

= 48.0000 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 5.2036E+04 Elemental I (Ci) 0.0000E+00 3.4873E+02 Organic I (Ci) 0.OOOOE+00 1.5329E+01 Aerosol I (Ci) 0.OOOOE+00 1.9161E+01 Aerosols (Ci) 0.OOOOE+00 1.9161E+01 Aerosols (kg) 0.OOOOE+00 6.7174E-08 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 48.0000 Nuclide Filter Br-82 3.3088E-04 Br-83 1.3841E-08 I-130 3.3884E-04 1-131 1.7409E-01 I-132 1.1070E-04 I-133 5.3696E-02 I-135 1.5863E-03 environment to control room Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 8.9494E+01 Elemental I (Ci) 2.0943E-01 1.7366E-01 Organic I (Ci) 9.2059E-03 7.6335E-03 Aerosol I (Ci) 1.1507E-02 9.5419E-03 Aerosols (Ci) 1.1507E-02 9.5419E-03 Aerosols (kg) 9.0180E-1l 3.2958E-11

NEDC+/-;FO-0/RCV /

At / pageZ-*of.L2 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 48.0000 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 3.7639E+01 Elemental I (Ci) 0.OOOOE+00 2.5230E-01 Organic I (Ci) 0.OOOOE+00 1.1090E-02 Aerosol I (Ci) 0.0000E+00 1.3862E-02 Aerosols (Ci) 0.OOOOE+00 1.3862E-02 Aerosols (kg) 0.OOOOE+00 5.2735E-11 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 48.0000 Nuclide Filter Br-82 3.4203E-04 Br-83 1.4307E-08 Kr-83m 2.7941E-06 Kr-85 1.4648E+00 Kr-85m 8. 1135E-03 Kr-87 1. 1291E-10 Kr-88 2.9923E-04 I-130 3.5025E-04 I-131 1.7995E-01 I-132 1.1443E-04 I-133 5.5505E-02 I-135 1.6398E-03 Xe-129m 3.4673E-04 Xe-131m 5.9091E-01 Xe-133 8. 9294E+01 Xe-133m 2.1148E+00 Xe-135 4.5241E+00 Xe-135m 1.0643E-05 control room to environment Transport Group Inventory:

Pathway Time (h) = 48.0000 Filtered Transported Noble gases (Ci) 9.7997E+01 0.OOOOE+00 Elemental I (Ci) 2.1649E-01 0.OOOOE+00 Organic I (Ci) 9.5160E-03 0.OOOOE+00 Aerosol I (Ci) 1.1895E-02 0.OOOOE+00 Aerosols (Ci) 1.1895E-02 0.OOOOE+00 Aerosols (kg) 8.4355E-11 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 120.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 4.2222E-01 3.3632E+01 1.4575E+00 Low Population Zone Doses:

NEDCG! 6O7./RevL/-

Aft-.J....p age/-!27ot-LL Time (h) = 120.0000 Whole Body Thyroid TEDE Delta dose (rem) 7.4459E-39 9.3611E-37 3.6045E-38 Accumulated dose (rem) 2.3567E-01 1.8775E+01 8.1360E-01 control room Doses:

Time (h) = 120.0000 Whole Body Thyroid TEDE Skin Delta dose (rem) 1.0265E-05 4.0024E-04 2.2491E-05 5.1089E-04 Accumulated dose (rem) 1.4572E-01 1.4201E+02 4.5096E+00 8.7561E+00

C******************************** * *******N * * ****

a****** **

containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 120.0000 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Total 2.5040-140 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 containment Compartment Group Inventory Distribution:

Time (h) = 120.0000 Atmosphere Sump Noble gases (Ci) 2.5040-140 0.OOOOE+00 Elemental I (Ci) 0.OOOOE+00 0.OOOOE+00 Organic I (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosol I (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosols (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 environment Integral Nuclide Release:

Time (h) = 120.0000 Ci kg Atoms Bq Br-82 4 .2794E-01 3.9527E-10 2.9029E+15 1.5834E+10 Br-83 1.0853E-02 6.8702E-13 4. 9848E+12 4 .0158E+08 Kr-83m 8.3517E+00 4.0479E-10 2.9370E+15 3.0901E+11 Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2140E+02 1.4752E-08 1.0452E+17 4 .4919E+12 Kr-87 1.7682E-02 6.2422E-13 4.3209E+12 6.5422E+08 Kr-88 3.7212E+01 2.9676E-09 2.0308E+16 1.3768E+12 I-130 1.0390E+00 5.3273E-10 2.4678E+15 3.8443E+10 I-131 1.5397E+02 1.2419E-06 5.7092E+18 5.6968E+12 I-132 1.1361E+02 1.1006E-08 5.0213E+16 4.2035E+12 I-133 9. 6042E+01 8.4782E-08 3.8389E+17 3.5536E+12 I-134 4.1956E-06 1.5727E-16 7.0681E+08 1.5524E+05 I-135 1.5451E+01 4.3997E-09 1.9626E+16 5.7169E+11 Xe-129m 1.4462E-01 1.1430E-09 5.3359E+15 5.3509E+09 Xe-131m 2.3994E+02 2.8646E-06 1.3169E+19 8.8779E+12 Xe-133 3.9286E+04 2.0988E-04 9.5033E+20 1.4536E+15 Xe-133m 1.1077E+03 2.4687E-06 1. 1178E+19 4 .0986E+13 Xe-135 1.0551E+04 4.1315E-06 1.8430E+19 3.9037E+14 Xe-135m 3.4443E+02 3.7811E-09 1.6867E+16 1.2744E+13 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 120.0000 Release Rate/s Noble gases (Ci) 5.2257E+04 1.5121E-01 Elemental I (Ci) 3.4630E+02 1.0020E-03

NEDC,0:F'- R-.V--L-AtL-/page-ZEAt-1.724, Organic I (Ci) 1.5222E+01 4.4045E-05 Aerosol I (Ci) 1.9027E+01 5.5056E-05 Aerosols (Ci) 1. 9027E+01 5.5056E-05 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

120.0000 Nuclide COMPARTMENT EXPOSURE PATHWAY 2 PATHWAY 4 Atomsphere (Ci-hr) Filter Filter Br-82 4.3291E-26 1.0202E-03 8.0478E-05 8.3190E-05 Kr-85 7.8039E-22 2.8528E+00 0.OOOOE+00 1.4640E+00 Kr-85m 6.2804E-29 4.7751E-01 0.OOOOE+00 1.1782E-07 Kr-88 3.7241E-33 1.2958E-01 0.0000E+00 6.9865E-12 I-130 3.2147E-27 2.3255E-03 5.9761E-06 6.1775E-06 I-131 7.2304E-23 3.7796E-01 1.3441E-01 1.3894E-01 I-132 2.2456E-35 1.8128E-01 -4.1745E-14 4.3152E-14 I-133 2.6220E-24 2.2349E-01 4.8743E-03 5.0386E-03 I-135 4.4887E-28 3.1981E-02 8.3444E-07 8.6255E-07 Xe-129m 1.4252E-25 7.3043E-04 0.OOOOE+00 2.6737E-04 Xe-131m 8.8431E-06 1.2139E+00 0.0000E+00 4.9645E-01 Xe-133 6.7922E-05 1.9607E+02 0.OOOOE+00 6.0074E+01 Xe-133m 4.7879E-06 5.4929E+00 0.OOOOE+00 8.1789E-01 Xe-135 1.6354E-07 4.6833E+01 0.OOOOE+00 1.8686E-02 Xe-135m 1.5815E-07 2.9444E-01 0.OOOOE+00 9.8015E-09 Total 8.1874E-05 0.OOOOE+00 1.3937E-01 6.3016E+01 Dose Effective (Ci/cc) I-131 (Thyroid) 1.8108E-32 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 1.8174E-32 Total I (Ci) 7.4926E-23 control room Compartment Group Inventory Distribution:

Time (h) = 120.0000 Atmosphere Sump Noble gases (Ci) 8.1874E-05 0.OOOOE+00 Elemental I (Ci) 6.8225E-23 0.OOOOE+00 Organic I (Ci) 2.9989E-24 0.OOOOE+00 Aerosol I (Ci) 3.7486E-24 0.OOOOE+00 Aerosols (Ci) 3.7486E-24 0.OOOOE+00 Aerosols (kg) 2.9279E-32 0.OOOOE+00 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

= 120.0000 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 5.2036E+04 Elemental I (Ci) 0.OOOOE+00 3.4873E+02 Organic I (Ci) 0.OOOOE+00 1.5329E+01 Aerosol I (Ci) 0.OOOOE+00 1.9161E+01 Aerosols (Ci) 0.OOOOE+00 1.9161E+01 Aerosols (kg) 0.OOOOE+00 6.7174E-08 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 120.0000 Nuclide Filter Br-82 8.0478E-05

NEDC 5 °703Rev Att / pageL-Ybtf7L I-130 5.9761E-06 I-131 1.3441E-01 I-133 4.8743E-03 I-135 8.3444E-07 environment to control room Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 8.9494E+01 Elemental I (Ci) 1.2683E-01 1.7366E-01 Organic I (Ci) 5.5749E-03 7.6335E-03 Aerosol I (Ci) 6.9687E-03 9.5419E-03 Aerosols (Ci) 6.9687E-03 9.5419E-03 Aerosols (kg) 9.0180E-11 3.2958E-11 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 120.0000 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 3.7639E+01 Elemental I (Ci) 0.OOOOE+00 2.5230E-01 Organic I (Ci) 0.OOOOE+00 1.1090E-02 Aerosol I (Ci) 0.OOOOE+00 1.3862E-02 Aerosols (Ci) 0.OOOOE+00 1.3862E-02 Aerosols (kg) 0.OOOOE+00 5.2735E-11 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 120.0000 Nuclide Filter Br-82 8.3190E-05 Kr-85 1.4640E+00 Kr-85m 1.1782E-07 I-130 6.1775E-06 I-131 1.3894E-01 I-133 5.0386E-03 1-135 8.6255E-07 Xe-129m 2.6737E-04 Xe-131m 4.9645E-01 Xe-133 6.0074E+01 Xe-133m 8.1789E-01 Xe-135 1.8686E-02 Xe-135m 9.8015E-09 control room to environment Transport Group Inventory:

Pathway Time (h) = 120.0000 Filtered Transported Noble gases (Ci) 6.2872E+01 0.OOOOE+00 Elemental I (Ci) 1.3110E-01 0.OOOOE+00 Organic I (Ci) 5.7628E-03 0.0000E+00 Aerosol I (Ci) 7.2035E-03 0.OOOOE+00 Aerosols (Ci) 7.2035E-03 0.OOOOE+00 Aerosols (kg) 8.4355E-11 0.OOOOE+00

NEDO 0-.,0LRe V-Att /page/6~'0 of-LZo-Exclusion Area Boundary Doses:

Time (h) = 744.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 4.2222E-01 3.3632E+01 1.4575E+00 Low Population Zone Doses:

Time (h) = 744.0000 Whole Body Thyroid TEDE Delta dose (rem) 7.3122-148 0.OOOOE+00 7.3122-148 Accumulated dose (rem) 2.3567E-01 1.8775E+01 8. 1360E-01 control room Doses:

Time (h) = 744.0000 Whole Body Thyroid TEDE Skin Delta dose (rem) 2.1984E-07 1.9620E-20 2. 1984E-07 2.4302E-05 Accumulated dose (rem) 1.4572E-01 1.4201E+02 4.5096E+00 8.7561E+00 containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 744.0000 Nuclide COMPARTMENT EXPOSURE Atomsphere (Ci-hr)

Xe-131m 8.8431E-06 6.4207E+01 Xe-133 6.7922E-05 1.0434E+04 Xe-133m 4.7879E-06 2.9655E+02 Xe-135 1.6354E-07 2.8222E+03 Xe-135m 1.5815E-07 7.9291E+01 Total 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 containment Compartment Group Inventory Distribution:

Time (h) = 744.0000 Atmosphere Sump Noble gases (Ci) 0.OOOOE+00 0.OOOOE+00 Elemental I (Ci) O.OOOOE+00 O.OOOOE+00 Organic I (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosol I (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosols (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 environment Integral Nuclide Release:

Time (h) = 744.0000 Ci kg Atoms Bq Br-82 4.2794E-01 3.9527E-10 2.9029E+15 1.5834E+10 Br-83 1.0853E-02 6.8702E-13 4. 9848E+12 4.0158E+08 Kr-83m 8.3517E+00 4.0479E-10 2.9370E+15 3.0901E+ll Kr-85 5.6099E+02 1.4299E-03 1.0131E+22 2.0757E+13 Kr-85m 1.2140E+02 1.4752E-08 1.0452E+17 4 .4919E+12 Kr-87 1.7682E-02 6.2422E-13 4.3209E+12 6.5422E+08 Kr-88 3.7212E+01 2.9676E-09 2.0308E+16 1.3768E+12 I-130 1.0390E+00 5.3273E-10 2.4678E+15 3.8443E+10 I-131 1.5397E+02 1.2419E-06 5.7092E+18 5.6968E+12 I-132 1.1361E+02 1.1006E-08 5. 0213E+16 4.2035E+12

AftL page/oe/of-LZ7-I-133 9.6042E+01 8.4782E-08 3.8389E+17 3.5536E+12 I-134 4.1956E-06 1.5727E-16 7.0681E+08 1.5524E+05 1-135 1.5451E+01 4.3997E-09 1. 9626E+16 5.7169E+11 Xe-129m 1.4462E-01 1.1430E-09 5.3359E+15 5.3509E+09 Xe-131m 2.4067E+02 2.8733E-06 1. 3209E+19 8.9047E+12 Xe-133 3. 9417E+04 2.1058E-04 9. 5351E+20 1.4584E+15 Xe-133m 1.1078E+03 2.4688E-06 1. 1179E+19 4.0987E+13 Xe-135 1.0551E+04 4.1315E-06 1.8430E+19 3.9037E+14 Xe-135m 3.4443E+02 3.7811E-09 1.6867E+16 1.2744E+13 environment Compartment Group Inventory Distribution:

Total Release Time (h) = 744.0000 Release Rate/s Noble gases (Ci) 5.2389E+04 2.0212E-02 Elemental I (Ci) 3.4630E+02 1.3360E-04 Organic I (Ci) 1. 5222E+01 5.8726E-06 Aerosol I (Ci) 1. 9027E+01 7.3408E-06 Aerosols (Ci) 1. 9027E+01 7.3408E-06 control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =

744.0000 Nuclide COMPARTMENT EXPOSURE PATHWAY 2 PATHWAY 4 Atomsphere (Ci-hr) Filter Filter Br-82 0.OOOOE+00 1.0202E-03 3.8402E-10 3.9696E-10 Kr-85 1.5856-160 2.8528E+00 0.OOOOE+00 1.4573E+00 I-131 0.OOOOE+00 3.7796E-01 1.4288E-02 1.4769E-02 I-133 0.OOOOE+00 2.2349E-01 4.5396E-12 4.6925E-12 Xe-129m 3.0577-165 7.3043E-04 0.OOOOE+00 2.8104E-05 Xe-131m 9.4319E-07 1.2162E+00 0.OOOOE+00 1.0954E-01 Xe-133 6.3472E-14 1.9607E+02 o.OOOOE+00 1.9340E+00 Xe-133m 4.4745E-15 5.4931E+00 0.OOOOE+00 2.1657E-04 Total 9.4319E-07 0.OOOOE+00 1.4288E-02 3.5159E+00 Dose Effective (Ci/cc) I-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 control room Compartment Group Inventory Distribution:

Time (h) = 744.0000 Atmosphere Sump Noble gases (Ci) 9.4319E-07 0.OOOOE+00 Elemental I (Ci) 0.OOOOE+00 0.OOOOE+00 Organic I (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosol I (Ci) 0.0000E+00 0.OOOOE+00 Aerosols (Ci) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)

= 744.0000 Nuclide Filter containment to environment Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 5.2036E+04 Elemental I (Ci) 0.OOOOE+00 3.4873E+02 Organic I (Ci) 0.OOOOE+00 1.5329E+01

N EDCAeJ:1 Mev i/

Att / PageLK 6 -Zot-L7Z Aerosol I (Ci) 0.OOOOE+00 1.9161E+01 Aerosols (Ci) o.OOOE+00 1.9161E+01 Aerosols (kg) 0.OOOOE+00 6.7174E-08 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 744.0000 Nuclide Filter Br-82 3.8402E-10 I-131 1.4288E-02 I-133 4.5396E-12 environment to control room Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 8.9494E+01 Elemental I (Ci) 1.3002E-02 1.7366E-01 Organic I (Ci) 5.7150E-04 7.6335E-03 Aerosol I (Ci) 7.1438E-04 9.5419E-03 Aerosols (Ci) 7.1438E-04 9.5419E-03 Aerosols (kg) 9.0180E-11 3.2958E-11 environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 744.0000 Nuclide Filter environment to control room Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (Ci) 0.OOOOE+00 3.7639E+01 Elemental I (Ci) 0.OOOOE+00 2.5230E-01 Organic I (Ci) 0.OOOE+00 1.1090E-02 Aerosol I (Ci) 0.OOOOE+00 1.3862E-02 Aerosols (Ci) 0.OOOOE+00 1.3862E-02 Aerosols (kg) 0.OOOOE+00 5.2735E-11 control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h) = 744.0000 Nuclide Filter Br-82 3. 9696E-10 Kr-85 1.4573E+00 I-131 1.4769E-02 I-133 4. 6925E-12 Xe-129m 2.8104E-05 Xe-131m 1.0954E-01 Xe-133 1.9340E+00 Xe-133m 2.1657E-04 control room to environment Transport Group Inventory:

Pathway Time (h) = 744.0000 Filtered Transported Noble gases (Ci) 3.5011E+00 0.OOOOE+00 Elemental I (Ci) 1.3440E-02 0.OOOOE+00 Organic I (Ci) 5.9076E-04 0.OOOOE+00 Aerosol I (Ci) 7.3845E-04 O.OOOOE+00

NEDCC2S°/Rev...L..Re.

Att .LpageoLoftZUT Aerosols (Ci) 7.3845E-04 O.OOOOE+00 Aerosols (kg) 8.4355E-11 O.OOOOE+00 935 I-131 Summary containment environment control room Time (hr) I-131 (Curies) I-131 (Curies) I-131 (Curies) 24.000 2.3765E+01 2.2805E-02 1.6231E-04 24.004 1.5319E+02 9.5425E-01 6.7812E-03 24.017 1.4625E+02 7.8816E+00 5.5452E-02 24.350 4.6251E+01 1.0777E+02 1.3323E-01

24. 600 1.9488E+01 1.3450E+02 1.4093E-01 24.850 8.2112E+00 1.4577E+02 1.3393E-01 25.100 3.4598E+00 1.5051E+02 1.2197E-01 25.350 1.4578E+00 1.5251E+02 1.O900E-01

25. 600 6.1423E-01 1.5335E+02 9.6577E-02 25.850 2.5881E-01 1.5371E+02 8.5218E-02 26.000 1.5408E-01 1.5381E+02 7.8975E-02 26.250 6.4923E-02 1.5390E+02 6.9490E-02 26.500 2.7355E-02 1.5394E+02 6.1115E-02 26.750 1.1526E-02 1.5396E+02 5.3738E-02 27.000 4.8565E-03 1.5396E+02 4.7247E-02 27.250 2.0463E-03 1.5397E+02 4.1537E-02

27. 500 8.6220E-04 1.5397E+02 3.6517E-02 27.750 3.6329E-04 1.5397E+02 3.2103E-02 28.000 1.5307E-04 1.5397E+02 2.8222E-02 28.250 6.4496E-05 1.5397E+02 2.4811E-02

28. 500 2.7175E-05 1.5397E+02 2.1811E-02 28.750 1.1450E-05 1.5397E+02 1.9175E-02 29.000 4.8246E-06 1.5397E+02 1.6857E-02 29.250 2.0328E-06 1.5397E+02 1.4819E-02 29.500 8.5653E-07 1.5397E+02 1.3028E-02 29.750 3.6090E-07 1.5397E+02 1.1453E-02

30. 000 1.5206E-07 1.5397E+02 1.0068E-02 30.250 6.4072E-08 1.5397E+02 8.8511E-03 30.500 2.6997E-08 1.5397E+02 7.7811E-03 30.750 1.1375E-08 1.5397E+02 6.8405E-03 31.000 4.7928E-09 1.5397E+02 6.0136E-03 31.250 2.0195E-09 1.5397E+02 5.2866E-03 31.500 8.5090E-10 1.5397E+02 4.6475E-03 31.750 3.5852E-10 1.5397E+02 4.0857E-03 32.000 1.5106E-10 1.5397E+02 3.5918E-03 32.250 6.3651E-11 1.5397E+02 3.1576E-03 32.500 2.6819E-11 1.5397E+02 2.7759E-03

32. 750 1.1300E-11 1.5397E+02 2.4403E-03 33.000 4.7613E-12 1.5397E+02 2.1453E-03

33. 250 2.0062E-12 1.5397E+02 1.8860E-03

33. 500 8.4530E-13 1.5397E+02 1.6580E-03 33.750 3.5617E-13 1.5397E+02 1.4576E-03 34.000 1.5007E-13 1.5397E+02 1.2814E-03 34.250 6.3232E-14 1.5397E+02 1.1265E-03

48. 000 1.4330E-34 1.5397E+02 9.4231E-07 120.000 O.OOOOE+00 1.5397E+02 7.2304E-23 744 .000 O.OOOOE+00 1.5397E+02 O.OOOOE+00

NEDC !E5°7/YRev/L AtL ./page /6 YotL.f2 Cumulative Dose Summary Exclusion Area Bound Low Population Zone control room Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem)

(rem) 24.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 24.004 2.0885E-01 9.1492E-03 1.1648E-01 5. 1025E-03 3.4451E-03 1.0819E-04 24.017 1.7250E+00 7.5546E-02 9.6203E-01 4.2132E-02 1.617 6E-01 5.0799E-03 24.350 2.3579E+01 1.0268E+00 1.3150E+0l 5.7265E-01 1.324OE+01 4.2077E-01 24.600 2.9420E+01 1.2781E+00 1.6407E+0l 7.1280E-01 2.6315E+01 8.3754E-0l 24.850 3.1878E+01 1.3832E+00 1.7778E+0l 7.7139E-01 3.9300E+01 1.2514E+00 25.100 3.2913E+01 1.4271E+00 1.8355E+0l 7.9591E-0l 5.1337E+01 1.6348E+00 25.350 3.3349E+01 1.4456E+00 1.8598E+01 8.0618E-01 6.2174E+01 1.9798E+00 25.600 3.3532E+01 1.4533E+00 1. 8701E+01 8.1049E-01 7. 1804E+01 2.2861E+00 25.850 3.3609E+01 1.4565E+00 1.8744E+0l 8.1229E-01 8.0310E+01 2.5565E+00 26.000 3.3632E+01 1.4575E+00 1.8756E+0l 8.1282E-01 8.4 918E+01 2.7029E+00 26.250 3.3632E+01 1.4575E+00 1.8767E+01 8.1327E-0l 9.1853E+01 2.9231E+00 26.500 3.3632E+01 1.4575E+00 1.8772E+01 8.134 6E-01 9.7947E+01 3.1166E+00 26.750 3.3632E+01 1.4575E+00 1.8774E+01 8.1354E-01 1.0330E+02 3.2864E+00 27.000 3.3632E+01 1.4575E+00 1.8774E+0l 8.1357E-01 1.0801E+02 3.4355E+00 27.250 3.3632E+01 1.4575E+00 1. 8775E+01 8.1359E-01 1.1214E+02 3.5665E+00 27.500 3.3632E+01 1.4575E+00 1.8775E+01 8.1359E-01 1.1577E+02 3.6814E+00 27.750 3.3632E+01 1.4575E+00 1.8775E+01 8.1359E-01 1.1896E+02 3.7823E+00 28.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.2176E+02 3.8709E+00 28.250 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.2422E+02 3.9487E+00 28.500 3.3632E+01 1.4575E+00 1.8775E+0l 8.1360E-01 1.2638E+02 4.0170E+00 28.750 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.2828E+02 4.0770E+00 29.000 3.3632E+01 1.4575E+00 1. 8775E+01 8.1360E-01 1.2995E+02 4.1297E+00 29.250 3.3632E+01 1.4575E+00 1. 8775E+0l 8.1360E-01 1.3141E+02 4.1759E+00 29.500 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3270E+02 4.2165E+00 29.750 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3383E+02 4.2522E+00

NEDC 'O-TfRov_

Att_/- p ageAot °Z 30.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3482E+02 4.2835E+00 30.250 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3569E+02 4.3110E+00 30.500 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3646E+02 4.3351E+00 30.750 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1. 3713E+02 4.3563E+00 31.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3773E+02 4.3749E+00 31.250 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3825E+02 4.3913E+00 31.500 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3870E+02 4.4057E+00 31.750 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1. 3910E+02 4.4183E+00 32.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3946E+02 4.4294E+00 32.250 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.3977E+02 4.4391E+00 32.500 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4004E+02 4.4476E+00 32.750 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4028E+02 4.4551E+00 33.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4049E+02 4.4617E+00 33.250 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4067E+02 4.4675E+00 33.500 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4083E+02 4.4726E+00 33.750 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4098E+02 4.4771E+00 34.000 3.3632E+01 1.4575E+00 1. 8775E+01 8.1360E-01 1. 4110E+02 4.4810E+00 34.250 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1. 4121E+02 4.4845E+00 48.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1. 4201E+02 4.5095E+00 120.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4201E+02 4.5096E+00 744.000 3.3632E+01 1.4575E+00 1.8775E+01 8.1360E-01 1.4201E+02 4.5096E+00

or71,fev Q NEDO~

AtU /page986jotZ 7J0 ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:36 Worst Two-Hour Doses Exclusion Area Boundary Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 24.0 4.2222E-01 3.3632E+01 1.4575E+00 Final Doses Low Population Zone Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 744.0 2.3567E-01 1.8775E+01 8.1360E-01 control room Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 744.0 1.4572E-01 1.4201E+02 4.5096E+00

NEDCA-taO)'RevL/ 7 Page:-HI ofH4_

Att/ pageZ!6FotL70 Caic. No.: ALION-CAL-NPPD-3236-001 LI A AND 0 N Ticuf""t

$0190CE Rev. Number: I ATTACHMENT H Design Calculations and Analysis Review Checklist

NEOC °K°7;Rev- /

ALION Aft. -/pageL<Jwf t 701 Page: H2 ofH4__

A LI0 N Caic. No.: ALLON-CAL-NPPD-3236-00l

{

A L. I A) _Design

°N Form 3.4.2 Calculations and Analysis Review Checklist Revision: 0 Effective: 10/ 1/04 41 Rev. Number: I Document No: C ,J°PD 3 23L By j Revision R No: l Review Date: b 4-Til:)ao)A~ se- A ,,)Srs A.x 4 ~~f~4 ~~~ P4~ a4-4 QaerVJck,- ;

Criteria COmments Initials Document was prepared and forinatted consistent with governing procedure and is fMlly legible. J LZ Title of the document is consistent with contents. _

The objectives of the work arm consistent with the project objectives and are clearly described.

Any acceptance criteria identified are reasonable, _

Thse technical approach used for the analysis is clearly defined and appropriate for the stated objectives. eLb The technical basis for the analysis is either fully described or appropriately referenced.

Technical inputs am clearly defined, identified, and appropriately referenced.

Any codes, standards, and regulatory requirements are clearly defined, identified, and appropriately referenced. c)___

Any assumptions made are clearly defined and adequately justified, or flagged for fuirther verification as appropriate.

Any computer programs used are clearly identified as to name, version fl, and verification status.

NEDC" °03/Rev /

At. Z."paged6(&fLŽ7 Page._H2_of 114 Cak. No.: v -2r Re.Numb 1r

1 Desir Calculatons and Analyds Roiw Checl weeLI~i IWad3A. l on: 0 Effefedv 1lO1llJ4 4 D um to Aim-e - o-3 3Ae Revision No: Review Date:

_r1d _

Docuientwas prepared and fonated cositent with gowuning pRcedure andis fiill le bleg Tift of the documet s canseat with contents. _

The objectives ofah wic ua: conmistea withtheproject abJoctvs.

ndare clerly described.

Any acmptaamo criteria idendfled are rcasonable.

The tectnical approach ued for die anaysis is elrly defined and approptiate for tho stated olectives.

The tbnical basis fir the analysis is either fully deuirbed or Are- .

aDI 'ntitefwjire appropnamt _ f Teochical inputs am clearly defined, identifed, and appropriately Auy codks, stmdards, and regulaouy requiremts are cles.-y deingd, identified4 an aproaE refmuced.

Any assumptions ma w clearlydefinedand adequately jutified, or flaiged for fiutherverificatioa as appropnian. ___

Any co tpwgromn used am clerly idenified as to name1 version#, and verffication status __ _ _ _ _ _ _ _ __ _ _ _ _ _

Page:_H_ ofH4_

A L 10 N OCI{E"' A~o ?I~EKK*SC AltP~e&tL Calc. No.: ALIONAL-NPPD-3236-0 1 Rev. Nuwber- I Any computer programs used are appropriate for their intended use. _ _ _

The calculations/analyses are clearly presented and are consistent with the stated technical approach, design inputs, and assumptions. -___LB Where results rely on computer calculations, the work clearly references the supporting computer runs, and the input and output listinE andprovided.s e e n thw Where computer calculations are used, appropriate analysis pararnmetas are used. cLbd Analytical steps in tic analyses can be verified without recourse to..

the origiator. ei ar T ahe results presented reasonablepi are Thle conclusions presented are reasonable.i Any acceptance caiteria identified have been met. Lb3 Revision history, if applicable, clearly documents revisions. J) <f Appropriate quality reqairements, including choice of governing procedure, have beew identified. C)V6 Where appropriate, applicable construction and operating, experience, has been considered. S L Where appropriate, the specifed padts, equiipment, and processes are suitable for the required application.-d Where appropriate, specified materials are compatible with each other and the design enviromnental conditions to which thevy will be .

exposed. c o Where appropriate, adequate mnaintenance feaffires and__

reuirements are specified. .4, Where appropriate, acmesibilip and other design provisions are <> Ldt adequate forperffonnanoe of routine inaintmiance and repair., _

NEDCAftpagoev-Lz Page:_13_ofH4_

AfttL Pag aZfr-4fL?- Cale. No.: yA A L ION

.Um.OctLLM

&v. Nuibr. 1 Anty coputlr program used ane approiaW for Their intendod use.

The caculations/analyses arm clerypreaented and are consisten.

with doe stated tachniial NML&dig aud usgsamon.

uim* ______________________

Where wesulsh rely on cooputer walculaons. t work clearly referamcs tU supporting computer nm, atitba inpuLaud oulput listiny ae prvidcd.

Where computer cdculaons am ussd apprpriate analysis Analytical steps i the awyses can be verifoed witreo ourse to

& oxnat.

Tbo rmults pmsawted am reasonable.

TMcoacISaI=pmtecd e raeasomble. r Any acceptance criteia Wnfified have becamst. _

Rlvisli history, iapplifaie. cleadyr docuumueni n s.i.ons Apprmpriate quality rcuisemenh6 i;a~dlng clvoice of governing _r voceduc& Ieve been idetifed.

Whee approprina aplicable cauton and opeating erience bas bn considemd.

Whem appipriast, th specifiedpars. equipznat, and processes am suitable for fthrcqihed applicatioc.

Whee apppdat, speciied maerials are coompatble widk each oteh and the design eavimrnueatal conditiam to which tboy will be eosed.

Whm apriale, adequate mainterwo featumes and ireqmenl are SOcitled. __f Where appmpriate, aeadbity a other "aiaprviions arm _

adequate forperfrmance ofroutine waintame and repair.

NEDC 032/ RevL..

AtL /page6z.Xf-oL7 Page:_H4_ of_H4_

A L IO

£(ICE 4 O OhlStIVI" N

C Calc. No.: ALION-CANPPD-3236-OOI Rev. Number: I Where appropriate, adequate accessibility is provided to perform the in-senrice inspection required during system life.

Where appropriate, design considered radiation exposure to the public and plant personnel. _)

Where appopriate, adequate handl ingg storage, cleaning, and shipping requirements lhave been specified.

Where appropriate, adequate identification requirements have been specified.

iDCoS-°7/Rev.L/

AtLJ/ pageLofL _ Pwago:_H4.of_ 4__

ALION

!CA.Lme 1q1" Calo. No.: ALION-CA&UNP -3640 Rev. Number:

Whete approPdate, adcuat awwesibility is pLodvd to perfim the in-sewice jpoectio ieqoir d during __ . A.

Wheim approprt, deigtonsidrod riudin w tposuu lie .

4o mblic sad plaq Vesmud.

Wheeappropriate, adequate hundlin& BtomM clen*, and shipping regurenmds have bow speciiod, Where appropriate. adequate idcaifiion zequirauews have been specified. _ _ _ __.

NLS2005075, Calculation Nedc 05-031, Review of Alion Calculation ALION-CAL-NPPD-3236-001, Radiological Dose Analysis for a Fuel Handling Accident (FHA) at Cooper Nuclear Station.

Contents

Text

Title:

Description:

SUMMARY

Navigation menu

NLS2005075, Calculation Nedc 05-031, Review of Alion Calculation ALION-CAL-NPPD-3236-001, Radiological Dose Analysis for a Fuel Handling Accident (FHA) at Cooper Nuclear Station.

Text

Title:

Description:

SUMMARY

Navigation menu

Search